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Abstract
The rise of antimicrobial resistance has been identified as one of the major emerging health-
care problems of the 21st century. Microorganisms represent a great potential source of
novel chemistry needed to combat the rise of this resistance. Identifying the correspondence
between genomic regions and metabolites represents a vital step in the discovery and utili-
sation of such chemistry. One way in which this correspondence manifests is in the form of
links between genomic regions and tandem mass spectra in metabolomic data.
This thesis presents an improvement on an established method of statistically correlating
microbial genomic information with the results of metabolomic experiments, based on the
correlation of strains in a population of microorganisms. We demonstrate how this method
of correlation as currently used is adversely affected by the sizes of the objects under con-
sideration and demonstrate how we can reduce the effect of object size by standardisation.
We also demonstrate how this approach can penalise genomic regions shared by horizontal
gene transfer, giving preference to regions that are shared by inheritance. By taking into
account the evolutionary relationship between the microorganisms, we present a way of re-
ducing this bias.
Furthermore, we propose a new method of linking genomic and metabolomic data for in-
dividual microorganisms to metabolites using kernel functions to quantify their similarities.
We demonstrate how this method can be applied to both genomic and metabolomic data
individually to establish links to metabolites, and how two such models can be combined
to establish links between genomic regions and mass spectra without the intermediary of a
metabolite.
Finally, we demonstrate the complementarity of the two approaches. We also present a
principled methods of combining the scores to make use of this complementarity to capture
information only present in either one of the scores.
To evaluate the proposed models we compile two data sets. One is a database of paired
spectra and genomic regions from established databases, combined using structural anno-
tations from both databases. The other is a collection of microbial experiments, each with
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genomic and metabolomic data for a collection of strains as well as a number of validated
links between genomic regions and tandem mass spectra.
By improving existing methods, proposing new prediction models, and establishing ground
truth data sets, the results presented in this thesis can help to further explore the metabolomic
potential of microorganisms, both by facilitating the identification of links between genomic
and metabolomic data for microorganisms and by providing the research community with
much-needed benchmark data.
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Arguably one of the most important events in the history of modern medicine is the discovery
and adoption of antibiotics [1]. Many of the infectious diseases that had up to that point
been the leading causes of morbidity and mortality were suddenly no longer as much of a
threat, and the ability to manage bacterial infections paved the way for enormous advances
in surgical medicine [2].
The dawn of the so-called Age of Antibiotics is typically considered to be Alexander Flem-
ing’s fortuitous discovery of penicillin in 1928, its mass-production starting in 1942, and the
1943 discovery of streptomycin [1]. However, the documented use of antibiotics stretches
back further — arguably the first known methodical approach to drug discovery was Paul
Ehrlich’s 1904 large-scale systematic screening of compounds to discover a drug against
syphilis [1], and the purposeful use of antibiotics in ancient Egypt, Greece, and China has
been well documented [3] with evidence of the use of antimicrobials in Sudanese Nubia dat-
ing as far back as 350 CE [4, 5]. The decade between 1950 and 1960 has been termed the
golden age of antibiotic discovery [6] and saw the discovery of over half of the antibiotics in
common use today [6], but since then, the rate of discovery has slowed down significantly
with most new antibiotics being modified versions of existing ones [1]. In fact, since the
1970s only three new classes of antibiotics have reached market [7]. A brief overview of the
history of antibiotics can be found in [8].
While the theoretical potential for antimicrobial resistance (AMR) in microorganisms was
acknowledged early on it was not considered a serious problem, as the actual development
of such resistance was considered unlikely [6]. The intervening decades have shown conclu-
sively that this optimism was sadly misplaced [9]. Already by the 1950s penicillin resistance
was becoming a problem, and the emergence of methicillin-resistant Staphylococcus aureus
(MRSA) in the mid-1960s and of vancomycin resistance in strains of coagulase-negative
staphylococci in the early 1980s demonstrated that in general, microorganisms seemed to
rapidly develop resistance to new antibiotics [9].
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The ease with which microorganisms seem to develop resistance to antibiotics, coupled with
the lack of new antibiotics, has lead the World Health Organisation (WHO) to label AMR
as one of the top 10 global public health threats facing humanity [10, 11], with 10 million
annual deaths projected by 2050 due to AMR [12]. The emergence of multi-drug or pan-drug
resistant bacteria threatens to undermine many of the most significant medical advances of
the last century, not only with regards to infectious diseases but also major surgeries, organ
transplants and chemotherapy [13], as well as already putting a considerable economic strain
on the healthcare systems of the world [9]. The need for new antimicrobial drugs is therefore
great.
Microorganisms achieve resistance to antimicrobials in various ways: by limiting the uptake
of the drug, by modifying or protecting the target, or by active efflux, i.e. actively pushing the
molecules out of the organism [14, 15]. This resistance can be acquired in several ways: by
overexpression or duplication of existing genes, by point mutations, insertions or deletions,
or by acquiring genetic material from other microbes in the environment in a process known
as horizontal gene transfer (HGT) [15].
Antimicrobial drugs can be broadly split into three categories: natural, semi-synthetic (based
on natural molecules) and synthetic [16, 17]. Of these, the class of natural drugs is by far the
largest, with 70% of commercially available antibiotics from microbial sources [7]. Although
novel approaches are being developed for drug lead research [18], the so-called microbial
specialised metabolites remains a rich source of antimicrobial drugs, both in pre-clinical and
clinical stages [19, 20].
Microbial specialised metabolites (also known as secondary metabolites) are the compounds
that a microorganism produces that are not strictly necessary for the survival of the organism
but may confer an evolutionary advantage [21]. These include various molecules that the
microorganism uses to affect its environment, including pigments, signalling molecules, and
compounds with bactericidal activity [22, 23]. Specialised metabolites have for a long time
been extremely important both for medical and industrial applications [24, 25]. For example,
the majority of drugs are so-called small-molecule drugs (with a molecular weight less than
900 Dalton) and the majority of small-molecule drugs are either specialised metabolites (e.g.
the anticancer drug paclitaxel), derived from specialised metabolites (e.g. the antibacterial
drug tigecyclin), or inspired by specialised metabolites (e.g. the antiparasitic drug chloro-
quine) [26, 27]. A large number of these are of microbial origin, and in general, microbial
specialised metabolism has been a great source of useful novel chemistry [25, 27].
In the last few years, research into microbial specialised metabolism has experienced a resur-
gence [23, 28]. Interest in the field declined sharply in the 90s, brought about by the diffi-
culties of doing untargeted metabolomics, such as high rediscovery rates and low throughput
of available methodologies [23]. Recently, however, advances in genomics, and in particular
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advances in the prediction of metabolite-producing genomic regions, have brought about the
realisation that researchers have still only scratched the surface of the metabolomic poten-
tial of microorganisms [23]. Recent research shows that it is common for the the microbial
genome to contain a large number of metabolite-producing regions than are either not ex-
pressed at all, only expressed under specific conditions, or expressed at such a low level
that when doing metabolomic analysis, the signal from the resulting metabolites is drowned
out by metabolites that are produced in greater abundance. Such regions are called cryptic
[29]. For instance, while many strains of Streptomyces contain between 25 and 50 poten-
tially metabolite-producing regions, about 90% of these are cryptic under normal laboratory
growth conditions [23]. A variety of methods exist to activate such cryptic regions, including
heterologous expression, where the relevant region is inserted into a host microorganism, or
promoter engineering [30, 31, 32].
The realisation that microorganisms have greater metabolomic potential than previously
thought, along with the fact that most antibiotics in use today are of microbial origin in
one way or another, has raised hopes of finding novel antibiotics among the metabolites that
microorganisms either produce or could produce under the right conditions. However, map-
ping the correspondence between the genomic space, where the prediction of the producing
region takes place, and the metabolomic space is still a laborious process. A priori, any one
of the producing regions of the genome could be responsible for any one of the metabolites,
giving a number of potential links that grows combinatorially with the number of genomic
regions and the number of metabolites. For example, a microorganism that has 10 regions
that might be producing secondary metabolites, and produces 10 distinct molecules, yields
100 potential links between a genomic region and a metabolite. Since many microorganisms
are prolific producers of secondary metabolites, and have a potentially even higher number
of genomic regions that are predicted to produce specialised metabolites, verifying each link
by laboratory methods is obviously untenable. Instead, we would like to be able to prioritise
the potential links for verification.
One way of approaching this problem is to develop methods to assign scores to these po-
tential links and use the score to prioritise the links for further research in laboratories, for
instance by heterologous expression or promoter engineering [30, 31, 32]. This prioritisa-
tion can take the form of either pairing regions producing novel metabolites with their cor-
responding data points in the metabolomics results, or identifying regions homologous (i.e.
structurally similar and with a shared ancestry) to known regions and metabolites, thereby
reducing the number of possibilities for the remaining regions and metabolites by a process
of elimination.
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1.1 Thesis statement
Current methods to rank potential links between genomic and metabolomic features in mi-
crobial data sets can be improved by the application of both statistical approaches and ma-
chine learning approaches. However, unified methodology and data sets are required to
evaluate such methods and quantify improvements. Furthermore, different approaches to the
problem are complementary, and combining them in a principled manner outperforms their
separate application.
1.2 Thesis structure
This thesis consists of seven chapters. Following the introductory Chapter 1, Chapter 2 intro-
duces necessary terminology and background, both in microbial genomics and metabolomics,
with a particular focus on mass spectrometry. Chapter 3 describes how the results of sub-
sequent chapters will be evaluated and the problems involved in obtaining ground truth data
for such experiments. Furthermore, it describes the creation of the data sets used in the
subsequent chapters and how they will be used to evaluate the models proposed.
Chapters 4 and 5 discuss each one of the two major approaches to the problem of linking
metabolite-producing regions in microorganisms to their associated metabolites. Chapter 4
describes two improvements on a commonly-used statistical method while Chapter 5 intro-
duces a novel method to link microbial metabolomic and genomic data using kernel methods.
Chapter 6 demonstrates how the two approaches described in the preceding chapters com-
plement one another, and suggests how this complementarity can be used in a principled
manner. The thesis concludes with Chapter 7, where the results presented in the preceding




The study of the molecules that are formed as a part of the metabolism of an organism is
known as metabolomics [33]. As mentioned in the previous section, microorganisms have
historically been a rich source of compounds with a variety of uses. Commonly known as
metabolites or natural products, these molecules are usually classified into primary metabo-
lites, which are the metabolites involved in normal growth, development, and reproduction of
the organism, and specialised metabolites, also referred to as secondary metabolites, which
are all other metabolites that the organism produces. As such, any compounds that the or-
ganism uses to change its environment, interact with other organisms or affect its appearance
(e.g. via pigmentation) is a secondary metabolite.
In order to biosynthesize these microbial metabolites, knowing how the production takes
place is of great value, since knowing this allows for potentially greater control of the syn-
thesis. This control can be via altering expression levels, either upregulating the expression
of the metabolite of interest or downregulating others, changing fundamentally the expres-
sion of the metabolite by e.g. inserting enhancer domains in the vicinity, or by transplanting
the genomic region to other organisms where the expression can be controlled to a greater
degree.
Figuring out which genomic region is responsible for the production of which metabolite can
therefore play a key part in making use of the metabolite.
2.1 Metabolomics
2.1.1 Mass spectrometry
Given a chemical sample, for instance a sample of microorganisms that have been cultured
in a plate and the metabolites extracted using an organic solvent, one of the primary ap-
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Figure 2.1: The relationship between microbial genomics and metabolomics. Biosyn-
thetic gene clusters (BGCs) in microbial genomes are predicted, and clustered into gene
cluster families (GCFs), containing BGCs from one or more strains. GCFs can also be con-
sidered as the set of strains contributing BGCs to the GCF. Identical MS2 spectra are iden-
tified across microbial samples and further clustered into molecular families (MFs). Spectra
or MFs can also be considered sets of strains where the spectrum, or any spectrum in the
MF, is observed in the sample for the strain. Feature-based linking, discussed in Chapter 5,
can be used to link BGCs and spectra links, while correlation-based linking, discussed in
Chapter 4, can be used to link GCFs to either MFs or spectra.
proaches to analysing the metabolite contents of the sample to figure out which molecules
are present is mass spectrometry (MS) [34]. In principle, mass spectrometry involves impos-
ing an electric charge on the molecules in the sample, which allows the researcher to measure
the mass-to-charge ratio (m/z) of the molecule, i.e. the ratio between the atomic mass of the
molecule and the electric charge that it carries [34].
The first instrument to make such measurements was built by J. J. Thomson in 1910 and soon
proved a valuable tool in chemical analysis. To gain more structural information about the
molecules, tandem mass spectrometry (MS2, MS/MS) was introduced in 1966. This involves
two separate MS steps separated by a fragmentation step which breaks the molecules into
component parts. The first step separates the molecules into classes by their m/z, after which
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the molecules are fragmented and the fragments for each class sorted by their m/z. For a
subset of the ionisable molecules in the original sample, this yields a fragmentation spectrum
of m/z peaks which can serve to characterise the molecule. Various approaches exist to
choose the m/z ranges of molecules that get fragmented, which are discussed in the next
section. MS2 is currently one of the most common profiling tools in metabolomics [35]. An
overview of the history of mass spectrometry can be found in [36].
2.1.2 LC-MS2
When multiple metabolites are ionised at the same time, the most abundant or the most easily
ionisable metabolite can overwhelm the capacity of the ionisation source, meaning that less
abundant or less easily ionisable metabolites do not get ionised and thus are not analysed
by the mass spectrometer [37, 38]. To overcome this problem, known as ion suppression, a
common first step in mass spectrometry-based metabolomics is separation of the metabolites
in the input sample by the way of chromatography [35, 38, 37]. Usually, this is done by either
liquid chromatography (LC) or gas chromatography (GC) although other methods exist [35].
Both LC and GC operate on the same principle: the sample is passed through a medium
(column) which lets the molecules through at different speeds, so different metabolites come
out of the column, or elute, at different times. The time at which a metabolite comes out of
the column is known as retention time.
After passing through the column, the metabolites are ionised. When using LC, this is most
commonly done using electrospray ionisation (ESI) although other methods are also possible
[35, 38]. This usually involves adding a proton to or removing a proton from the molecule,
although other charged particles can also be added or removed [39]. The molecule, after the
change, is called an adduct. This addition affects the mass of the metabolite, so instead of
measuring the m/z of the original metabolite the mass spectrometer measures the m/z of the
adduct. This means that identical molecules can present as having more than one m/z, where
each m/z corresponds to a different type of adduct, i.e. a different ion being added or removed
[39]. Molecules containing different isotopes of atoms, i.e. atoms that have the same number
of protons but a different number of neutrons, also present as different m/z peaks, where the
difference in m/z corresponds to the difference in neutrons between the isotopes.
Metabolomics experiments are can be either untargeted or targeted. Targeted metabolomics
aim to measure one or more known metabolites in a sample, and thus focus on particular,
pre-calculated m/z values, while in untargeted metabolomics, all ions in a given m/z range
are subject to analysis [40]. As targeted metabolomics focuses on known metabolites, the
remainder of this section is concerned with untargeted metabolomics.
For untargeted metabolomics using tandem mass spectrometry, data are collected using ei-
ther data-dependent acquisition (DDA) or data-independent acquisition (DIA) [41, 42]. In
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LC-MS2 using DDA, an initial mass spectrometry step (MS1) is performed at intervals,
analysing the material eluting from the LC column at the time of the scan [41]. The m/z of
the metabolites is measured, giving an intensity signal along the m/z axis where the intensity
corresponds to the the number of molecules at each m/z value. This signal is then processed
into peaks corresponding to particular m/z values [43], i.e. a collection of pairs of m/z- and
intensity values. The most relevant peaks — according to some heuristic, usually intensity
[44, 45, 46] — are selected for fragmentation and subsequent mass spectrometry scan (MS2),
which happens before the next MS1 scan of material currently eluting from the column [41].
The selected ions are called precursor ions or parent ions [38].
The most common algorithm for choosing which MS1 peaks to fragment involves fragment-
ing the n peaks of highest intensity in the last scan, where the number of peaks n, which is
constant throughout the experiment, is set to ensure that the last MS2 step finishes before
the next MS1 scan is scheduled to start [47]. This choice of peaks is normally also sub-
ject to some further criteria, intended to ensure for instance that the same metabolite is not
immediately fragmented again [42].
The ions corresponding to each selected m/z value from the MS1 step are sent through a
fragmentation step individually per selected m/z value. This fragmentation step normally
takes the form of collision-activated decomposition (CAD, also known as collision-induced
dissociation [CID]) [34]. This breaks chemical bonds in the metabolite and results in a so-
called product ion and a neutral fragment, where the former retains the charge from the
parent ion. The fragmentation can occur in various places on the metabolite, depending on
the metabolite, and the product ions can fragment again into a new product ion and a neutral
fragment. Only the product ions from this process are analysed in the subsequent MS2 step
[34].
The product ions resulting from the fragmentation step are then each subject to another MS
scan, which similarly to the first step sorts the ions from the fragmentation of each precursor
ion by their m/z value, giving intensity values along the m/z axis. As is the case with the MS1
data, the intensity data along the m/z axis in the MS2 scan is converted into pairs of intensity
and m/z values.
Once all the chosen ions have been sent through the MS2 step in this way, another MS1 scan
is performed on the material currently eluting from the LC column, and the process repeated.
DIA is an alternative data acquisition mode to DDA. Unlike with DDA, instead of selecting
specific narrow m/z ranges to fragment based on particular ions, either all ions in particu-
lar m/z ranges are fragmented or all ions at once (known as all ions fragmentation [AIF]).
Therefore, DIA results in MS2 spectra that each may contain peaks from multiple ions in a
particular m/z range. Further processing (deconvolution) is needed to extract the spectra for
individual precursor ions from the combined spectra [41, 38].
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There is a trade-off between the two data acquisition modes: while DIA captures all ions,
within a pre-determined range, the calculations needed to extract the individual spectra are
far from trivial and involve a considerable degree of uncertainty [41, 38]. Conversely, while
DDA involves choosing which ions to fragment and generally does not fragment all the ions
in the sample, the fragmentation spectra from DDA are generally from individual metabo-
lites and can be used without further processing [41], although this is not always the case.
However, the choice of ions to fragment in DDA is still an unsolved problem, and the choice
of ions can be improved considerably [48].
The intensity signal along the retention time axis is influenced by the amount of material that
elutes from the column and by how easily it ionises. [37, 34] Ideally, only one metabolite
elutes from the column at a time, with the intensity signal along the retention time axis form-
ing a chromatographic peak [37]. However, this is not always the case as several metabolites
can elute from the column at the same time, even metabolites with similar molecular weight,
which might then get fragmented together.
The final LC-MS2 data can be considered as consisting of MS1 data and MS2 data. The
MS1 data takes the form of a collection of triads of retention time, m/z, and intensity of the
ions in the sample (parent ions). The MS2 data, which exists for a subset of the triads in the
MS1 data, consists of a collection of tuples of m/z and intensity values for the fragments of
the corresponding data point in the MS1 signal [49, 50].
As retention time can vary greatly between experiments, based on conditions, standards and
instruments, differences in retention time are difficult to interpret except in specific circum-
stances, such as when analysing multiple samples using the same instrumentation, or when
analysing samples containing known metabolites, which can then be used to compensate for
the difference in retention time [34, 51]. The data normally used for analysis of MS2 spectra
are the triads composed of precursor m/z, fragment m/z and fragment intensity.
In general, there are a number of reasons why a metabolite can be present in a sample with
no corresponding MS2 spectrum [42]. Firstly, the mass spectrometer only measures ionised
metabolites, so if the ionisation step fails to ionise a particular metabolite, it does not get
analysed. As different ionisation methods have their strengths and weaknesses, the particular
ionisation method used can affect the output [34].
Secondly, using DDA only a subset of the peaks detected in the MS1 data get fragmented [44,
45, 46]. Although algorithms exist to try to select the most informative peaks to fragment,
based on the peaks previously fragmented, this may lead to metabolites missing from the
data. This can happen not only when different metabolites elute from the LC column at the
same time, and therefore enter the mass spectrometer at the same time, but also if the mass
spectrometer fails to identify MS1 peaks with similar m/z in consecutive MS1 scans as the
same metabolite and fragments them again, at the cost of not fragmenting other precursor
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ions.
Another reason for a metabolite not being analysed by the mass spectrometer is because
the metabolite is overwhelmed by another metabolite that is eluting at a similar time. This
can be either because it is expressed in a far greater abundance, or because it is more easily
ionised. The result is the same in both cases: only, or overwhelmingly, the abundant or easily
ionised metabolite gets ionised, and thus the rarer or less easily ionised metabolite does not
get analysed by the mass spectrometer [52, 34].
Another problem is when two or more molecules are fragmented in a single MS2 scan,
creating a chimeric spectrum [53]. This can happen when two molecules that elute from the
LC column at the same time have a similar m/z, since although the MS1 peak that is chosen
to fragment has a particular m/z value, in fact all ions in a particular m/z range around that
value are fragmented [53].
The collision energy used to fragment the molecules can also impact the resulting spectra
[54]. The same metabolite fragmented at different energy levels can yield very different
spectra because of difference in how the metabolite fragments at different energy levels.
Although the set of potential m/z values will generally be the same, representing all the pos-
sible ways in which the molecule can fragment, the peaks can have very different intensities
depending on the collision energy, resulting in dissimilar spectra.
For a more thorough review of common problems in MS2 analysis of metabolites, the reader
is referred to [55].
Ideally, this process would yield MS2 spectra for most or all of the metabolites in the sample,
although in reality this is dependent on abundance and ionisation potential. Furthermore, as
discussed earlier, the selection of ions to fragment is still not an adequately solved problem,
and current methods have in fact been demonstrated to be sub-optimal [48]. To finally iden-
tify the metabolites in the sample, curated databases of MS2 spectra for known compounds
[38], such as MassBank [56] or METLIN [57], are searched for spectra similar to the ones
in the sample.
Similarity between MS2 spectra is usually calculated using cosine similarity [58]. To cal-
culate the cosine similarity between two spectra, the spectra are first aligned, i.e. matching
peaks between the two spectra are identified. If n peaks are matched between the two spec-
tra, the intensities of those peaks form an n-dimensional vector for each spectrum, and the




In natural product research, where many of the metabolites may be unknown, it can be use-
ful to identify metabolites from different microbial strains that are identical or analogous,
regardless of whether they are previously known. This can be done using molecular net-
working [51, 59, 60], which clusters the spectra across strains based on their similarity.
The key idea of molecular networking is to take the spectra for a given population of strains
and cluster them such that analogous metabolites belong to the same cluster. The clusters
resulting from the molecular networking are called molecular families (MF).
Various pipelines exist to perform molecular networking [51, 59, 60]. Two of the most
popular are referred to as feature-based molecular networking (FBMN) [51] and classical
molecular networking [59].
Both pipelines start by creating consensus spectra for precursor ions that are considered
to correspond to the same metabolite. FBMN does this using MS1 data, by aligning the
chromatographic peaks using exclusively MS1 data [51]. Retention time and MS1 ion m/z
are used to cluster the MS1 ions into peak sets, where the peak sets represent the distinct ions
in the experiment. For each peak set, a representative MS2 spectrum is chosen from among
the available MS2 spectra for the peaks in the set, if any are available. This means that a
metabolite in a particular sample can belong to a peak set, with a consensus spectrum, even
if it was not fragmented in that sample, based exclusively on the MS1 data.
In contrast, classical molecular networking operates exclusively on MS2 data [59]. The
pairwise cosine similarity between spectra is computed, and spectra that are very similar are
deemed to be from the same metabolite. A consensus spectrum is then created by averaging
the peak intensities over all of the spectra for the metabolite. This means that any metabolite
that did not get fragmented in a particular sample is excluded from further analysis.
After establishing this set of distinct ions in the experiment for which MS2 is available, both
pipelines proceed in the same fashion [51, 59]. The consensus spectra form a fully-connected
graph, with edge weights set to a modified version of the cosine similarity between the nodes
of the edge.
The goal of this modified cosine similarity [22] is to ensure that spectra for metabolites that
differ by the addition or removal of a substructure are regarded as similar, given a simple
model of the fragmentation of the metabolites, where the only effect of the fragmentation is
to break the bonds in the molecule. This is done by allowing the peaks in either one of the
spectra to shift by the difference in m/z between the precursor ions. After matching the peaks
from both the un-shifted and shifted spectra, the final peak matches are chosen so that each
peak is only matched once. The final result is that an MF can contain spectra with a range of
parent ion m/z, potentially corresponding to different analogues of the metabolite.
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The fully-connected graph is then pruned by removing edges with weights below a thresh-
old value, and further by iteratively removing the lowest-scoring edges from the connected
components of the graph until they fulfil a size criterion. The connected components of the
graph are then taken to be the molecular families.
Molecular networking can be used to guide the identification of unidentified metabolites
which belong to the same MF as known metabolites. This approach was used by Atencio and
co-workers in [61] to identify two previously unknown molecules, dibromoalterochromides
D/D’, by their inclusion in an MF of bromoalterochromides. It has also been successfully
used for dereplication [62, 63], i.e. the identification of known metabolites in a sample, by
the inclusion of known metabolites in the molecular network. Finally, the composition of
molecular families from related microbial strains can be used to statistically identify regions
in their genome that may encode the production of the metabolite. This approach was used
by Duncan and co-workers in [63] to identify the metabolite retimycin A and the BGC that
encodes its production.
A discussion of the various uses of molecular networking can be found in [60].
FBMN has two main advantages over classical molecular networking. The first advantage
is that it is less dependent on the data acquisition algorithm, i.e. the particular choice of
ions to fragment at the MS1 stage, because it is enough for an ion to be fragmented in one
of the samples in the experiment for a viable MF with a consensus spectrum to form for
that ion. For instance, if a particular MS1 feature (i.e. a chromatographic peak and an m/z
peak) appears in samples from three strains, but a corresponding MS2 feature appears in
only two of them, meaning that the MS1 peak was only chosen for fragmentation in two of
the samples, a consensus spectrum will be created using the two MS2 measurements, but all
the MS1 ions belong to the peak set, so the consensus spectrum will be extended to all three
strains. This means that the peak set — and by extension the MF — can contain ions that
were detected in the MS1 scan but not fragmented. This makes the method less sensitive to
the particular selection of ions from the MS1 scan for fragmenting.
Another advantage of FBMN is that using retention time, it is in some cases possible to
distinguish between metabolites that have the same MS2 spectrum, e.g. stereoisomers [51].
If there is a difference in retention time between the isomers they will form two distinct
consensus spectra, although as MS2 spectra do not distinguish between stereoisomers, the
consensus spectra themselves will be very similar and thus end up in the same MF.
One drawback of FBMN is that as the clustering of the precursor ions is done using exclu-
sively MS1 data, this will lead to the method missing identical metabolites with significant
difference in the parent ion m/z, e.g. different adducts, and forming separate peak sets for
the different types of adducts. These would, however, belong to the same MF.
Another drawback is that as the creation of consensus spectra is done using exclusively MS1
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data, i.e. retention time and parent ion m/z, ions that happen to have the same retention time
and parent ion m/z will be grouped together, regardless of how similar their MS2 spectra are.
This can present a problem if two distinct metabolites have similar retention time and m/z,
which is a possibility, particularly depending on the resolution of the MS1 scan [55].
A final drawback of FBMN, compared to classical molecular networking, is that the former
is more likely to be affected by differences in experimental conditions or by batch effects
and instrument settings, as these can influence MS1 measurements [51].
Both classical molecular networking and FBMN are currently integrated into the public
Global Natural Products Social (GNPS) pipeline [64] which is further discussed in Section
3.6. The state of the art molecular networking pipeline is FBMN, but as it is quite a recent
development, the microbial data sets considered in this paper have mostly been processed
with classical molecular networking. However, both algorithms produce similar outputs: a
collection of spectra, assumed to be from identical or closely related molecules, represented
as tuples of m/z and intensity values, and the m/z of the precursor ion, along with a list
indicating in which samples each spectrum was found.
2.2 Microbial genomics
As previously mentioned, since specialised metabolism is the part of the metabolism of an or-
ganism that is not strictly speaking necessary for survival, the specialised metabolites include
various metabolites that the organism uses to affect its environment to confer an evolutionary
advantage, including signalling molecules, pigments and molecules to kill other organisms.
While many species produce interesting and useful molecules as a part of their specialised
metabolism, microbial specialised metabolites are of particular interest. This is mainly due
to two things: firstly, microorganisms are extremely prolific producers of secondary metabo-
lites, with many actinomycetes containing 20–50 regions thought to produce secondary
metabolites [23]. Secondly, in microorganisms, all the genetic information for the produc-
tion of a particular microbial secondary metabolite is usually in one place in the genome,
making the relevant portions of the genome easier to detect and investigate [65].
Microbial secondary metabolism is in most cases controlled by biosynthetic gene clusters
(BGCs), which are contiguous regions of adjacent genes which together encode for the pro-
duction of a single molecule or a family of related molecules [66, 67]. This means that in
most cases, everything that is needed for both the production and the control of expression
of a molecule, i.e. the control of whether the molecule is produced at all or not, and in what
quantity, are located in the same place in the genome [68]. This again makes microbial BGCs
easier to analyse and affect than if they were spread over the genome, with remote parts of
the genome interacting to affect the expression of the final product [65].
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Metabolites, and by extension the BGCs that encode for their production, are sorted into nat-
ural product classes based on their properties and how they are synthesised. Three of these
classes, nonribosomal peptides (NRPs), polyketides (PKs), and ribosomally synthetised and
post-translationally modified peptides (RiPPs), have the distinction of lending themselves
more readily than others, such as alkaloids an terpenes, to predicting the molecular structure
of the resulting product. In the case of NRPs and PKs, this is because they are principally
formed from preexisting modules by assembly line-like enzymes, while RiPPs are formed
from so-called precursor peptides whose structure can in some cases be predicted from BGCs
[69, 70, 71]. The availability of tools to predict metabolite structure for BGCs is therefore
not the same for different natural product classes, with tools to predict metabolomic features
for the so-called modular or multi-modular natural products most developed [71], i.e. for
the metabolites where the assembly can to a large extent be seen as combining pre-defined
parts with minimal post-translational alterations. These natural product classes include NRPs
and PKs. Often, the differentiation of secondary metabolites by class is not clear-cut, and
products can be classified as hybrids of more than one type, for instance NRP-PK hybrids.
2.2.1 BGC prediction
The resurgent interest in microbial specialised metabolites is to a large extent due to improve-
ments in genomic sequencing, such as improved coverage and increased read length, along
with advances in assembly, and subsequent identification and prediction of microbial BGCs.
When the first complete genomic sequences of the genus Streptomyces became available, in
2002–2003, it became clear that the microorganisms had the potential to produce roughly 10
times the number of specialised metabolites that were known from fermentation studies, i.e.
studies in which the bacterial colonies were grown and then subjected to chemical analysis.
This large number of cryptic BGCs demonstrated that only a part of the metabolomic poten-
tial of each microorganism was already known, whether this is because the cryptic BGCs are
not expressed at all, or only expressed at a low level, and thus drowned out by more abundant
metabolites in the analysis [23, 72].
In the intervening years, the detection of BGCs has evolved into a fairly mature discipline.
Tools such as antiSMASH [73], PRISM [74] and SMURF [75] have emerged as a standard
for BGC detection in microorganisms and fungi. All of these tools are based on matching
curated statistical models based on sequences of protein family domains (Pfam domains) to
genomic sequences [76], and as they are explicitly modelled on known examples they tend
to exhibit high specificity (low number of false positives) at the expense of relatively low
sensitivity (high number of false negatives).
While BGC detection has traditionally been done using manually curated, rule-based logic
to detect tell-tale composition of Pfam domains indicating the presence of a BGC, Hannigan
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and co-workers recently introduced DeepBGC [77], which uses a text-mining-based recur-
rent neural network to detect BGCs from the Pfam data. However, all of the approaches,
including DeepBGC, rely on detecting Pfam domains in genomic sequences by the align-
ment of hidden Markov models (HMMs).
The main advantage of DeepBGC over antiSMASH is the detection of novel BGCs, and
BGCs less related to known ones. As such, DeepBGC is likely to have a higher rate of
false positives than traditional, arguably more conservative, approaches, such as taken by
antiSMASH.
Other more speculative algorithms exist to try to increase the sensitivity, such as Clus-
terFinder [78], MIDDAS-M [79] and MIPS-GC [80]. In recent versions, antiSMASH has
incorporated ClusterFinder as an alternative prediction strategy.
For an in-depth review of BGC detection, the reader is referred to [81].
In our work with microbial data sets, we have restricted our research to BGCs detected
by antiSMASH. There are three reasons for this. Firstly, the methods presented here are in
principle independent of the tool used for BGC detection. Secondly, as parts of this work rely
heavily on clustering BGCs into GCFs, and the only major tool to do this, BiG-SCAPE, does
not accept PRISM or DeepBGC output at the moment, only a limited part of the results could
be tested on other BGC detection approaches in any case. Lastly, as the MIBiG-GNPS data
set (discussed in Section 3.6) is not dependent on antiSMASH-detected BGCs, evaluation
on that data set ensures that we already have some method of evaluating our performance
independent of antiSMASH.
2.2.2 BGC similarity evaluation and clustering
When working with multiple BGCs, often from multiple microbial strains, grouping them
together into gene cluster families (GCFs) can be useful [82]. GCFs are defined as groups of
BGCs such that that BGCs belonging to the same GCF produce the same or similar metabo-
lites [82]. To be able to cluster BGCs, the space of BGCs must first be associated with
some sort of similarity function, i.e. a real-valued function which accepts two BGCs as ar-
guments and returns their similarity, the assumption being that similar BGCs encode similar
metabolites.
Various similarity measures have been proposed for BGCs [83, 84, 82], but no clear con-
sensus has been established yet. This is largely because measuring the performance of such
functions is very difficult.
The clustering of BGCs builds upon early work by Lin and co-workers [83] on clustering
homologous BGCs. They defined their distance function largely based on the decomposition
of the BGC into Pfam domains, based on the Pfam database [85]. The entries in the Pfam
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database are each a family of proteins, composed of functional regions called domains, along
with multiple sequence alignments and HMMs, which are aligned to a sequence to evaluate
its similarity to the Pfam domains.
The use of Pfam domains as building blocks for BGCs is a common thread in later work as
well. Most similarity measures that have been proposed use the Pfam domain composition
of the BGCs to a greater or lesser extent, although some also incorporate sequence similarity,
either directly, as in [82], or by including the output scores of sequence alignment algorithms,
as in [84]. Additionally, many similarity functions encode more complex features of the Pfam
composition of the BGCs in various ways, e.g. accounting for duplications and ordering
[82, 84, 83].
When defining similarity or distance functions in this way, it is not automatically clear if the
resulting functions satisfy various conditions making them e.g. metrics or kernel functions.
This applies in particular to the sequence similarity measures, both raw and alignment score
based. This restricts the choice of machine learning approaches applied to the problem, un-
less extra steps are taken to make sure the similarity measures fulfill the necessary conditions
for e.g. a kernel function. A notable exception from this is the recently-published pfam2vec
algorithm [86], which projects BGCs into a shared latent space, where the appropriate choice
of function on the latent space, combined with the function projecting the BGC into the la-
tent space, can ensure that the combined function defined on the space of BGCs satisfies the
desired conditions.
Once a similarity function has been defined, the BGCs can be clustered into GCFs. Various
clustering algorithms have been used for this purpose: Lin and co-workers [83] used the
distance-based neighbourhood-joining clustering method [87], Doroghazi and co-workers
[84] used DBSCAN [88], while BiG-SCAPE [82] uses affinity propagation [89] for clus-
tering. All of these approaches are to a greater or lesser extent influenced by one or more
manually-tuned parameter affecting cluster size or number of clusters, which are in this con-
text closely related, if not downright equivalent.
The state-of-the-art tool for BGC clustering is BiG-SCAPE [82]. Another recently-developed
tool in the same vein is BiG-SLICE [90], which exhibits superior computational performance
on large data sets but at the cost of decreased accuracy. In fact, the authors of BiG-SLICE
recommend that BiG-SCAPE be used for more granular analysis of GCFs of interest, in ad-
dition to BiG-SLICE [90]. Since the data sets considered in this thesis are small enough that
the running time of BiG-SCAPE does not pose a problem, we choose to do all GCF analysis
using BiG-SCAPE.
When clustering BGCs, BiG-SCAPE restricts cluster members to a single natural product
class, and in fact uses a different similarity measure depending on the class. The assign-
ment of BGC to natural product class is based on the antiSMASH annotations for the BGC.
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However, BiG-SCAPE does not specifically cover all natural product classes assigned by
antiSMASH. Instead, it classifies BGCs into NRPS, type I PKS, other PKS, PKS-NRP hy-
brid, RiPP, Terpene, Saccharide, and Other. To accommodate hybrid natural product classes,
BGCs that are assigned as hybrids get clustered along with each of the hybridised types,
i.e. NRPS-PKS hybrids get clustered three times: once as NRPS, once as PKS, and once as
NRPS-PKS hybrids.
One of the key features of BiG-SCAPE is their particular definition of a similarity measure
on the space of BGCs. While many definitions of the similarity between BGCs exist, as
described earlier, the BiG-SCAPE definition of similarity is unique in that the component
weights vary by natural product class.
The BiG-SCAPE metric is composed of three components: Jaccard index (quantifying the
overlap in Pfam domain composition), adjacency index (quantifying the difference in order in
which pairs of Pfam domains occur) and direct sequence similarity (quantifying the sequence
similarity between matched Pfam domains). The final similarity measure is a weighted com-
bination of these terms, with different weights defined for each natural product class. For
instance, similarity between RiPP BGCs is computed using all three components, while for
NRPs, the BGC similarity is computed exclusively in terms of sequence similarity for the
shared domains. This is because adenylation domain specificity, i.e. which amino acids are
incorporated into the final product, which is a key characteristic of NRPs, is not captured by
any of the other component metrics.
In addition, BiG-SCAPE can be made to cluster all BGCs together, as a special product class
called ‘mix’. In this mode, the same coefficients are used for all comparisons, both within
class and between classes.
Although only recently released, BiG-SCAPE has already been used for example by Männle
and co-workers to assess the diversity of BGCs in Nocardia, and to identify the BGCs in
Nocardia producing distinct structural types of nocobactin-like siderophores [91], as well as
by Soldatou and co-workers to putatively identify the BGCs encoding for the production of
ectoine and chloramphenicol in polar actinomycetes [92].
2.3 Linking genomic and metabolomic data
As previously stated, the combinatorial nature of the problem means that the number of
potential links to be evaluated increases quadratically with the number of BGCs and MS2
spectra. Tools to aid in the prioritisation of the potential links are therefore indispensable to
be able to focus verification efforts on the most likely links. Three recent reviews on linking
genomic and metabolomic data are [93], [71], and [94].
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Efforts to link genomic and metabolomic information for microorganisms can be broadly
split into two approaches: feature-based linking, where predicted molecular features from
the BGC are used to search the MS2 spectra for tell-tale signs of the predicted features, and
correlation-based linking, where correspondences between BGC content and metabolomic
output in multiple microbial strains are analysed to determine how likely they are to be
connected.
Although the most concrete relationship is between a BGC and the spectrum of the metabo-
lite encoded by that BGC in the MS2 results for that particular strain, the links thus defined
generalise to GCFs and MFs as well. Since all BGCs in a GCF are assumed to encode for
the production of the same or similar metabolites, and all spectra in an MF are assumed to
arise from the same or similar metabolites, BGC-MS2 links generalise in a natural way to
GCF-MF links, and vice versa. This also applies to links between GCFs and spectra, and
BGCs and MFs.
2.3.1 Feature-based linking
At its root, feature based linking involves predicting some aspect of a metabolite from a BGC
and then searching a set of MS2 spectra for signs corresponding to the molecular feature. A
number of tools exists that can be used to this effect, although their integration into the
metabolomics and genomics workflows is of a varying depth.
Some tools encompass the whole pipeline, taking genomic- and MS2 data as input and estab-
lishing links between BGCs in the genome and spectra in the MS2 data. Notably, MetaMiner
[95] predicts the structure of RiPPs from genomic sequences and searches a set of spectra
for corresponding features, while NRPquest [96] does the same for NRPs. Pep2path [97]
predicts sequences of losses for peptidic natural products (i.e. NRPs and RiPPs) and looks
for corresponding peaks and losses in MS2 spectra, while GNP [69] aims to link NRPs and
PKs to LC-MS2 data.
Other tools are not as integrated, predicting various structural properties of the metabolites
but leaving the interpretation of how these will appear in MS2 spectra to the researcher.
SANDPUMA ([98]) predicts substrate specificity for adenylation domains in NRPS BGCs,
which makes it possible to looks for peaks or neutral losses indicative of the corresponding
amino acids in the MS2 data. RODEO [99] predicts metabolomic features of RiPPs but is
not yet integrated with MS2 data. Similar approaches, i.e. predicting features of a metabolite
from a BGC and looking for corresponding features in metabolites are described by Panter,
Krug and Müller [100] for PKs.
This process, of explicitly predicting features of peptidic metabolites (i.e. PKs, NRPs and
RiPPs) from genomic data and looking for corresponding features in MS2 spectra, has been
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termed peptidogenomics [101].
Some of these tools, such as GNP [69], do their own BGC detection, while others, such as
MetaMiner [95] incorporate antiSMASH [73] for BGC detection.
The recently-published PRISM4 [102] incorporates structural predictions for a wide variety
of natural product classes. This is an improvement from previous versions, since PRISM
has historically mostly focused on NRPs and PKs. These structural predictions can be used
to search the set of spectra from the data set for the best match, either by in silico MS2
fragmentation of the metabolite, or by using methods such as IOKR (see Section 5.5).
With the exception of PRISM4, all of the tools mentioned above are restricted to particular
natural product class by design. While this is reasonable, as particularly PKs and NRPs
are both diverse and historically important, matching spectra to BGCs one natural product
class at a time can become problematic, if the same spectrum is assigned to different BGCs
belonging to different natural product classes. In those cases, the strength of evidence for
each match would have to be evaluated against the other matches. Such comparison is not
straightforward.
Tools primarily developed for dereplication, i.e. using structural information, rather than
spectral similarity, to identify various spectra as belonging a particular metabolite, can also
be used to link BGCs and metabolites. Tools such as DEREPLICATOR [103] have been
used to predict possible fragmentation patterns of a metabolite, which can then be matched
to spectra in a sample. Based on similarity of a microbial BGC to a BGC with a known
product, this approach has been used to tentatively link a novel BGC to its resulting spectrum,
even for an unknown metabolite, based on the structural similarity of the metabolite to a
known metabolite [104]. In this case the workflow involves using DEREPLICATOR to link
a spectrum to a spectrum from a known metabolite, using MIBiG [66] or similar databases
to find the BGC producing the known metabolite, and then searching the microbial BGCs
for the BGCs most similar to the reference BGC.
2.3.2 Correlation-based linking
When working with samples from multiple strains it can be useful to consider each MS2
spectrum (or MF) as the set of strains where the spectrum (or any spectrum from the MF)
occurs in the results for that strain [63, 84, 92]. This allows the comparison of strains based
on metabolomic similarity, by looking at how they co-occur in these sets. In the same way,
GCFs can be considered as the set of strains which have a BGC in the GCF.
Since microbial specialised metabolites are generally produced by BGCs, if a BGC is respon-
sible for the production of a metabolite, then microorganisms that contain the BGC — or,
equivalently, contain a BGC in the corresponding GCF — should be more likely to produce
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the metabolite than microorganisms that do not contain the BGC. In other words, consider-
ing the set of strains from the GCF and the set of strains from the MF, the intersection of the
two should be larger than expected if the two were not related.
This is the fundamental idea behind the correlation-based linking approach, where whole
populations of microorganisms are analysed for similarities in the patterns of presence and
absence of BGCs and spectra. Building upon the early work of Lin and co-workers [83] clus-
tering homologous BGCs, Doroghazi and co-workers presented a scoring function for poten-
tial links based on the shared strain contents of GCFs and MFs, coining the term metabologe-
nomics for the approach [84, 105]. Their scoring function is based on the intersection and
differences of the sets of strains in the GCFs and the MF, rewarding correspondence between
the two and penalising differences. Although in principle similar to genome-wide associa-
tion studies (GWAS) [106, 107], this is done asymmetrically, to reflect the fact that a strain
that contains a BGC does not necessarily produce the resulting metabolite in any measurable
quantity, if the BGC is cryptic, while strains should only be able to produce the metabolites
for which they have a corresponding BGC [84]. This scoring function is discussed in detail
in Section 4.2.
2.3.3 Combined linking
Although two different approaches exist to the problem of linking BGCs to spectra, they
are highly complementary and are indeed often used together [93]. Clustering BGCs can be
used to infer previously established feature-based matches onto other members of the cluster,
and conversely, shared predicted properties of BGCs can give indications of what features to
search for in the metabolomic data.
While the two approaches are generally used together, no attempt has been made at system-
atically quantifying the extent to which they complement one another, nor has any principled
investigation been done into how to best make use of their complementarity. This is dis-
cussed in detail in Chapter 6.
The relationship between BGCs, GCFs, MS2 spectra and MFs, and the different linking
approaches, is shown in Fig. 2.1. For detailed reviews of linking microbial specialised





The following chapter is concerned with how the performance of methods to link BGCs and
MS2 spectra are evaluated. Sections 3.2 and 3.3 discuss how such approaches are commonly
evaluated, while Section 3.4 gives an overview of common metrics for information retrieval
tasks and how they relate to the problem at hand. Section 3.4 also explains how performance
evaluation will be carried out throughout the thesis.
To evaluate the models proposed in this thesis two data sets are compiled: Section 3.6 de-
scribes the construction of a database of BGC-spectrum links, while Section 3.7 describes
the assembly of three microbial data sets with several validated GCF-MF links.
3.2 Establishing ground truth
A major problem in the development of methods to link BGCs to MS2 spectra is the lack
of ground truth data [108, 38]. Although large databases exist of both MS2 spectra and
microbial BGCs [109, 64, 67], databases of MS2 spectra with their associated BGCs or vice
versa are small and hard to come by. Furthermore, although many validated BGC-MS2 links
exist in the literature, resources to gather the information in a single place, along with their
associated genomic and metabolomic data sets, have been scarce.
While the NPAtlas database [110] contains links to MIBiG and GNPS for a subset of entries,
this is a considerably smaller subset than the one presented in Section 3.6, containing roughly
180 metabolite-spectrum pairs.
In any data set consisting of a population of strains, a number of BGCs per strain, and a
number of MS2 spectra, there will as previously stated be a vast number of potential links
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between a BGC and a spectrum. A very small number of the potential links will be true,
meaning that the BGC encodes for the production of the metabolite to which the spectrum
corresponds. Furthermore, in any given strain, not all BGCs present in the strain are nec-
essarily expressed, particularly not in such quantity that the product appears in the MS2
analysis. This also depends on the growth conditions, as some BGCs are only expressed in
certain situations, e.g. as a reaction to some sort of external stimulus. Finally, as discussed in
section 2.1.2, the metabolite may be present in the sample but not analysed by the MS2, for
instance if it does not ionise, if it comes through the LC column at the same time as a much
higher-concentration or more easily ionisable metabolite, or if the data acquisition workflow
does not choose that particular precursor ion to fragment.
From the above, it follows that if a strain has a BGC in a GCF that is in fact responsible for a
particular metabolite, it is perfectly possible that the strain does not appear in the correspond-
ing molecular family. Conversely, some of the spectra in a microbial sample may belong to
either contaminants or primary metabolites, although depending on solvent choice, these
will be much rarer than the spectra belonging to specialised metabolites [111, 112]. These
spectra are not likely to be produced by any of the detected BGCs.
Even among the relatively few potential BGC-spectrum links that are in fact true, fewer
still have actually been validated for any data set. For any of the data sets from microbial
cultures, we therefore have a very small subset of true links within a very large subset of
potential links. Of these true links, only an even smaller subset has been validated.
Furthermore, knowing when the whole set of true links has been discovered is almost impos-
sible, unless either all BGCs or all spectra (or both) have been accounted for. This is a tall
order, especially in microbes with a rich secondary metabolism: any cryptic BGCs would
have to be identified to a high degree of certainty using genomic methods, and all spectra
that do not have a validated link to a BGC would have to be matched to a library spectrum
with very high similarity.
3.3 Current approaches to evaluation
As may be expected for an emerging field of study, no benchmark data sets for microbial
BGCs and spectra have yet been compiled. By benchmark data sets we mean data sets with
thoroughly validated links, ideally where all true links in the data set have been identified,
and with as extensive annotations as possible. Once adopted by the research community, such
data sets can be used to evaluate performance differences between different approaches.
This lack of benchmark data sets makes comparison of results from different research articles
difficult. As the methods in many cases only have partial overlap, for instance because
they are designed to work for different natural product classes, this is to some extent to be
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expected. However, the sharing of experimental data has been lacklustre as well. The recent
development of the Paired omics Data Platform [108], discussed further in Section 3.8,
stands to remedy this latter point by making data sets easier to access, but the adoption of the
platform is in the hands of the research community, and the problem remains of comparison
between approaches with different but overlapping domains.
Traditionally, most articles presenting new ways of establishing links between BGCs and
MS2 spectra demonstrate the utility of the proposed method by applying it to a microbial
data set, finding a potential link, and validating the link. In this way, Kersten and co-workers
introduced natural product peptidogenomics and used it to identify the BGC in Strepto-
myces griseus IFO 13350 encoding the known ribosomal peptide AmfS [101]. Panter, Krug
and Muller introduced a novel statistical approach to identify the BGC in Myxococcus ful-
vus MCy9280 encoding the production of fulvuthiacene, which they verified by inactivating
the BGC [100], and Johnston and co-workers introduced the Genomes-to-Natural Products
platform (GNP), which they used to identify six genetically predicted metabolites in various
microorganisms.
While this serves to demonstrate the validity of the methods, they are not generally compared
to one another in terms of performance on a data set containing previously validated links.
Correlation-based approaches are not tied to particular natural product class and should
therefore be somewhat easier to compare than feature-based approaches. To validate both
their BGC clustering algorithm and their scoring scheme in [84], Doroghazi and co-workers
assembled a microbial data set of MS2 spectra and predicted BGCs, for which they had sev-
eral previously validated links. They then demonstrated that the validated links scored high
within the distribution of all potential links in the data set.
To demonstrate the validity of their clustering approach in [82], Navarro-Muñoz and co-
workers took a similar approach, by assembling a (different) microbial data set, with a set of 9
validated BGC-MS2 links, and demonstrating that a large proportion of these links appeared
in the top end of the distribution of scores for all potential links. They also evaluated the
clustering algorithm on a manually-curated set of clusters in a database of BGCs.
Easy access to such paired data sets of genomic and metabolomic information, along with a
thoroughly annotated set of validated links, as provided by the Paired omics Data Platform
[108], is crucial to be able to compare novel methods to existing ones.
3.4 Evaluating ranking results
Assume that we have an information retrieval model which returns from a set of documents
a subset of results which are either relevant or not. We denote the number of true positives,
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i.e. number of relevant results in the result set, as TP , and the number of false positives, i.e.
the number of non-relevant results in the result set, as FP .
The problem of ranking BGC-MS2 links can be formulated as an information retrieval task
in the following way. Given a BGC (query), we want to search a set of spectra (documents)
for the spectra for the metabolite or metabolites encoded by the BGC (relevant documents).
Precision (P ), recall (R) and Fβ , which are all commonly used to evaluate information re-













where β2 controls the trade-off between precision and recall in the evaluation of the model.
Most commonly, the Fβ measure is balanced, with β2 = 1.
However, none of these scores are particularly well suited to the problem at hand. For most
BGCs, there is a single correct spectrum, or at most very few, so unless the result set is very
small, precision will always be fairly low. For example, if there is a single correct spectrum
for a given BGC, a result set of size 2 would never give precision higher than 0.5 for that
query. Recall would be less of a problem, as that does not penalise false positives in the
result set, and for Fβ , the parameter β could be chosen > 1, to skew the Fβ score towards
weighing recall higher than precision, but the question still remains what a good number of
results would be, i.e. the appropriate size of the result set.
A common performance measure for ranking lists of results, which is not dependent on a










where rank(i) is the rank of the best-ranking true match for the i-th query, i.e. MRR is the
mean of the inverse of the rank of the best-ranked true match.













is the average precision of the q-th query, with K as the set of all documents, Kq ⊆ K the
set of relevant documents for the q-th query, rel(k) as an indicator function returning 1 if
document k is relevant, and 0 otherwise, and P (k) as the precision at index k, as defined in
Eq. 3.1.
In cases where there is only ever one correct result, as is frequently the case in our situation,
MAP simplifies to MRR: for each query q, the indicator function rel(k) is 0 except exactly
for the relevant document, so the product P (k)rel(k) is non-zero only once, and the value of
k for which rel(k) = 1 is the rank of the correct match.
Following [113], for evaluating IOKR performance, we generally use top-n performance.
For the problem of ranking a list with a single correct match, this measures for what propor-
tion of cases the correct match is among the top n entries on the list, i.e.
top-n(Q) =
#{q ∈ Q | rank(q) ≤ n}
#Q
. (3.7)













A perfect ranking, which always ranks the correct match highest, would have an AUC of
1, while a random ranking would have an AUC of 0.5. Put differently, the AUC is the area
under the curve formed by plotting n (x-axis) against the top-n performance (y-axis). In this
way, a top-1 performance of 100% would give an AUC of 1.0.
Assuming one-to-one correspondence between the objects and the candidate set, i.e. each
query object has exactly one match in the candidate set, an AUC of 0.5 corresponds to ran-
dom assignment. Assume that the ranking is randomly ordered, and the number of candidates
is N . For k < N , the proportion of query objects that have the correct match among the k
highest-ranking assignments is therefore k
N
. The AUC is then






























The last term tends to 0 as N →∞, so the AUC tends to 1
2
with increasing N .
The above can also be demonstrated in terms of expected values. Taking N to be the number
of candidate objects, andM to be the number of query objects, the expected number of query
objects x with the correct match ranked at i (denoted here as rank(x) = i) is











. We have therefore







































































When calculating the AUC, the summation is done over the number of candidates in the
candidate set. Of course, the top-n value is not informative for values of n larger than the
size of the candidate set, so in order for the AUC calculations to be valid, they must all be
done in relation to the same candidate set. In order to calculate the top-n AUC for different





In this formulation, the n in top-n is replaced by r, with r ∈ [0, 1], giving
top-r(Q) =
#{q ∈ Q | rrank(q) ≤ r}
#Q
(3.27)
and we can define rAUC similarly to AUC, with the summation as before, but with the
caveat that the intervals along the x-axis will no longer have equal length. Equivalently, we





For Nq = N , where all the candidate sets are identical, this simplifies to AUC as defined in
Eqs. 3.8 and 3.9.
For a candidate set N and BGC set Q, we can express the AUC differently, by doing the
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summation along the x-axis instead of the y-axis, i.e. summing over the size of the candidate
set first and then the proportion of the queries, instead of summing first over the proportion
of the queries and then the size of the candidate set, as in Eq. 3.8.
Taking δrank(b),i to be the Kronecker delta function returning one when rank(b) = i and zero




















= #M − rank(b) (3.31)
where the first term on the right hand side of Eq. 3.29 sums to zero because i < rank(b), and
in the second term, i = rank(b) is true exactly once for every value of n.




























































Considered thus, the AUC ends up being the complement of the average relative rank taken
over all BGCs, i.e. one minus the average relative rank.
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While a BGC will occasionally have a number of associated metabolites, we choose to look
at the rank of the top associated metabolite for our top-n calculations. In that way, the top-n
AUC is similar to the MRR, which only considers the top-ranked match for each query.
As demonstrated above, AUC is the complement of the average relative rank, while MRR
is the average of the reciprocal of the rank. While the two are closely related, they are

















so for the two scores to be in agreement for any two models, we would need a + b < c + d








to hold. As a counterexample, set a = 100, b = 1, c = 50 and




, but 101 > 100.
In particular AUC is sensitive to changes in performance only relative to the magnitude of the
change, while MRR is also sensitive to the ranking itself, with the changes in good rankings
having a higher effect than changes in bad rankings, i.e. if a BGC changes rank from one
to two, it affects the MRR much more than a change from 101 to 102, while both affect the
AUC in the same way.
For an overview of performance evaluation for information retrieval tasks, the reader is re-
ferred to [114].
3.5 Creating data sets for evaluation
The remainder of this Section is dedicated to compiling the data sets needed to evaluate the
approaches proposed in the following chapters, as well as to explain how this performance
evaluation will be carried out.
The data used to validate the approaches proposed in this thesis take two forms. The first
is a library of BGC-spectrum pairs, compiled from databases of BGCs and MS2 spectra
without regards to source strain, by using molecular structures. This was created by merging
two databases, one of BGCs and the other of MS2 spectra, using the molecular structure
annotations from both to establish the links.
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The other is a collection of microbial data sets, each with genomic information, MS2 spectra,
and a small number of experimentally validated links. While numerous such data sets exist,
it is only with the recent development of the Paired omics Data Platform [108] that these data
sets, and in particular the validated links, have become easily accessible. The metabolomic
and genomic data sets from the platform, along with the validated links, can be used indi-
vidually or in combinations to investigate the ratio of validated links to the total number of
links in various subsets of the potential links.
3.6 The MIBiG-GNPS data set
One way to evaluate the performance of link scoring functions is using a set of validated
BGC-spectrum pairs, irrespective of the rest of the BGCs in the genome and the spectra from
the experiment. While this is only useful for feature-based scoring functions, this provides
us with a much larger set of validated links than would be available for a data set of microbial
strains.
Several databases of microbial BGCs exist. In particular, three databases are currently ac-
tively maintained and growing: MIBiG, IMG-ABC and antiSMASH DB [115]. MIBiG
[66, 67] contains exclusively known, experimentally validated BGCs with known metabo-
lites and detailed, high-quality annotations. In contrast, both IMG-ABC and antiSMASH
DB contain a large number of computationally predicted BGC, as well as validated ones.
Of the three, MIBiG is therefore best suited to serve as a source of ground truth. Since its
release in 2015, it has become the primary repository of characterised microbial BGCs and
currently contains roughly 2000 community-curated BGCs, with extensive metadata.
The MIBiG database is integrated into many BGC analysis tools. Notably, both antiSMASH
and BiG-SCAPE use MIBiG to characterise the similarity of detected BGCs and GCFs,
respectively, to BGCs with known metabolites.
As a part of the analysis of each detected BGC, antiSMASH computes the similarity of the
detected BGC to all entries in MIBiG, in terms of the BLAST [116] score of the component
Pfam domains, and returns for each BGC a (possibly empty) list of MIBiG BGCs showing
considerable similarity. Assuming that similar BGCs produce similar metabolites, this list
can be used to assign zero or more metabolites to the detected BGC, depending on how many
MIBiG-matches are reported.
To assign MIBiG matches to GCFs, BiG-SCAPE can include the entries from the MIBiG
database in its input of BGCs to cluster, thus assigning the associated metabolites for the
MIBiG BGC to the GCF in which they are placed.
Although MIBiG contains structural annotations for a large majority of its entries, it does
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not contain MS2 spectra for the entries. While tools exist to predict MS2 spectra in silico
[117], such tools are generally intended to find the correct metabolite for a given spectrum
from a set of candidate metabolites, by simulating the fragmentation of the metabolite and
matching the predicted spectra to the input spectrum. This means that given a metabolite,
the spectrum that these tools predict cannot necessarily be taken as an indicator of what a
spectrum for the metabolite would look like in reality, but only that enough of the features of
the spectrum are similar to the actual spectrum such that the distance between the predicted
and actual spectrum is the least distance among the candidates.
While these in silico fragmentation tools could nevertheless be used to find putative matches
for the predicted BGC structures, by taking an entire database of MS2 spectra as a candidate
set, we prefer the higher accuracy afforded by the fact that databases of MS2 spectra also
have structural annotations. These annotations can be matched to the structural annotations
in MIBiG, and used to link the MIBiG BGCs to the manually curated MS2 spectra.
Two databases in particular exist for MS2 data, MetaboLights and the Global Natural Prod-
ucts Social (GNPS) [115]. Both serve as repositories for MS2 results from microbial data
sets, where researchers can upload their data. In addition, GNPS has a curated subset of
spectra with known structural annotations, and is the largest freely available such library.
The GNPS database was introduced in 2016 [64] and is focused on the community-sharing
of MS2 data. It contains 147647 spectra (as of March 2020), 77102 of which have structural
annotations.
The structural annotations of the entries from the MIBiG and GNPS databases were used to
link the two. MIBiG contains structural annotations as SMILES strings [118], and GNPS
variously as SMILES or InChI [119]. This presents two problems. Since SMILES strings
are not uniquely determined (i.e. the same molecule can be represented by multiple valid
SMILES strings) they cannot be used for comparison without further processing. Secondly,
both SMILES and InChI contain information about molecular properties such as chirality,
which would not be visible in MS2 analysis, and should therefore be ignored in the matching.
InChIKey [119] is a fingerprint representation of a molecule, in the form of a set of hashes
based on the molecular structure. It is split up into two blocks, where the first block encodes
information about the molecular skeleton of the metabolite, while the second block encodes
various types of isomerism [120]. Therefore, metabolites with identical first block, and
differing second block, would be expected to have identical or very similar spectra, while
metabolites that have different first block of the InChIKey would be unlikely to have identical
spectra. For an investigation into the collision resistance of InChIKey, please see [120].
Since InChI and SMILES are really two ways of encoding the same information, the InChIKey
of a metabolite can be computed from either SMILES or InChI representation. Only the first
block of the InChIKey of each entry was used to link the MIBiG and GNPS databases, since
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molecules sharing the first block are not expected to be distinguishable from one another
using MS2 spectra. For each entry of either database, the InChIKey was computed, and each
entry from the MIBiG database paired with all entries from the GNPS database that had a
matching first block of the InChIKey.
This resulted in 2966 BGC-spectrum pairs, where each pair has two associated structures,
one from MIBiG and the other from GNPS. In 1355 cases these structures matched com-
pletely, i.e. the entire InChIKey matched. These pairs consist of 2069 unique spectra and
242 unique BGCs, the natural product classes of which can be seen in Table 3.1. While the
NPAtlas database [110] contains links to MIBiG and GNPS for a subset of entries, this is a
considerably smaller subset than the one presented here, containing roughly 180 metabolites.
As the same BGC can produce multiple structurally related metabolites, and each metabolite
can have multiple spectra in GNPS, each MIBiG BGC can be linked to many spectra. Con-
versely, the same metabolite can be produced by multiple MIBiG BGCs, e.g. when the same
metabolite is produced by more than one strain. The relationship is therefore potentially
many-to-many.
By taking for instance a BGC, considering all potential links between the BGC and any of
the spectra, and ranking the list of those links, or vice versa, this list of validated BGC-
spectrum pairs can be used to evaluate feature-based link-scoring algorithms, by observing
the position of the validated links wihtin the collection of all potential links.















Table 3.1: Natural product classes of BGCs in the MIBiG-GNPS data set
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3.7 Microbial data sets
Microbial samples generally contain many metabolites, products of both primary and spe-
cialised metabolism. In our analysis, we are mostly interested in the spectra for secondary
metabolites. This is both because the space of secondary metabolites contains a greater
number of useful metabolites [25], and because the production of primary metabolites is
generally not encoded by BGCs [66]. However, the processing of the sample greatly affects
the results of the metabolomics analysis. In particular, the choice of solvent dictates the type
of molecules that will be analysed, since no single solvent can extract all types of metabolites
from the sample [111, 112]. Therefore, by making a judicious choice of solvent, it can be
assumed that the majority of the spectra in the MS2 data belongs to secondary metabolites,
and should therefore have a corresponding BGC.
For a population of strains with a given set of BGCs or GCFs and spectra or MFs the number
of potential links is vast. If the strains are active producers of secondary metabolites, as
many microbes are, a number of these potential links are true, meaning that the BGCs in the
GCF are responsible for the production of a metabolite in the MF.
When scoring the potential links, the ideal scoring function would rank all true links higher
than any of the other potential links. Therefore, the proportion of true links to all links in
the top quantiles of the distributions can be used to evaluate two scoring functions against
one another. Taking the number of links that have a score above a given percentile for each
scoring function, and looking at the ratio of true links to all links, should give a higher ratio
for the better-performing scoring function.
However, for any given data set, only a small subset of the true links are likely to have been
validated. Complicating matters further, the number of true links in the data set is unknown,
although a rough upper bound of the number of true links can be estimated from the number
of GCFs, since most BGCs are only responsible for the production of a single metabolite,
and the number of MFs.
Even so, looking at the proportion of validated links in the top quantiles of the distributions
of scores can be used as a measure of performance, since by increasing the proportion of
true links in the top quantiles of the distribution, we would be increasing the proportion of
validated links. In this way, we can use the small subset of validated links to evaluate the
performance of scoring functions even without knowing the set of true links.
Considering only a subset of the true links may create the illusion of a performance differ-
ence between two ideal scoring functions, by ranking the subset of validated links relatively
higher or lower within the subset of true links. This can be avoided by considering a large
enough set of potential links: if the set of high-scoring potential links used for the perfor-
mance evaluation is larger than the set of true links, then two ideal scoring functions would
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demonstrate the same performance in this metric.
3.8 Paired omics Data Platform
One of the major obstacles to the development of new computational methods to link BGCs
to metabolites is the difficulty of accessing ground truth data for performance evaluation.
Such ground truth data would ideally be in the form of paired MS2- and genomic data for a
collection of strains, along with a set of validated links between the two. Although plenty of
such paired data experiments exist [108], the data has been scattered in the various genomic
and metabolomic databases with no clear way of systematically identifying corresponding
entries. Furthermore, as no standardised way has existed to specify the correspondence
between BGCs and spectra, re-establishing the link within the data set has required consid-
erable effort.
To improve the situation, Schorn and co-workers recently developed the Paired omics Data
Platform (PoDP) [108]. The purpose of the platform is to document the location of microbial
genomic and metabolomic data sets, in particular data sets with information about BGCs
and MS2 spectra, which entries in the genomic databases correspond to which entries in the
metabolomic databases, along with information on which exact BGCs are linked to which
exact spectra or MFs. This gives ground truth data which can be used to compare both
feature-based and correlation-based scoring functions as described above.
From the PoDP, three data sets in particular were selected for evaluation: MSV000078836
[121], MSV000085018 [122] and MSV000085038 [123], hereafter referred to as the Crüse-
mann, Gross and Leão data sets, respectively. As the platform has only recently been devel-
oped, the choice of data sets was in part dictated by the presence of data on the platform, and
in part by how easily the reported BGC-spectrum links could be resolved to the genomic and
metabolomic data, i.e. if the validated links had already been entered into the platform by
the submitter.
Table 3.2 shows the sizes of the data sets obtained from the PoDP, along with the types of
links included, while Table 3.3 shows the natural product class of the validated links in each
data set, along with the BGC sizes.
3.8.1 Mapping validated links to detected BGCs
The links from the PoDP are characterised by MIBiG IDs on the genomic side, and IDs
of either individual spectra or MFs on the metabolomic side. As long as the molecular
networking data set used for the analysis is provided, resolving the metabolomic IDs to the
underlying data is a relatively simple matter.
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On the genomic side, the links are defined by BGCs in specific strains, characterised by
MIBiG IDs. After accessing the sequence for the strains, and running antiSMASH to detect
the BGCs, the problem remains to identify which of the BGCs detected by antiSMASH is
the annotated BGC from the link. This can be done in either of two ways (see Fig. 3.1):
• Using BiG-SCAPE. When BiG-SCAPE clusters the BGCs into GCFs, it can include
the MIBiG reference BGCs in the clustering. These get assigned to GCFs, and can
then be used to tag the corresponding BGCs. If a BGC from the strain is in a GCF
that includes the MIBiG entry involved in the link, then that BGC can be assumed to
correspond to the BGC associated with the link.
• Using antiSMASH known cluster BLAST. When running antiSMASH to detect BGCs,
the similarity of the detected clusters to MIBiG entries can be evaluated, by using
the so-called known cluster BLAST mode (KCB). For each MIBiG entry, this aligns
the sequence of each Pfam domain in the entry to the detected BGC using BLAST
[116], quantifying how similar the detected BGC is to the MIBiG BGC. The outcome
can be evaluated as either the cumulative BLAST score, or the average similarity for
domains in the MIBiG BGC where there is significant similarity. This can be used to
assign each detected BGC zero or more MIBiG matches, possibly with a threshold on
the score to reduce noise, and the strain involved in the link can then be searched for
BGCs that show high similarity to the MIBiG ID implicated in the link.
Using BiG-SCAPE to assign links from the PoDP to GCFs is not without risks. As BiG-
SCAPE assigns MIBiG labels by embedding the MIBiG database in the data set being pro-
cessed, and clustering the database entries along with other BGCs, each MIBiG entry be-
longs to exactly one (possibly singleton) GCF. If BiG-SCAPE happens to split a GCF in
two (for instance because of a bad choice of parameters for the clustering algorithm) only
one of the GCFs gets tagged by the MIBiG entry. This can be seen in action for instance
in the Crüsemann data set, where antiSMASH identifies far more BGCs as having signifi-
cant homology to MIBiG ID BGC0000827 (staurosporine) than BiG-SCAPE places in the
corresponding GCF. This holds true for all cutoff values tested in BiG-SCAPE, indicating a
potential discrepancy that merits further investigation.
For GCFs associated with MIBiG IDs, antiSMASH can in fact be used as an alternative
strategy to define GCFs, by taking all BGCs that have a significant KCB hit for the MIBiG
ID to belong to the GCF. In theory, this should be equivalent to using BiG-SCAPE to cluster
the BGCs, including MIBiG BGCs, and taking the relevant GCF to be the one including the
particular MIBiG BGC.
Given a MIBiG BGC, the corresponding GCF as defined by BiG-SCAPE should contain
BGCs that are similar to each other, where similarity is evaluated using the similarity func-
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Figure 3.1: Using antiSMASH and BiG-SCAPE to tag GCFs and BGCs. Strain 1 contains
BGCs 1 and 3, while Strain 2 contains BGCs 2, 4 and 5. BiG-SCAPE clusters BGCs 1 and
2 into a GCF, 3 and 4 into another GCF, and BGC 5 into a GCF of its own. antiSMASH
tags BGC 1 as similar to MIBiG 1 and 2, and BGC 2 as similar to MIBiG 1 and 3. BGCs
1 and 2 can be assembled into a GCF corresponding to MIBiG 1 by either considering the
inclusion of MIBiG 1 in the GCF by BiG-SCAPE, or the fact that antiSMASH annotates
both as similar to MIBiG 1.
tion defined by BiG-SCAPE. Let ∼ denote similarity relation between BGCs, i.e. we say
that a and b are similar if a ∼ b. If we assume that the similarity relation is transitive, i.e.
a ∼ b and b ∼ c implies a ∼ c for BGCs a, b, and c, then all of the BGCs in the GCF are
similar to the MIBiG BGC.1 This is exactly the condition that would be used to define the
corresponding GCF using antiSMASH, albeit using a different similarity function, so assum-
ing the similarity functions used by BiG-SCAPE and antiSMASH show similar behaviour,
the resulting GCFs should generally be identical.
However, as described previously, this is not always the case.
When BiG-SCAPE clusters BGCs, it does so separately for each natural product class, as
described in Section 2.2.2. When dealing with BGCs that do not have an unambiguously
assigned natural product class, such as hybrid PK-NRP BGCs, they are classified three times:
once as PK, once as NRP and once as hybrid. After clustering, identical GCFs resulting
from different product classes are removed, so that a given BGC of the “PKS-NRP Hybrid”
product class can belong variously to one, two or three GCFs.
For instance, the MIBiG ID BGC0000137 has a validated link against two MFs in the Crüse-
mann data set. Two BGCs from the relevant strain show considerable homology to the
1Obviously this is not generally true if we consider for instance similarities as inverse distances in Rn, with
a ∼ b if the similarity exceeds a given threshold. By considering a, b and c as points on a line in Rn, it is
easy to envision a case where a ∼ b, b ∼ c but a 6∼ c. However, in our case we can justify this assumption by
observing that the space of metabolites is discrete, and we are trying to cluster things that are relatively similar,
i.e. in general we expect the intra-cluster similarity to be much higher than the inter-cluster similarity. We can
therefore define the relation ∼ in such a way that the transitivity holds.
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Crüsemann Leão Gross
ID MSV000078836 MSV000085038 MSV000085018
Strains 118 4 7
Links 8 5 9
Type of links BGC-MF BGC-spectrum BGC-MF
BGCs 3316 147 131
BGCs w. structure 2242 57 83
GCFs 454 110 120
GCFs w. structure 323 54 77
Spectra 6246 173 9593
MFs 3094 90 6518
Table 3.2: Size and properties of the microbial data sets. A subset of BGCs are assigned
molecular structures using antiSMASH, and correspondingly a subset of GCFs are are as-
signed molecular structures from their BGCs.
MIBiG BGC, according to antiSMASH. As BGC0000137 belongs PKS-NRP Hybrid natu-
ral product class, each of these gets clustered in three different natural product classes. After
merging identical GCFs, one of the BGCs ends up in three GCFs, while the other one ends
up in two. The result is five distinct GCFs being linked to two distinct MFs, for a total of 10
validated links.
3.8.2 Extending validated links with similarity matching
For many applications, especially for prioritising potential links for verification, similarity
searches have been used: a spectrum that closely resembles that of a known metabolite in
a database, and a BGC that has a high similarity to a BGC that is known to produce the
metabolite from the database, are assumed to be linked [124, 125, 61]. This would present a
way of expanding the set of validated links in the microbial data sets.
However, since there is no way of knowing how exhaustive the coverage of the set of val-
idated links is, and in particular no way of knowing if all true links have been discovered,
adding the similarity-based links to the set of validated links would not change the fact that
the only method of comparison between two link ranking approaches would be the relative
enrichment of validated samples in the top quantiles. Expanding the set of validated links in
this way and would therefore not be of great value, while increasing the danger of incorrect
links being classified as validated, due to possible false positives in the similarity search. We
therefore choose to only use experimentally validated links in the subsequent work.
Crüsemann Size (nt) Type Genes
BGC0000827 24300 Alkaloid 17
BGC0000333 47477 NRP 23
BGC0000940 7328 Other 6
BGC0000241 62231 Polyketide (Other), Saccharide (hybrid/tailoring) 58
BGC0001228 37781 NRP (Cyclic depsipeptide) 23
BGC0000137 91573 Polyketide 39
BGC0001830 64171 Polyketide 23
Leão Size (nt) Type Genes
BGC0001165 87427 NRP, Polyketide (other) 14
BGC0000962 40156 NRP, Polyketide (other) 12
BGC0001000 41964 NRP (Other lipopeptide), Polyketide (other) 8
BGC0001001 69900 NRP, Polyketide (other) 26
BGC0001560 28792 NRP, Polyketide 12
Gross Size (nt) Type Genes
BGC0000632 16122 Terpene, Saccharide 13
BGC0001381 210303 Polyketide 102
BGC0001842 42814 NRP (other lipopeptide) 7
BGC0000463 43207 NRP (other lipopeptide) 4
BGC0001116 57999 NRP, Polyketide 18
BGC0000399 47020 NRP (cyclic depsipeptide) 17
BGC0000296 66086 NRP 28
BGC0001298 41001 Polyketide 9
Table 3.3: Natural product classes of the validated links in the microbial data sets.
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Figure 3.2: Assigning structures to BGCs and spectra. As well as describing the an-
notation of the data set discussed in Section 3.7, this diagram shows the processing of the
data discussed in subsequent chapters. Black arrows indicate processing of data, red arrows
indicate assignment of molecular structures to objects, and blue arrows indicate scoring func-
tions. Structures are assigned to BGCs from MIBiG entries using antiSMASH, and to MS2
spectra using PoDP, while GCFs inherit their structures from their component BGCs and
MFs from their component MS2 spectra. The scoring functions σcorr and σIOKR are discussed
further in Chapters 4 and 5.
3.9 Summary
In this section, we have defined the two types of data sets that will be used for the verification
of the methods presented in this thesis, and discussed how these data sets will be used to
evaluate the performance of the proposed methods.
We have created a new data set of BGC-spectrum links by joining the MIBiG and GNPS
databases, using annotations of molecular structure present in both databases. This gives us
a set of thoroughly validated links, albeit without the context of strain information.
Finally, using the PoDP, we have collected a set of three microbial experiments, each con-
taining genomic and metabolomic results for a different population of strains, along with





If an organism produces a particular specialised metabolite, the production of the metabo-
lite must be somehow encoded within its genome. In particular, since microbial secondary
metabolism is most commonly controlled by BGCs, any microbe that produces a given spe-
cialised metabolite can be expected to contain a specific BGC encoding the production of
that metabolite.
This chapter is concerned with the use of patterns of metabolite production and patterns
of genomic similarities across microbial strains to establish correspondence between BGCs
and spectra. Section 4.2 introduces a common method for such correlation and discusses its
benefits and shortcomings. Two shortcomings in particular are discussed: the difficulty in
comparing correlation of different objects, and the tendency of the method to prefer BGCs
shared between strains because of common ancestry.
Section 4.3 derives the formula for calculating the statistical significance of such approaches.
The last two sections of the chapter are concerned with correcting the two problems pointed
out in Section 4.2. Section 4.4 demonstrates how standardising the strain correlation score
fixes the problem of comparing objects of different sizes, while Section 4.5 investigates the
effect of shared ancestry on the score and suggests a way to mitigate this effect.
4.2 Metabologenomics
When working with a population of (closely related) microbes, this offers a way of ranking
prospective BGC-spectrum links according to the patterns of BGC similarities on one hand,
and metabolite expression on the other: after clustering the BGCs from the strains in the
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population into GCFs, and possibly the spectra into MFs, each one can be considered as
a set of the strains making a contribution to the GCF and MF. For a given GCF-MF pair,
considerable overlap in the strain sets would constitute evidence that the GCF is responsible
for the production of the metabolite.
This approach, termed metabologenomics, has been used to good effect, for instance in [105]
to identify the metabolite tambromycin, in [63] to identify the metabolite retimycin A, and
in [126] to identify the tyrobetaine class of metabolites, and to link each of them to their
producing BGC.
As mentioned in Section 2.3.2, metabologenomics can be considered a close relative of
GWAS, which have been a mainstay of human genomics for a long time [127], and have
seen increased use in microbial research in recent years [107]. Broadly speaking, GWAS
aims to correlate patterns of genotypes to patterns of phenotoypes by presence or absence
[106]. In recent years, microbial GWAS (mGWAS) approaches have been developed to
manage problems particular to correlating phenotypes and genotypes for microbial data sets,
such as the impact of the evolutionary relationship between the strains [107]. While mG-
WAS is closely related to the problem of correlating BGCs and MS2 spectra, the asymmetry
introduced by cryptic BGCs compounds the problem. mGWAS approaches are generally
symmetrical, treating the absence of a phenotype in the presence of a genotype equivalently
to the presence of a phenotype in the absence of a genotype. This is in contrast to the de-
sired behaviour of a scoring function for BGC-MS2 links, where the absence of a spectrum
(phenotype) in the presence of a BGC (genotype) can merely imply that the BGC is cryp-
tic, and should therefore be far less harshly penalised than the presence of the spectrum in
the absence of the BGC. Since a large proportion of microbial BGCs are in fact cryptic this
severely limits the applicability of mGWAS tools to the problem of linking BGCs and MS2
spectra [23, 29, 72].
In mathematical notation, given sets of strains N , GCFs G and MFsM, each GCF and MF
can be considered as the set of strains that have a BGC in the GCF, or a spectrum in the MF,
i.e. for all GCFs G ∈ G and MFs M ∈ M, we can consider them as subsets of N , G ⊆ N
and M ⊆ N . We can then use the overlap M ∩G and the set differences G \M and M \G
to evaluate how likely it is that the GCF G is responsible for the production of the metabolite
corresponding to M . We denote the size, or cardinality, of a set M by #M .
The most common scoring function in metabologenomics is defined in [84]. For a given
GCF-MF pair, the score is calculated by starting from zero and considering each strain in
turn:
• add 10 to the score if the strain is in both the GCF and the MF,
• add 1 to the score if the strain is neither in the GCF nor the MF,
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• subtract 10 from the score if the strain is in the MF but not the GCF,
• leave the score unchanged if the strain is in the GCF but not the MF.
In subsequent discussion, we refer to this scoring function as strain correlation score or
σcorr, writing σcorr :M×G → R, where G is the set of all GCFs andM the set of all MFs.
Considering the GCF as the set G of strains that contribute a BGC to the GCF, and the MF as
the set M of strains in which a spectrum in the MF is observed, σcorr depends on #G, #M ,
the size #(M ∩ G) of their overlap, and the total size of the population, #N , as well as a
set of weights α, β, γ and δ, here set to 10, -10, 1 and 0. In mathematical notation, it can be
written as
σcorr = α#(M ∩G) + β#(M \G) + γ#(N \ (G ∪M)) + δ#(G \M). (4.1)
Leaving aside the exact choice of weights, this scoring scheme makes intuitive sense. It
highly rewards overlap in the strain set, severely penalises strains that produce the metabolite
but do not contribute to the GCF, slightly rewards shared absences and slightly penalises
(relatively) non-expressed BGCs.
The first two choices are fairly obvious, but other two are also sensible. In particular, shared
absence is mildly indicative that the prospective link is true, while a particular strain con-
tributing to the GCF but not the MF is not strong evidence against the link, since the BGC
might be cryptic or not strongly expressed enough to be detected in the MS2 data.
Given a population N , a GCF G and MF M , and assuming that G and M are independent,
the size of the overlap #(M∩G) follows a hypergeometric distribution with the total number
of strains #N as the population size, the size of the molecular family #M as the number
of positive cases in the population, the size of the GCF #G as the number of draws from
the population, and the size of the overlap #(M ∩G) as the number of positive cases in the
draw.
One way in which this independence assumption can be violated is if the GCF G is actually
encoding for the production of the metabolite M , in which case the overlap between the two
would be higher than expected. This is what the strain correlation score is intended to detect.
However, the strain correlation score is highly dependent upon GCF and MF sizes, as further
discussed in Section 4.4.
This independence assumption is also affected by strain phylogeny, i.e. how closely related
the strains are in evolutionary terms. If the strains are closely related, they would be expected
to have similar metabolism, and therefore show similar patterns of presence or absence in
GCFs and MFs, that is, if a strain is present or absent in a particular GCF or MF, a closely
related strain is more likely to show the same pattern of presence or absence than a distantly
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related one. The effect of strain phylogeny on the correlation score is discussed in Section
4.5.
To fix the former, we propose standardising the score to reduce the impact of the sizes of the
elements under consideration, and to fix the latter we propose taking strain phylogeny into
account when calculating the score.
The next section is dedicated to calculating the statistical significance of the strain correlation
score, while the following sections explain in greater detail our proposed solutions to each
of the problems mentioned above.
4.3 Significance tests for strain correlation scores
When working with the strain correlation scoring function for a given GCF-MF pair, a rea-
sonable question to ask is what the p-value of a given score is, i.e. what is the probability of
the pair getting assigned this score or a better one, assuming that the GCF and MF are inde-
pendent. Recall that for a population N of strains, a GCF G and an MF M with #N = n,
#M = m, #G = g and #(M ∩ G) = o, the strain correlation function σcorr is defined in
Eq. 4.1 as
σcorr(M,G) = α#(M ∩G) + β#(M \G) + γ#(N \ (M ∪G)) + δ#(G \M) (4.2)
= αo+ β(m− o) + γ(n− (m+ g − o)) + δ(g − o) (4.3)
where the weights α, β, γ and δ are set at α = 10, corresponding to the strain being in both
the GCF and the MF, β = −10, corresponding to the strain being in the MF but not the
GCF, γ = 1, corresponding to the strain being in neither the GCF nor the MF, and δ = 0,
corresponding to the strain being in the GCF but not the MF.
For the strain correlation score σcorr we can define a corresponding function σ′corr : N4 → R,
which depends on the cardinality of the sets. For a MFM ∈M and GCFG ∈ G, and setting
m = #M , g = #G, o = #(M ∩G) and n = #N , we define σ′corr as
σ′corr(m, g, n, o) = σcorr(M,G). (4.4)
By making use of the fact that given a GCF G and an MF M , the cardinalities m and g
are constant, the strain correlation score σcorr(M,G) = σ′corr(m, g, o, n) is determined by
the cardinality of the overlap o, which follows the hypergeometric distribution as previously
stated. Given an MF M and a GCF G, we can therefore define a second scoring function
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σ̂corr(o) which depends only on the overlap o. This can be used to calculate the p-value of a
given score.
Given a GCFG and an MFM , and given a value s, we want to calculate p(σcorr(M,G) > s),
assuming that M and G are independent. Since #M and #G are given, we have
p(σcorr(M,G) = s) =
∑
o∈N
p(#(M ∩G) = o)p(σ̂corr(o) = s) (4.5)
We can then calculate the probability that the score is higher than s, i.e. the p-value, by
calculating















p(#(M ∩G) = o)p(σ̂corr(o) = s). (4.8)
Since σ̂corr is completely determined by o, the expression p(σ̂corr(o) = s) is always either 1
or 0, and equals one exactly for those values of o where σ̂corr(o) = s′.
Since we assume M and G to be independent, the first factor of Eq. 4.8,
p(#(M ∩G) = o) = p(o | n,m, g), (4.9)
follows hypergeometric distribution, with the population size n, the size of the MF, m, as the
number of ‘successes’ in the population, the size of the GCF, g, as the number of draws, and
the overlap, o, as the number of ‘successes’ in the draw.
The two sums of Eq. 4.8 can therefore be taken together as
p(σcorr(M,G) > s) =
∑
o|σ̂(o)>s
p(o | m, g, n) (4.10)
where p(o | m, g, n) follows hypergeometric distribution.
To calculate the sum in Eq. 4.10 requires calculating the scores for a range of possible
overlaps, in order to determine which of them give a score higher than s. This is made
manageable by the fact that the range of values that o can take is limited by m and g, the
sizes of the MF and GCF, as well as n, the total population size. In fact, the lower bound of
o is omin = max(0, (m+ g)− n) and the upper bound of o is omax = min(m, g).
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While calculations carried out in this Section are done using σcorr as defined in Eq. 4.1, they
generalise to any scoring function that can be expressed as a function of #M , #G, #(M∩G)
and #N . In particular, the same equations can be used to calculate the significance level for
the standardised strain correlation function defined in Section 4.4, substituting σ̄corr for σcorr.
4.4 Standardising the strain correlation score
The strain correlation score is highly dependent not only on population size, but also the size
of the GCF and MF being considered at each time. This makes not only comparison between
links from different data sets difficult, but even within the same data set, comparing two links
containing GCFs and MFs of different sizes does not always yield the expected results.
Figure 4.1 (A) shows two GCF-MF pairs, where each box represents a strain in the popula-
tion, and shaded boxes indicate that the strain has a BGC in the GCF or a spectrum in the
MF. Since the pattern of strain membership for the GCF and the MF in the lower example is
exactly the same, the evidence for that link is arguably stronger than for the top link. How-
ever, the strain correlation score assigns the top link a score of 30, and the bottom link 26,
ranking the top link higher than the bottom link. In general, a link containing a large GCF
and a moderately-sized MF can easily outscore a link between a smaller GCF and MF, even
if the pattern of strain membership for the smaller GCF and MF is much more similar, and
the evidence for the link therefore much stronger.
By making use of the fact that given a GCF G and an MF M , the cardinalities m = #M and
g = #G are constant, the strain correlation score σcorr(M,G) = σ′corr(m, g, o, n) is deter-
mined by the size of the overlap o = #(M ∩ G). Assuming that M and G are independent,
o follows the hypergeometric distribution as previously stated.
For given sizes of G and M, and assuming their independence, we can therefore compute the




p(o = k)σ′corr(m, g, k, n) (4.11)
with k running over all possible values of the overlap o and where p(o = k) is the probability
of the overlap o being of size k, which follows the hypergeometric distribution as previously
stated.
The variance V ar[σcorr(M,G)] can then be computed as
V ar[σcorr(M,G)] = E[σcorr(M,G)
2]− E[σcorr(M,G)]2. (4.12)














































Figure 4.1: The effect of GCF and MF size on the strain correlation score. (A) Example
of the impact of GCF and MF sizes on link score. Each box represents a strain, with the filled
boxes indicating the presence of the strain in the GCF or MF. Using the unmodified version
of the strain correlation score, the top pair is assigned a score of 30, while the bottom pair
is assigned a score of 26. This is in contradiction to the obviously closer correspondence
between the GCF and MF in the bottom pair. (B) The expected value and variance of the
strain correlation score for varying sizes of GCF and MF, in a population of size 8, as in the
example in (A). Comparison between links involving GCFs and MFs of different sizes are
virtually meaningless, because both expected value and variance have a considerable range.
For instance, a GCF and MF of size 6 could easily get a score of 40 or higher by chance,
while for a GCF and MF of size 2, a score of 40 would be highly significant.
The expected value and variance of σcorr as a function of m and g can be seen in Figure
4.1 (B) for a population of size n = 8, as in the example in Figure 4.1 (A). Both show
considerable variation across the range, with the expected value being particularly variable
for larger GCF sizes.
To reduce the size effect on the strain correlation score, we propose a standardised strain





This has the effect of setting the expected value to 0 and the variance to 1 across the whole
domain of the function, negating the size effect of the MF and the GCF.
Taking the synthetic example in Figure 4.1 (A), we can calculate σcorr and σ̄corr for both
potential links. Let m1,m2, g1 and g2 be MF1, MF2, GCF1 and GCF2, respectively. For
both links, we have n = 8, and for the link between MF1 and GCF1 we have m = 3, g = 8
and o = 3, while for the link between MF2 and GCF2, we have m = 2, g = 2 and o = 2.
For the strain correlation score σcorr, we therefore have, by Eq. 4.3,
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σcorr(m1, g1) = 10× 3− 10× 0 + 1× 0 = 30, (4.14)
σcorr(m2, g2) = 10× 2− 10× 0 + 1× 6 = 26. (4.15)
To calculate σ̄corr(m1, g1) and σ̄corr(m2, g2), we calculate E[σ̄corr(m1, g1)], E[σ̄corr(m2, g2)],
V ar[σ̄corr(m1, g1)] and V ar[σ̄corr(m2, g2)] using Eqns. 4.11 and 4.12, giving
E[σ̄corr(m1, g1)] = 30, (4.16)
V ar[σ̄corr(m1, g1)] = 1, (4.17)
E[σ̄corr(m2, g2)] = −5.5, (4.18)
V ar[σ̄corr(m2, g2)] = 141.75. (4.19)
Using the calculated expected value and variance, by Eq. 4.13, we get
σ̄corr(m1, g1) = 0, (4.20)
σ̄corr(m2, g2) = 2.645, (4.21)
giving a higher standardised strain correlation score, σ̄corr, for the lower example in Figure
4.1 (A), as intended.
Results on a microbial data set To observe the effect of standardisation more gener-
ally, we can consider the relative abundance of verified links among all potential links for
the three data sets introduced in Section 3.7. In particular, we can pay attention to the Crüse-
mann data set, as that has the highest number of strains, which means that out of the three,
the strain correlation score gives the richest information for that data set.
An ideal scoring function would assign all true links a score higher than all incorrect links.
Failing that, in general, true links should score higher than incorrect ones. Even for an im-
perfect scoring function, since the vast majority of the potential links are incorrect, the mean
score of true links should be higher than the mean score of all links. The same should be true
for the subset of validated links. Tables 4.1 and 4.2 show the mean score of the validated
links compared to the mean score of all links within the data set for the three microbial data
sets, along with the p-value for t-test using the null hypothesis that the distributions of all
potential links, on the one hand, and validated links, on the other hand, have identical means.
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Mean σcorr all Mean σcorr valid p-value
Crüsemann 83.5144 14.6667 0.0001
Leão -1.9843 12.625 0.0001
Gross -0.7386 0.6 0.7929
Table 4.1: Mean raw correlation score for links in the microbial data sets
Mean σ̄corr all Mean σ̄corr valid p-value
Crüsemann -0.0060 3.6717 6.8302e-64
Leão -0.0218 1.4962 1.1887e-05
Gross 0.0092 1.6149 6.0056e-06
Table 4.2: Mean standardised correlation score for links in the microbial data sets
Considering first the raw strain correlation score σcorr displayed in Table 4.1, the mean score
for validated links in the Crüsemann data set is actually lower than the mean score for all
links, underscoring the impact of the size of the GCFs and MFs on the scores. While the
mean score for the validated links is higher than the mean score for all links in the other two
data sets, the difference is only statistically significant for one of the data sets.
Turning to the standardised strain correlation score σ̄corr displayed in Table 4.2, the mean
score for the validated links is significantly higher than the mean score for all links in all of
the data sets.
Another way of considering the relative performance of link scoring function is to observe
the relative enrichment of validated links in the upper percentiles of the scoring functions,
as described in Section 3.7. Table 4.3 shows the proportion of verified links compared to
all links, first among all potential links, and then filtered to links scoring above the 90th
percentile for the raw and standardised correlation scores. Figure 4.2 shows the distribution
of scores for the potential links for the three data sets, with the verified links indicated in
black below the histograms.
As can be seen in both the table and the figure, the verified links are more concentrated
towards the higher end of the distribution using the standardised strain correlation score than
Crüsemann Leão Gross
Total 1.50× 10−5 0.00086 9.96× 10−6
> 90% σcorr 6.22× 10−5 0.00266 3.48× 10−5
> 90% σ̄corr 0.00013 0.00385 7.69× 10−5
Table 4.3: Proportion of links that are validated in the whole data set, and scoring above the




Figure 4.2: Standardised vs. raw strain correlation score. Distribution of standardised and
raw strain correlation scores for the three microbial data sets. Verified links are indicated in
black below the histogram.
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the raw strain correlation score. This demonstrates how standardising the strain correlation
score makes it more useful to rank potential GCF-MF links for further verification.
4.5 Phylogenetic correction for the strain correlation
score
We now turn our attention to a more subtle property of the strain correlation score. While the
previous sections were concerned with correcting a fundamental flaw in the strain correlation
score, the impact of the evolutionary context between strains, or strain phylogeny, on the
score is not a flaw in the score itself, but rather a question of trying to emphasise links of
particular interest, that might otherwise be drowned out.
The evolutionary relationship of organisms is quantified using phylogenetics, where observed
traits of the organisms, such as genomic sequence, are used to infer the evolutionary relation
between the organisms [128, 129]. The degree of similarity between organisms is often
referred to as phylogenetic distance [129].
The two major factors involved in shared genetic traits between microbes are common ances-
try, where two microbes share an ancestor, and horizontal (or lateral) gene transfer (HGT),
where a microbe acquires a BGC from another microbe in the environment [128]. The ac-
quisition of a BGC by HGT can indicate that there is evolutionary pressure to acquire the
trait encoded by the BGC [130]. As this has been observed for BGCs responsible for e.g.
bactericidal activity or antimicrobial resistance, BGCs acquired by HGT can in some cases
be of particular interest [131, 132].
If two strains are closely related in evolutionary terms, their genomes are generally more
similar than those of more distantly related strains. This means they are more likely to share
BGCs, and therefore end up in the same GCFs. This can lead the strain correlation score to
reward GCF-spectrum links where closely related strains co-occur in the GCF.
Consider a population consisting of three strainsA,B and C, where two of the strains, A and
B, are closely related, and the third, C, has a larger phylogenetic distance from the other two.
Because of their closely-shared ancestry, A and B have in common a BGC which encodes
a particular metabolite, while C has an unique BGC which encodes a different metabolite.
For the links between the GCFs and the corresponding metabolites, the former link would
be assigned a higher strain correlation score than the latter, based mostly on the fact that two
of the strains are phylogenetically more similar than the others.
In some cases, this bias in the strain correlation score caused by phylogenetic distance could
cause the signal for BGCs shared because of common ancestry to drown out the signal for
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BGCs shared because of HGT. Since BGCs acquired by HGT may be of particular interest,
as alluded to earlier, this can potentially be a problem.
While mGWAS approaches, such as those discussed in Section 4.2 have been developed
precisely to take into account factors such as phylogeny when doing association studies of
this sort, these have limited applicability to the problem at hand in their current form because
of the asymmetry introduced by cryptic BGCs, as discussed in Sections 2.2.1 and 4.2.
By incorporating the phylogenetic distance between strains into the strain correlation score,
we hope to decrease this phylogenetic bias towards GCFs and MFs containing closely-related
strains. We propose to do this by considering the cases where two phylogenetically related
strains show the same pattern of membership with respect to a particular GCF and MF as
no more informative than if we had a single strain showing the same pattern of membership.
In doing so we construct a new, synthetic collection of strains by starting with the actual
collection of strains and, taking into account the phylogenetic relationship between them,
assigning the new, synthetic strains GCF and MF memberships according to the original
strains.
We now describe the method to generate this new synthetic data set.
In keeping with standard graph theory terminology, we consider a graph to be a tuple (V,E)
of sets, with V a set of nodes (or vertices) and E of edges, and with each edge in E con-
necting two nodes in V .1 The degree of a node is the number of edges containing that
node. A path between two nodes a and b is an ordered sequence of edges {ei}n0 , where ei
is the edge between nodes vi,0 and vi,1, where v0,0 = a, vn,1 = b, and vi,1 = vi+1,0 for
i ∈ {0, 1, . . . , n − 1}, and no edges are repeated. The distance between two nodes is the
shortest path between them.
A tree is a graph such that between any two nodes there exists exactly one path. A node in a
tree is called a leaf node if it has degree one. Two leaf nodes in a tree are siblings if they each
have an edge connecting them to the same parent node. This is equivalent to the distance
between the nodes being equal to two.
The phylogenetic relationship between multiple organisms can be expressed as a tree, where
the leaf nodes of the tree represent the organisms being analysed, and the branches of the
tree represent evolutionary divergence between them [128, 129]. In this setting, the distance
between two leaf nodes in the tree can be though of as a marker of the phylogenetic distance
between the corresponding organisms, i.e. how evolutionarily related they are relative to the
other organisms in the tree.
For an overview of phylogenetic trees in the context of natural products, the reader is referred
to [133], while a more detailed explanation of the general principles of phylogenetic tree
1The graphs considered here are undirected, i.e. the order of the tuples of nodes that make up an edge does
not matter, and we take them to be presented in the order most convenient at any given time.














Figure 4.3: Collapsing the phylogenetic tree. The strains labelled A, B and C on the initial
tree (left) have the same phenotype with regards to membership patterns in a particular GCF
and MF, as do the strains labelledD, E, F andG. On the collapsed tree (right), strainsA and
B have been collapsed into the synthetic strain γ, with the same phenotype as A and B, and
strains E, F and G have been collapsed into the synthetic strain δ by first collapsing strains
F andG, and then collapsing the resulting synthetic strain with strainE. The synthetic strain
δ has the same phenotype as strains E, F and G. Strains C and D are not collapsed, since
they do not have identical phenotype, and neither γ nor δ are further collapsed since neither
has a sibling with the same phenotype.
building can be found in [128].
To mitigate the effect of strain phylogeny, we can use the phylogenetic tree for the strains to
reduce the number of closely-related nodes with identical properties. Given a GCF G and
a MF M , a strain in the population can be said to have a certain membership pattern with
regards to its membership in G and M . For each strain, four patterns are possible: the strain
being in both G and M , neither of them, or only in one of the two.
Recall that the leaf nodes of the tree are precisely the strains in the population. To perform
the phylogenetic correction, two leaf nodes in the tree that have the same membership pattern
are collapsed into a single artificial strain having the same membership pattern as the original
strains. That strain replaces the shared parent node of the original strains, which are removed,
leaving the artificial strain as a new leaf node in the tree. This process, which we refer to
as phylogenetic collapsing, is repeated until no sibling leaf nodes in the tree have the same
membership pattern, at which point we consider the tree fully collapsed. Figure 4.3 shows
an example of collapsing the phylogenetic tree according to membership patterns.
To calculate the phylogenetically corrected strain correlation score for the (M,G) link, we
take as an updated population set N ′ the set of leaf nodes from the fully collapsed tree,
and define the updated MF M ′ and GCF G′ as the members of N ′ with the appropriate
memberships. We then proceed to calculate the standardised strain correlation score σ̄corr in
the usual fashion, but using N ′, M ′ and G′ in place of N , M and G.









Figure 4.4: Phylogenic tree of the strains in the synthetic example. The tree represents
the phylogenetic relationship between the strains with the GCF and MF memberships shown
in Table 4.4.
It should be pointed out that, as demonstrated in Section 4, the strain correlation score is
greatly affected by the population size, and the sizes of the MF and GCF being scored. As the
proposed phylogenetic correction works by altering the strain count of the population, and
therefore also the strain count of the MF and GCF, the scores before and after the correction
would not be comparable using the raw strain correlation score. Therefore, standardising
the strain correlation score, as discussed in section 4.4, is necessary to make the scores
comparable.
Synthetic example To observe the reordering of links afforded by phylogenetic cor-
rection, and the prioritising of BGCs acquired by HGT, we can take a look at a synthetic
example.
Assume eight strains, labelled A through H , with the phylogenetic tree shown in Figure 4.4.
Assume also three MFs α, β and γ, with corresponding GCFs Gα, Gβ and Gγ . The strain
membership for the MFs and GCFs is shown in Table 4.4, with Gβ being cryptic in strain G
and Gγ cryptic in strain H , i.e. the strain in the GCF but not in the MF, but the BGCs being
otherwise expressed.
Note that if the overlap between the GCF and the MF is complete, the standardised strain
correlation score is constant given the size of the population, and the value varies with pop-
ulation size due to the statistical power of the hypergeometric test. The variability in the
phylogenetically corrected score is therefore due to the different population sizes after col-
lapsing the phylogenetic tree.
We take the membership of GCF α to be purely due to homology, i.e. the shared ancestry
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A B C D E F G H
α x x x x
β x x x o x
γ x x o
Table 4.4: Strain membership of the GCFs Gα, Gβ and Gγ , and the corresponding MFs. ‘x’
denotes that the strain is a member of the GCF and the MF, while ‘o’ denotes that the strain
is only a member of the GCF, i.e. the BGC is cryptic.
Raw Standardised Phyl.corr.
α 44 α 2.6458 γ 1.7889
β 43 β 2.0494 β 1.5811
γ 25 γ 1.9720 α 1.0000
Table 4.5: Raw correlation score, standardised correlation score and phylogenetically cor-
rected correlation score for the links. The phylogenetic correction penalises the link α, as it
only occurs in phylogenetically related strains. This penalty changes the ranking of the links,
so that γ replaces α as the highest ranking link.
of strains A through D. For GCF β, the membership of strains E through H is also due to
shared ancestry, with a corresponding BGC in C due to HGT. Finally, for GCF γ, we assume
that B, F and H have all acquired the BGC through HGT from an unknown source.
While it could be argued that the plausibility of γ being in H because of HGT is perhaps at
odds with it being cryptic, the example is supposed to represent the outcome of a culture,
and the BGC may just not have been expressed under the growth conditions.
Table 4.5 shows the score of the true links in the data set (the other potential links are ranked
below the true links using all of the scoring methods). The phylogenetic correction penalises
the α link relatively, owing to the fact that it’s only present in phylogenetically related strains.
Conversely, since the γ link is not present in any of the strains most related to B, F and I , it
scores relatively higher than β, even if β is on the whole present in more strains. The ranking
of the links is therefore changed, so that γ replaces α as the highest-scoring link.
Continuing with the synthetic example, we can analyse the correlation between phylogenetic
distance and standardised strain correlation score σ̄corr using pairs of strains selected from the
population defined above. LetA andB be microbial strains,GA be the set of GCFs involving
A, and MB be the set of MFs involving B. Let σ̄corr(A,B) be the highest score of any GCF-
MF link involving a GCF from GA and a MF from MB, and d(A,B) be the phylogenetic
distance between them, calculated as path length in the phylogenetic tree. In this case, the
phylogenetic bias should manifest in a negative correlation between σ̄corr(A,B) and d(A,B),
i.e. a higher phylogenetic distance should result in a lower σ̄corr.
Table 4.6 shows the correlation coefficients for σ̄corr(A,B) and d(A,B) for all pairs of strains
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Corr.coeff. p-value
Uncorrected -0.7592 2.5771× 10−10
Corrected -0.3435 0.0157
Table 4.6: Spearman’s R for the correlation of distance between pairs of strains in the phy-
logenetic tree, and the highest scoring GCF-MF link, where one strain is a member of the
GCF and the other a member of the MF
































Figure 4.5: Correlation between phylogenetic distance and standardised strain correla-
tion score. The relationship between the phylogenetic distance and the standardised strain
correlation score without (left) and with (right) phylogenetic correction. While not remov-
ing it completely, correcting for phylogeny in the way proposed here reduces the correlation
between the two.
from the population defined above, calculating the correlation between the distance in the
phylogenetic tree and the highest score for any GCF-MF combination where one strain is
a member of the GCF and the other a member of the MF. Since the number of strains, and
number of GCFs, is very small, the distribution of the scores is far removed from the normal
distribution, so Pearson’s R is not appropriate, and calculations are done using Spearman’s R.
Figure 4.5 shows the relationship between the standardised strain correlation score without
(left) and with (right) the phylogenetic correction and the phylogenetic distance.
The phylogenetic correction greatly reduces the correlation between the two, however, it
does not remove it completely. This may be due to the uneven distribution of GCFs among
strains, the small size of the data set, or both.
Example on microbial data set To demonstrate the impact of phylogeny on link score
in real-world data, we can consider the Crüsemann data set. The data set contains several dif-
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ferent species, with a number of strains each. If the score were not affected by phylogenetic
distance, choosing a GCF and an MF at random, associated with the same species, should
yield the same distribution of scores as if the GCF and MF were associated with different
species.
Figure 4.6 shows the phylogenetic tree for the Salinispora arenicola and Salinispora pacifica
from the Crüsemann data set, generated using autoMLST [134]. The parameters used to
generate the tree can be found in Appendix A. As expected, the two exist on completely
different branches of the phylogenetic tree, so the separation of strains into S. arenicola and
S.pacifica can be used as a rough proxy for phylogenetic distance.
Using S. arenicola and S. pacifica from the Crüsemann data set as test cases, we restrict the
base sets G of GCFs and M of MFs to the sets Gare, where the GCF contains at least one
S. arenicola strain, Gpac, where the GCF contains at least one S. pacifica strain, and Mare
and Mpac where the MFs are similarly filtered. From each combination of base sets, we
choose 10000 random pairs of GCF G and MF M and calculate the strain correlation score.
Since choosing the pair from “matching” base sets, i.e. both associated with S. arenicola
or both with S. pacifica, would give a higher chance of strain overlap than choosing from
“mismatched” base sets, we impose the condition that the intersection between the MF and
the GCF is non-empty, to avoid exaggerating the bias by virtue of a non-empty intersection
between strains being more likely if both strains are selected from the same base set.
As strains belonging to the same species are more related than strains belonging to different
species, i.e. the phylogenetic distance between them is smaller, the phylogenetic bias should
result in a higher number of high-scoring links between an MF and a GCF from strains
belonging to the same species than an MF and a GCF from strains belonging to different
species.
Without correction With correction
M ∈Mpac, G ∈ Gare 0.0351 0.0459
M ∈Mare, G ∈ Gpac 0.0253 0.0408
M ∈Mpac, G ∈ Gpac 0.0803 0.0654
M ∈Mare, G ∈ Gare 0.0547 0.0479
Table 4.7: Percentage of high-scoring links associated with strains from different combina-
tions of base sets, as a proportion of all links.
To demonstrate the phylogenetic bias, we can observe Table 4.7, which shows the percentage
of links scoring above the 95th percentile of all links, broken down by the combination of
base sets. Selecting both GCF and MF from base sets associated with the same species
(rows 3 and 4) results in a considerably higher proportion of the links scoring above the 95th





















































































































Figure 4.6: Phylogenetic tree of the S. arenicola and S. pacifica strains from the Crüse-
mann data set. Strains belonging to S. arenicola are coloured red, while strains belonging
to S. pacifica are coloured blue.
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Figure 4.7: Distribution of scores for potential links broken down by base set. For com-
parison purposes, both scores are standardised to have mean zero and standard deviation one,
and only links that score above zero are considered. Without correction for phylogeny (left),
GCFs and MFs containing strains from the same base set (red and green bars) yield more
high-scoring links than from different base sets (blue and yellow bars). This difference is
reduced when correcting for strain phylogeny (right).
percentile on the raw strain correlation score (column 1) than selecting the GCF and the MF
from different base sets (rows 1 and 2).
The second column of table 4.7 shows the same statistics for the strain correlation score
after correcting for strain pylogeny. As can be seen, the bias is much less pronounced after
applying the proprosed correction.
The distribution of the scores for the sampled links, broken down by base set combinations,
is shown in Figure 4.7. Using the strain correlation score without phylogenetic correction,
choosing both strains from the same base set yields a relatively higher number of high-
scoring links compared to choosing the strains from different base sets. This difference is
reduced by applying the proposed phylogenetic correction to the score. In other words, a
high-scoring link in the uncorrected score is relatively more likely to be from matching base
sets than a high-scoring link in the corrected score.
To better quantify the impact of the phylogenetic bias, we can estimate the correlation be-
tween the strain correlation score σ̄corr and the phylogenetic distance, in a similar way as
with the synthetic example above. Letting A and B be strains, we take GA to be the set of
GCFs involving strain A, and MB to be the set of MFs involving strain B. Let σ̄corr(A,B) be
the highest score of any GCF-MF link involving a GCF from GA and a MF from MB, and
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Corr.coeff. p-value
Spearman without correction -0.5122 5.1240× 10−8
Spearman with correction -0.3147 0.0014
Pearson without correction -0.5053 8× 10−8
Pearson with correction -0.3102 0.0017
Table 4.8: Correlation coefficients between the corrected and uncorrected form of the strain
correlation score and the phylogenetic distance. The phylogenetic correction reduces both
Spearmann and Pearson correlation coefficients.






























Figure 4.8: Correlation between phylogenetic distance and strain correlation score.
Highest strain correlation score between a GCF and a MF associated with a pair of strains,
without phylogenetic correction (left) and with phylogenetic correction (right), and phyloge-
netic distance between the strains, for 100 randomly chosen strain pairs from the Crüsemann
data set. The right plot shows less correlation between the two axes than the right plot, as
demonstrated by the correlation coefficients in Table 4.8.
d(A,B) the phylogenetic distance between A and B.
As before, the phylogenetic bias should manifest in negative correlation between σ̄corr(A,B)
and d(A,B).
Figure 4.8 shows σ̄corr(A,B) with and without phylogenetic correction, plotted against d(A,B)
for 100 randomly sampled pairs ofA andB. The correlation coefficients for the for σ̄corr(A,B)
and d(A,B) can be seen in Table 4.8, with the non-phylogenetically-corrected form of the
strain correlation score in rows 1 and 3, and the phylogenetically corrected strain correla-
tion score in rows 2 and 4. While still significant, the correlation is much weaker for the
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Figure 4.9: Distribution of validated links in the distribution of scores for all potential
links. Validated links are indicated in black beneath the score histogram.
phylogenetically corrected score than for the raw score.
This demonstrates that adjusting the strain correlation score to correct for phylogenetic dis-
tance by collapsing nodes showing identical patterns of strain membership can dramatically
reduce the correlation between the phylogenetic distance and the strain correlation score.
This can serve to emphasise BGCs shared by virtue of HGT rather than inheritance, which
might otherwise in some cases be drowned out, despite their potential interest.
Distribution of validated links Observing the effect of the phylogeny correction on the
distribution of the validated links in the Crüsemann dataset, some reordering of the top links
takes place, and a small decrease in the number of validated links scoring above the 95th
percentile.
Figure 4.9 shows the distribution of scores for the verified links within the distribution of
scores for all hypothetical links, while Table 4.9 shows the proportion of verified links scor-
ing above the 95th percentile for the different scoring methods. Although the phylogeneti-
cally corrected score puts a smaller proportion of the verified links above the 95th percentile,
this may be compensated for by the ordering of the links, which is shown in Table 4.11.
Note that a drawback of the strain correlation score, particularly as it relates to BGC clus-
tering, is that it is very sensitive to the clustering algorithm splitting clusters up erroneously.
For instance, in the case of BGC0000137, merging all GCFs that get tagged with that MIBiG
entry by antiSMASH known cluster blast might change the position of BGC0000137 within
the ranking, particularly as strains missing from a GCF but present in a MF incur a large
penalty.
To verify that the behaviour of the phylogenetic correction is as expected, we can consider
how the relative ranking of the validated links changes as we apply the phylogenetic cor-
rection to the strain correlation score, and consider if the sharing of the BGC amongst the
strains is likely to be due to inheritance or HGT.
Scoring function Ratio
Raw strain correlation score 8.4899× 10−5
Standardised strain correlation score 0.0001423
Phylogenetically corrected strain correlation score 0.0001139
Table 4.9: Ratio of validated links to all links scoring above the 95th percentile
Metabolite name MIBiG ID Std. rank Phyl.corr. rank Rel. change
cyclomarin D BGC0000333 3216 2793 0.1315
retimycin A BGC0001228 275167 263920 0.0409
staurosporine BGC0000827 3789 885 0.7664
rosamicin BGC0001830 1543 5056 -2.2767
lomaiviticin BGC0000241 14676 66419 -3.5257
rifamycin BGC0000137 108063 1354052 -11.5302
rifamycin BGC0000137 105046 1357570 -11.9236
rifamycin BGC0000137 21594 88610 -3.1035
rifamycin BGC0000137 1240045 1402964 -0.1314
rifamycin BGC0000137 28765 14965 0.4797
rifamycin BGC0000137 15879 10275 0.3529
rifamycin BGC0000137 52362 698671 -12.3431
rifamycin BGC0000137 107105 1390611 -11.9836
rifamycin BGC0000137 39428 53325 -0.3525
rifamycin BGC0000137 28971 59940 -1.0690
Table 4.10: Change in ranking of potential links between standardised strain correlation
score and phylogenetically corrected strain correlation score. Change in rank is estimated
relative to the rank using the standardised strain correlation score.
Raw Standardised corrected
Name ID Score Name ID Score Name ID Score
staurosporine BGC0000827 486 rosamicin BGC0001830 7.8598 staurosporine BGC0000827 3.5736
cyclomarin D BGC0000333 114 cyclomarin D BGC0000333 7.2111 cyclomarin D BGC0000333 2.6458
rosamicin BGC0001830 111 staurosporine BGC0000827 7.0682 rosamicin BGC0001830 2.2657
retimycin A BGC0001228 105 lomaiviticin BGC0000241 3.2167 rifamycin BGC0000137 1.7363
lomaiviticin BGC0000241 91 rifamycin BGC0000137 3.0407 rifamycin BGC0000137 1.5152
rifamycin BGC0000137 12 rifamycin BGC0000137 2.6653 rifamycin BGC0000137 0.7280
rifamycin BGC0000137 -28 rifamycin BGC0000137 2.2103 rifamycin BGC0000137 0.6217
rifamycin BGC0000137 -45 rifamycin BGC0000137 2.1581 lomaiviticin BGC0000241 0.5345
rifamycin BGC0000137 -56 rifamycin BGC0000137 1.8053 rifamycin BGC0000137 0.1564
rifamycin BGC0000137 -63 rifamycin BGC0000137 1.3776 retimycin A BGC0001228 0.0000
rifamycin BGC0000137 -71 rifamycin BGC0000137 0.1790 rifamycin BGC0000137 -0.1877
rifamycin BGC0000137 -104 rifamycin BGC0000137 0.0930 rifamycin BGC0000137 -0.9641
rifamycin BGC0000137 -139 rifamycin BGC0000137 0.0549 rifamycin BGC0000137 -0.9877
rifamycin BGC0000137 -182 retimycin A BGC0001228 0.0000 rifamycin BGC0000137 -1.2770
rifamycin BGC0000137 -195 rifamycin BGC0000137 -0.3868 rifamycin BGC0000137 -1.7936
Table 4.11: Order of verified links for metabolites by strain correlation score
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While concrete methods exist to determine this [135, 136], their application to this problem
remains an avenue for future work. In the interim, we can try to determine, by looking at the
phylogenetic tree, if the change in relative ranking of validated links is consistent with the
phylogenetic tree.
Such comparison is by its nature rather vague, unless we can construct a way to quantify how
phylogenetically diverse a GCF is, a notion wich could be called the “phylogenetic area” of
the GCF. In contrast to e.g. the diameter of a set, such a measure would need to capture more
of the topology of the set, i.e. how many of the strains which are closely related to members
of the GCF are not themselves in the GCF. This will not be attempted here.
In general, we would expect some of the verified links to score relatively higher (those shared
partly because of HGT) and some relatively lower (those shared mostly because of shared
ancestry). Table 4.10 shows how the rank of the verified links is affected by the appli-
cation of the phylogenetic score. For verification purposes, we can look at BGC0000333
and BGC0000827 as examples of links that are positively affected, and BGC0001830 and
BGC0000241 as examples of links that are negatively affected. Our hope would be that the
two former show greater phylogenetic diversity, while the latter show more phylogenetic ho-
mogeneity, in the sense that whole branches of the tree have the same phenotype with respect
to GCF and MF membership.
Figure 4.10 shows the phylogenetic tree for the GCF-MF link associated with MIBiG ID
BGC0000333. The two strains that are in the GCF are not collapsed at all, while most of the
rest of the tree gets collapsed.
Figure 4.11 shows the phylogenetic tree for the GCF-MF link associated with MIBiG ID
BGC0000827. Although the GCF seems to be faulty, in that many of the strains are in the
MF but not the GCF, the phylogenetic tree is diverse enough not to be collapsed to a great
extent, and while the link does get penalised where the strains in the MF are not appearing
in the GCF, it is still fairly phylogenetically diverse.
Figures 4.12 and 4.13 show the phylogenetic tree for the GCF-MF links associated with
MIBiG IDs BGC0000241 and BGC0001830, respectively. Each phenotype occurs in a very
well-defined branch of the tree, indicating that the BGC is shared largely because of shared
ancestry, which causes the ranking of the links to be lower.
Discussion While further investigation is needed into the changes in ranking of the in-
dividual links, the reduced correlation between the strain correlation score and phylogenetic
distance, combined with the limited impact on the enrichment of validated links in the top
percentile of the scores, nevertheless indicates that this approach to compensating for the
phylogenetic bias in the strain correlation score holds considerable promise.
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cyclomarin D (BGC0000333)
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not GCF, in MF
Figure 4.10: Phylogenetic tree for the upgraded GCF-MF link BGC0000333, cyclo-
marin D
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not in GCF, not in MF
in GCF, not in MF
not GCF, in MF
Figure 4.11: Phylogenetic tree for the upgraded GCF-MF link BGC0000827, stau-
rosporine
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lomaiviticin (BGC0000241)
in GCF, in MF
not in GCF, not in MF
in GCF, not in MF
not GCF, in MF
Figure 4.12: Phylogenetic tree for the downgraded GCF-MF link BGC0000241, lo-
maiviticin
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While the strain correlation score defined in [65] has been successfully used in its raw form,
we have demonstrated that it has serious drawbacks when used to compare potential links,
even within a data set. We have proposed a way of fixing these by standardising the score,
and demonstrated how standardising the score improves its performance in prioritising links
for further investigation.
Furthermore, we have made the case that BGCs shared between strains by HGT can be
of particular interest, and demonstrated how the strain correlation score favours BGCs and
MFs which contain evolutionarily related strains at the expense of BGCs shared by virtue of
HGT. We have proposed a way to remedy this and demonstrated its efficacy in broad terms,





A common approach to link microbial genomic and metabolomic information is to predict
genomic features from metabolomic data, or to predict metabolomic features from genomic
data.
Section 5.2 gives an overview of feature-based approaches to linking genomic and metabolomic
data. Section 5.3 discusses this approach in the context of untargeted metabolomics, and
highlights a kernel-based algorithm used to match MS2 spectra to molecular structures.
Sections 5.4, 5.5 and 5.6 contain further discussion of the algorithm, while Sections 5.7, 5.8
and 5.9 present how this approach can be applied to genomic and metabolomic data.
The final three sections of the chapter describe three variants of this model. Section 5.10
presents a model to link metabolomic information to molecular structures, including an in-
vestigation into how the algorithm makes its predictions. Section 5.11 presents a similar
model to link genomic information to molecular structures, and finally Section 5.12 joins
two such models together to present a model to link genomic and metabolomic information.
5.2 Feature-based scoring
One of the central problems of genomics is identifying the role of particular parts of the
genome. This is known as functional genomics [137]. For microbial BGCs, which are, to
reiterate, the regions in the microbial genome predicted to produce specialised metabolites,
this question leads naturally to the problem of predicting molecular properties from genomic
data.
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Many approaches exist to do this, with various domains. As different natural product classes
are synthesised in different ways, most existing tools for structural prediction focus on a
particular class. So far, NRPs and PKs have lent themselves particularly to structural pre-
diction, as these are modular in structure, i.e. central to the synthesis of these molecules is
assembling previously-existing components (such as amino acids) to form the final product
[71].
However, even for NRPs and PKs, complete structural prediction for a novel BGC is difficult,
as the metabolites can undergo post-translational modifications in the form of e.g. tailoring
enzymes and cyclization [71]. Predicting the existence and outcome of such modification for
a given metabolite is difficult for BGCs not closely related to known BGCs [71].
Instead of trying to predict the entire structure of the metabolite, it is in some cases possible
to make predictions about parts of the moleclue, or substructures. For NRPs, and PKs,
the fact that they are modular to begin with makes identification of substructures easier,
provided that they are not affected by potential post-translational modifications to the extent
that they become unrecognisable. For most natural product classes other than NRPs and
PKs, predicting the molecular structure, or even the core scaffold — i.e. the general large-
scale structure of the molecule — is non-trivial [71]. However, common sub-clusters within
the BGCs can sometimes be identified, some of which are responsible for the production
of specific molecular sub-structures [71]. This can allow prediction of particular chemical
features in isolation from the rest of the molecular structure.
As tandem mass spectrometry involves fragmenting the molecules and measuring the m/z
of the resulting fragments, some properties — like amino acid or peptide composition —
are likely to be observable in the resulting spectrum [97, 95, 101] and some — such as
stereochemistry — are not [71]. In this context, the modular specialised metabolites are
particularly interesting, as the component modules tend to show up as characteristic peaks
(corresponding to the m/z of the module) or differences between peaks (losses, corresponding
to the loss of the module, i.e. one peak including the molecule and the other not). Identify-
ing e.g. the amino acid composition of a molecule produced by a BGC, as Pep2Path does
for NRPs and RiPPs [97], allows searching of spectra for tell-tale peaks or losses, or even
sequences of peaks or losses, characteristic of the metabolite.
Many of the tools used to detect BGCs also incorporate some predictions of the properties of
the product. antiSMASH incorporates both various predictors of amino acid composition of
the resulting molecules, such as SANDPUMA [138] for predicting NRP amino acid content,
but also its own predictive logic for predicting some structural properties of NRPs and PKs
[139]. RODEO [99] aims specifically to detect RiPP BGCs, particularly lassopeptides, but
only makes structural predictions as far as predicting the precursor peptides for the eventual
product.
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The most recent versions of both antiSMASH [73] and PRISM [102] both claim improve-
ments in structural predictions for their predicted BGCs. However, attempts at using struc-
tures predicted by antiSMASH to match BGCs to spectra via the intermediary of molecular
fingerprints have not fared well. To some extent, this is because many of the structural pre-
dictions are only partial, i.e. only specific parts of the metabolite are predicted. This does
not translate well to molecular fingerprints, as the absence of a molecular feature in a partial
prediction cannot be used to rule out the feature in the rest of the metabolite. It is there-
fore unclear how partial structural predictions can be used to predict molecular fingerprints
except to a limited degree.
Some tools predict specific features that are directly observable in spectra. PRISM [74, 102]
predicts the sequence of monomers that are incorporated into the molecule for NRPs and type
I and II PKs, although the predictions only extend to how the features would be expressed in
LC-MS data (but not LC-MS2). NRPquest [96] detects NRPS BGCs and makes predictions
about the fragmentation spectra for their associated products, while MetaMiner [95] does
the same for RiPPs, and GNP [69] links NRPS and PKS BGCs to LC-MS2 spectra. For
peptidic natural products (NRPs and RiPPs), Pep2Path [97] predicts amino acid sequences
from hypothetical series of losses in the spectra, and matches those to previously detected
BGCs.
5.3 Identifying metabolites from spectra
A central problem in untargeted metabolomics is finding the molecule associated with a
given spectrum from a candidate set of molecules [140]. This is generally done by using the
spectrum to predict properties of the molecule, and then searching the candidate set for the
molecule most similar to the predicted molecule.
A common approach to quantifying the similarity of molecules is the use of molecular fin-
gerprints [141, 142, 143, 144]. Molecular fingerprints are binary vectors that encode the
structure of a molecule. As an infinite variety of possible dimensions exist to model the fin-
gerprint on, and as there is no single correct way of defining similarity between molecules,
various similarity measures have proven useful in different contexts, and many different
molecular fingerprints have been defined. In many common approaches, each dimension
denotes the presence or absence of certain molecular substructures, such as in the Klekota-
Roth fingerprint [142] commonly used to characterise the biological activity of molecules,
but other molecular fingerprints, with less obvious interpretations, are common as well, such
as Extended Connectivity Fingerprints (ECFP) [143, 144].
The state of the art in such systems to map spectra to molecules is CSI:FingerID [145], which
computes a fragmentation tree for a given spectrum, uses the fragmentation tree to predict
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the molecular fingerprint for the spectrum using a separate binary classifier for each bit of the
fingerprint, and finally searches a database of candidate molecules for the closest matching
fingerprint.
While prediction times for CSI:FingerID are low, it suffers from long training time, as central
to the method is training a SVM to predict each bit of the molecular fingerprint from the
spectrum, and depending on the fingerprint, these can number in the thousands.
Brouard and co-workers have suggested input-output kernel regression (IOKR) [113, 146]
as an alternative. In this approach, starting with a spectrum and a candidate set of molecules,
the objects are mapped into a shared latent space, an abstract space which encodes a rep-
resentation of the relevant features of the original objects, where the distances between the
spectrum and the candidate molecules are computed. This distance can be used to rank the
candidate set so that the molecules with the shortest distance to the spectrum in the latent
space having the best rank. In this case, the shared latent space is the space of molecular fin-
gerprints, with a pair consisting of a spectrum and a molecule being assigned a high score if
the predicted fingerprint for the spectrum is similar to the fingerprint for the molecule. Using
this model, Brouard and co-workers demonstrate a slight improvement in performance over
CSI:FingerID, with greatly improved training- and prediction times.
Matching MS2 spectra to metabolites is, generally speaking, a very hard problem. Even for
state of the art approaches, such as CSI:FingerID and IOKR, top-1 accuracy above 20% is
highly non-trivial, unless the candidate set is severely restricted, which to a degree defeats
the purpose of the tool.
The use of kernel functions is central to IOKR. We now turn to a brief overview of kernels,
after which we discuss the IOKR model in detail.
5.4 Kernel functions
Let X be an arbitrary set, and Y be a vector space with an inner product 〈·, ·〉. A kernel
on the set X is a function k : X × X → R that satisfies k(x, z) = 〈φ(x), φ(z)〉, where
φ : X → Y , i.e. the computing the kernel product k of two elements x and y is equivalent
to projecting the elements into a given vector space using a particular function φ and taking
the inner product of the resulting vectors φ(x) and φ(y).
By this definition, and the properties of the inner product, it follows that k is symmetric, i.e.
k(x, y) = k(y, x).
If S = {x1, . . . , xn} is a finite subset of X , the matrix G where Gij = k(xi, xj) =
〈φ(xi), φ(xj)〉 is called the Gram matrix, or the kernel matrix, of the kernel (on the train-
ing set S).
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A symmetric n×nmatrixM ∈ Rn×x is said to be positive semi-definite if xTMx ≥ 0 for all
x ∈ Rn. A matrix is positive semi-definite if and only if all its eigenvalues are non-negative.
Let X be a set. A function k : X × X → R is a kernel if and only if the kernel matrix K
with Kij = k(xi, xj) is positive semi-definite (and therefore symmetric) for all finite subsets
S = {x1, . . . , xn} ⊆ X . In particular, if X is finite, this applies to the set S = X .
For a detailed background on kernel methods in machine learning, the reader is referred to
Shawe-Taylor and Cristianini [147].
Various approaches exist to turn arbitrary functions, such as functions describing similarity,
into kernel functions. When constructing kernels from similarity functions, which may not
fulfill the properties of kernel functions, care must be taken when extending the derived
kernel to new samples, so as not to break the kernel properties.
The use of general similarity functions as kernels is discussed further in Section 5.11.1, and
in more detail in [148].
5.5 Input-output kernel regression (IOKR)
Let X be the space of MS2 spectra, Y be the space of metabolites, and f : X → Y be the
function mapping a spectrum to its corresponding metabolite. Let F be the shared latent
space of molecular fingerprints with inner product 〈·, ·〉F . Let also KX and KY be kernel
functions on X and Y , respectively. Furthermore, let φ : Y → F be the mapping K(·, ·) =
〈φ(·), φ(·)〉F expressing the kernel function KY as an inner product in F , and h : X → F
be the function mapping elements x ∈ X to the image φ(y) of the element y ∈ Y which
corresponds to the spectrum x. An arrow diagram of the IOKR model is shown in Figure
5.1.
In the training phase, IOKR uses subsets X ⊂ X and Y ⊂ Y of paired examples (x, y) with
x ∈ X and y ∈ Y , where each x ∈ X has a corresponding y ∈ Y and vice versa, to learn an
approximation ĥ of the function h. This approximation is given as
ĥ : X → F , x 7→
∑
xj∈X
KX (x, xj)cj (5.1)
where cj ∈ F [113]. If F is finite-dimensional, the solution for cj using the regularised
least-squares loss function with regularisation parameter λ can be written in closed form as
ci = (λI +KX)
−1φ(yi) (5.2)







Figure 5.1: Arrow diagram of the input-output kernel regression (IOKR) framework.
X is the space of MS2 spectra, Y is the space of molecules, and F is the space of molecular
fingerprints. φ is the mapping that sends a molecule y ∈ Y to its molecular fingerprint
φ(y) ∈ F , the shared latent space. ĥ is the learned approximation to the function h which
takes a spectrum x ∈ X to the molecular fingerprint φ(y′) of the molecule y′ that gave rise to
the spectrum. Given an element x ∈ X a candidate set Y ⊆ Y is ranked for match to x using
the similarity between the images of the elements in F , i.e. the similarity between ĥ(x) and
φ(y). The dimensionality of F is controlled by the choice of molecular fingerprint.
where KX is the Gram matrix of the kernel KX on the training set [113, 149, 150]. This task
is called output kernel regression.
To rank a set Y ∗ ⊂ Y of candidate structures for a spectrum x ∈ X , the set of candidates is
ordered by decreasing value of the expression
σIOKR(x, y) = 〈ĥ(x), φ(y)〉F (5.3)
where y ∈ Y ∗, so that the element getting assigned the highest value is taken to be the most
likely candidate.
Taking KX and KY to be the Gram matrices of the kernels KX and KY on the training set,
and kxX and k
y
Y to be the column vectors composed of KX (xi, x) and KY(yi, y) for xi and yi
in the training set, and substituting ĥ(x) with Eqs. 5.1 and 5.2, Eq. 5.3 can be rewritten as





where λ is a regularisation parameter and I is an appropriately sized identity matrix.
5.6 Computational complexity
In the formulation presented here, the computational complexity of IOKR is dependent on
two factors: the size of the training set and the computational complexity of the kernel
functions.
5.7. Kernel functions for spectra and metabolites 76
In the training phase, the calculation of the kernel matrix in Eqn. 5.4 requires evaluating the
kernel functions for all pairs of elements from the training set, along with the inversion of
the kernel matrix.
In the prediction phase, the kernel function on the input space is evaluated against all ele-
ments of the training set, while in the output space, the kernel function is evaluated for each
of the elements in the candidate set against all of the training set elements.
While the kernel matrix grows quadratically with the size of the training set, with correspond-
ing impact on the matrix inversion, the prediction phase scales linearly with the size of the
training set. Both aspects depend heavily upon the computational complexity of the kernel
functions being used, in particular the training phase, which requires pairwise computation
of kernel values between elements of the training set.
However, the current size of the training data sets makes these computations very manage-
able. Furthermore, as the current training data sets include metabolites from a wide variety
of sources, optimisation of the training data set to focus on specific parts of the metabolite
space, e.g. on metabolites of microbial origin, may allow significant reduction of the training
set size without loss of precision for the metabolites of interest.
Given reasonable optimisations on the calculation of the kernel functions, the scalability of
the algorithms presented here should therefore not present a problem for the foreseeable
future.
5.7 Kernel functions for spectra and metabolites
As with all kernel methods, the choice of kernel function KX and KY is a very important
consideration for the performance of IOKR. For spectra, Brouard and co-workers use a com-
bination of kernels, the single best-performing of which is the recalibrated product proba-
bility kernel (PPKr) [113, 151], with a top-1 performance of roughly 22%, compared with
roughly 30% for the best-performing combination.
For the molecules, Brouard and co-workers used the Gaussian kernel
k(y, y′) = exp(−γ||c(y)− c(y′)||2), (5.5)
where y and y′ are molecules, and c is the function mapping a molecule to its fingerprint
vector.
In a follow-up article, however, Brouard and co-workers went on to show that substituting
the norm in the Gaussian kernel with the Tanimoto similarity for the molecular fingerprint
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vectors yields a slight improvement in performance [152]. For binary vectors X and Y , the
Gaussian-Tanimoto kernel is given by
d(X, Y ) = exp
(










is the Tanimoto similarity between X and Y .
In our context, as we take the Gaussian of the Tanimoto similarity as the inner product on
F , φ is simply the mapping of y ∈ Y to its molecular fingerprint, and h is the mapping of
a spectrum to its molecular fingerprint, i.e. the molecular fingerprint of the metabolite that
gives rise to the spectrum.
The structure of the IOKR model is described in detail by Brouard and co-workers in [146],
and its application to metabolomics is further described in [113], where the relevant equa-
tions are derived.
5.8 Using IOKR to score links
As described previously, the idea behind IOKR is to project the various elements into a
shared latent space and rank the matches based on similarity in the latent space. A link
between a spectrum x and a metabolite y will be assigned a high score if the fingerprints
predicted for the spectrum and calculated for the metabolite are similar. Although [113]
presents IOKR as a method to rank candidate molecules for spectra, it can also be used to
rank candidate molecules for BGCs, as long as we have an appropriate kernel function on
the space of BGCs. In this way, we can break the problem of mapping BGCs to spectra into
two components: mapping BGCs to metabolites, and mapping spectra to metabolites.
Each of these models can be trained individually and evaluated in isolation, and then coupled
together to link BGCs and spectra, bypassing the need for a candidate molecule set.
The following sections are dedicated to these problems in turn. Section 5.10 covers the IOKR
model linking MS2 spectra to metabolites, Section 5.11 covers the IOKR model linking
BGCs to metabolites, and Section 5.12 covers the combined model linking BGCs to MS2
spectra.
Besides adhering more closely to the structure of the model presented in [113], breaking the
problem in two in this way, and training each part of the model to use the space of molecular
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fingerprints as an intermediary, has the added benefit of a greater amount of available training
data. Whereas a model predicting the relations between BGCs and spectra directly would be
trained on the combined MIBiG-GNPS data set, which only has 242 unique BGCs and 2069
unique spectra in 2966 pairs, we can use the GNPS data set from [113] to train the model
linking spectra to metabolites, and the whole MIBiG database to train the model linking
BGCs to metabolites. For the GNPS data set, this means 4138 spectrum-metabolite pairs
with 4138 unique spectra and 2919 unique molecules. The MIBiG data set contains 2966
pairs consisting of 249 unique BGCs and 2069 unique spectra. By using the same molecular
fingerprints to train the two models, we ensure that they are compatible and can be coupled
to rank BGC-spectrum links.
5.9 Using IOKR to rank GCF-MF links
As IOKR ranks links between spectra and BGCs, and the strain correlation score ranks links
between GCFs and MFs (or spectra), the two are not directly comparable. To make them
comparable, therefore, we must either generalise the strain correlation score to individual
BGCs, or the IOKR score to GCF-MF links. The former can be achieved by assigning the
score for the GCF-MF link to each individual BGC-spectrum pair where the BGC is in the
GCF and the spectrum is in the MF. On the other hand, to generalise the IOKR score to
GCF-MF pairs, we take the IOKR score for a GCF-MF link to be the highest IOKR score for
a BGC-spectrum pair where the BGC is in the GCF and the spectrum is in the MF, i.e. for
a GCF G and a MF M , and a scoring function σ evaluating BGC-spectrum links, we define
the generalised scoring function σ̂ as
σ̂ = maxm∈M,g∈Gσ(m, g). (5.8)
In a slight abuse of notation, we will henceforth omit theˆand simply write σ for the gen-
eralised scoring function as well, with the understanding that the domain of the function is
clear from the context.
5.10 MS2-MIBiG IOKR
To apply the IOKR model as defined in [113] to match BGCs to MS2 spectra, we would like
to take the set of BGCs as a candidate set for each spectrum, and rank the links according
to the scores obtained by evaluating expression 5.4. However, to rank the candidate set, we
need molecular predictions for the BGCs. As mentioned before, for novel BGCs, these are
not easily obtained. We must therefore restrict ourselves to BGCs with known structure, or
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BGCs that have significant similarities to such BGCs. In practice, this means limiting our
candidate set to BGCs that are in MIBiG, or are similar to BGCs therein.
Although the application of IOKR to the BGC-MS2 linking problem is limited to BGCs that
are in MIBiG, it can still be considered useful in two ways: Firstly, searching for BGCs with
products that are similar to known metabolites is a common starting point in the search for
novel metabolites. This approach was for instance used by Duncan and co-workers in [63] to
identify the BGC encoding the production of retimycin A. Secondly, assigning BGCs with
known products to their spectra can aid in dereplication, i.e. identifying spectra belonging to
these known products, and thus help focusing the search for novel metabolites elsewhere by
a process of elimination. This is the idea behind DEREPLICATOR, developed by Mohimani
and co-workers [103].
To assign metabolite structures to BGCs, we use the antiSMASH KCB results, as described
in section 3.8.1. To estimate the similarity of MIBiG entries to a detected BGC, the Pfam
domains making up the MIBiG entry are aligned against the sequence of the detected BGC
using BLAST [73]. If the sum of scores of the BLAST hits for the individual Pfam domains
exceeds 10000 for a given MIBiG entry, we assign any molecular structures associated with
the MIBiG entry to the BGC. That means that a single BGC can have zero or more KCB
matches, any of which can have one or more associated structures. This results in each BGC
in the data set being assigned zero or more molecular structures. The cutoff is needed in
order to reduce the noise from low-quality KCB matches, but the data sets do seem stable
with regards to the exact value of the cutoff.
The set of all molecular structures that are assigned to a BGC in the data set becomes our
candidate set Y ∗ for IOKR, and we can define a scoring function σIOKR between a BGC g
with an associated set of molecular structures G′ ⊂ Y , and a spectrum m ∈ X , as
σIOKR(m, g) = maxg′∈G′〈ĥ(m), φ(g′)〉F (5.9)
5.10.1 Training data
The IOKR model is trained on the same data as in [113], namely, spectra and structural anno-
tations from GNPS [64]. In total, the data set consist of 4138 spectrum-metabolite pairs, with
the molecular fingerprints being computed from the InChI or SMILES annotations using the
Python bindings for Chemistry Development Kit (CDK) [153]. The fingerprint vector used
is a concatenation of three fingerprint vectors: CDK substructure, PubChem Substructure
and Klekota-Roth. Taken together, these cover a large majority of the features used in [113],
and result in similar performance on the test set used in [113]. The metabolites in the training
set come from various sources, and include microbial, plant and human metabolites.
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While this data set only represents a small subset of GNPS spectra with structural annota-
tions, this set contains high-quality MS2 data, generated with similar device configurations
and high-quality structural annotations. Furthermore, as the same data set has been used in
numerous previous experiments (such as [145] and [146]), using this subset as our training
data makes comparison with existing work easier.
5.10.2 Kernel choices
In order to be able to evaluate our model on data not included in the training set, we need to
be able to evaluate the kernel functions between the new input data and the training data. In
[113], Brouard et al. use the PPKr kernel on the MS2 spectra, while the kernel function on
the metabolites in [152] is the Gaussian-Tanimoto kernel in the molecular fingerprint space,
and we follow their example to a large extent.
A common preprocessing step in in-silico metabolite identification is to apply some kind
of filtering to the input spectra. The PPKr as used by Brouard and co-workers in [113]
involves computing a fragmentation tree for each spectrum, using the computed tree to filter
the spectrum to only those masses appearing in the tree, and then calculating the PPK as
defined in [154] on the filtered spectra. To avoid computing the fragmentation tree for each
input spectrum, which is computationally expensive, we instead assemble a collection of all
fragment m/z occurring in the training set, for which we have precomputed fragmentation
trees, and filter the input spectra to only include peaks that match those m/z values.
While it may be argued that this biases the model towards peaks seen in the training data,
peaks that are not present in the training data can by definition not be used by the predictive
model, and cannot therefore provide any information. In addition, the training set appears to
be large enough to contain enough ions to build a robust model, and the effects of the bias
are small, as confirmed by comparing our implementation of PPKr to the fragmentation-tree-
based filtering approach used by PPKr in [113] on the data set used in that paper.
After filtering, the PPK of the resulting spectra is computed as follows.
Given two spectra x and x′, the PPK kernel [151, 154] on the spectra is defined by modelling
each of the spectra as a mixture of Gaussians p(x) and p′(x′) [154]. The peaks xi of each
spectrum are modelled as (mass, intensity) tuples, with each xi corresponding to a non-
isotropic two-variate normal distribution pi(xi) ∼ N (xi,Σ) over the mass and intensity of
peak i. Assuming the mass and intensity to be independent, we set Σ′ = Σ = [σmass, 0; 0, σint]
for both p and p′. Following Brouard and co-workers, we set σint = 100000 and σmass =
0.00001 [113].
Letting k be the kernel function on the distributions, by [154], the kernel function k′ on the
spectra is computed as






































and xi and x′j are the features from x and x
′ respectively.
When working with MS2 spectra, the PPK kernel is usually computed for both the spectra
and the neutral losses. To compute the kernel for the neutral losses, for each pair of peaks
from the original spectrum, the mass is set to the m/z difference between the peaks, and the
intensity to the average of the two intensities. The values of the kernel function k for the
peaks and the losses are computed separately and added together for the final PPK value for
the two MS2 spectra [154].
On the space of metabolites, the kernel used is the Gaussian-Tanimoto kernel on the space of
molecular fingerprints, i.e. the Gaussian kernel with the l2-norm replaced by the Tanimoto
coefficient, as described in Section 5.7.
5.10.3 Results
Evaluation on MIBiG data As previously mentioned, the data set used to train the IOKR
model in [113] contains metabolites from various sources, and performance evaluation is not
broken down by metabolite source. To evaluate the performance of the model on microbial
secondary metabolites specifically, we can use the paired MIBiG-GNPS data set introduced
in Chapter 3.6.
Taking as candidate set the set of all molecular structures associated with a BGC in the data
set, IOKR assigns a score to each, which we use to rank the metabolites in the candidate set.
To translate this into the rank of a particular BGC, the rank of the BGC is taken to be the
number of distinct BGCs associated with any molecule that scores higher than the highest-
scoring molecule for the BGC, i.e. if σIOKR(m, s) is the IOKR score between a metabolite m





Figure 5.2: Ranking BGCs based on ranking of metabolites. (A) The metabolite m1 has
better rank against the spectrum s than the metabolite m2. (B) Based on the ranking of their
associated metabolites, the BGCs B1 and B2 are tied for best match with the spectrum s,
while B3 ranks lower than both, despite sharing the associated metabolite m2 with B2.
Top-1 Top-5 Top-10 Top-20 Top-200 AUC
Data 0.1208 0.1708 0.1870 0.2121 0.2946 0.6534
Random 0.0 0.0014 0.0044 0.0103 0.1486 0.5209
Table 5.1: Top-n accuracy and AUC of IOKR on the MIBiG-GNPS data set.
and a spectrum s, and B is the set of BGCs, where each B ∈ B is a set of the metabolites m
associated with it, then the rank of the link between a BGC B ∈ B and a spectrum s is given
by the expression
# {B′ ∈ B |maxm′∈B′σIOKR(m′, s) > maxm∈BσIOKR(m, s)} . (5.14)
As an example, considering Figure 5.2, assume that s is a spectrum, m1 and m2 are metabo-
lites which σIOKR ranks in this order. Assume also that B1, B2 and B3 are BGCs, with m1
associated with B1, m1 and m2 associated with B2 and m2 associated with B3. By the defi-
nition above, B1 andB2 are tied at rank 0, whileB3 has rank 2, as bothB1 andB2 are ranked
higher, because m1 has better rank than m2, and is used to place both b1 and b2 within the
ranking.
To estimate a baseline performance for comparison, the rank of the metabolites was ran-
domised, and the same logic used to rank the BGCs.
Table 5.1 shows the top-n performance of IOKR on the paired MIBiG-GNPS data, i.e. how
often the correct BGC for a spectrum is among the top-n BGC matches for the spectrum, for
a selection of n, as ranked by IOKR.
The last column of Table 5.1 is the AUC for the proportion of spectra correctly identified as
a function of increasing n. Recall that AUC of 1.0 would in this context mean that the top-1
accuracy was 100%, i.e. for all spectra, a molecule associated with the correct BGC would
be the top ranked molecule.
The proportion of MS2 spectra with a correct match in the top-n ranked BGC candidates
can be seen as a function of n in Figure 5.3. The AUC for IOKR is 0.6534, compared with
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Figure 5.3: IOKR performance on MIBiG data Top-n accuracy of IOKR on MIBiG data,
i.e. how often the correct BGC for a given spectrum is among the n top ranked BGCs,
compared to a baseline acquired by permuting the IOKR scores before ranking. IOKR out-
performs random ordering by a rather considerable margin, relatively, especially for low
values of n, i.e. when only the top few candidates are considered.
0.5209 for the baseline, and the difference between IOKR and baseline for a selection of n
is shown in Table 5.1. IOKR outperforms the baseline by a considerable margin, particularly
for low values of n, where the performance of IOKR is relatively much higher than of the
randomised baseline.
Evaluation on microbial data sets To evaluate the performance on microbial data
sets, we turn to the data sets introduced in Chapter 3.7. The distribution of IOKR scores for
all potential links in the data sets can be seen in Figure 5.4, with validated links indicated in
black below the histograms.
Looking at the mean IOKR scores for the validated links, and the mean scores for all of the
links, an effective scoring function should have a higher mean score for the validated links
than for all links. The mean IOKR score for the three microbial data sets is shown in Table
5.2. For all of the data sets, the mean for the validated links is higher than the mean for all
links, although the difference is only statistically significant for the Crüsemann data set.
Looking at the relative enrichment of the top quantiles for validated links — i.e. if the pro-
portion of verified links scoring above a certain percentile is higher than would be expected
if the scores were random — both the sets of links scoring above 90th and 95th percentiles
of all data sets are enriched for validated links relative to the whole set, but this difference is
only statistically significant for the Crüsemann data set.
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Data set Mean score all Mean score valid p-value
Crüsemann 0.0105 0.0364 1.7968e-9
Leão 0.0014 0.0038 0.3922
Gross 0.02721 0.037020 0.5155
Table 5.2: Mean IOKR score by microbial data set
Crüsemann Leão Gross total
All
Verified 15 8 5 28
Total 999362 9342 501886 1510590
Ratio 1.5010× 10−5 0.0009 9.9624× 10−6 1.8536× 10−5
> 95% σIOKR
Verified 6 1 1 8
Total 49970 437 25095 75502
Ratio 0.0001 0.0023 3.9849× 10−5 0.0001
p-value 0.0003 0.3378 0.2538 0.0002
> 90% σIOKR
Verified 6 1 1 8
Total 99937 935 50189 151061
Ratio 6.0038× 10−5 0.0011 1.9925× 10−5 5.2959× 10−5
p-value 0.009 0.5764 0.4355 0.0139
Table 5.3: Number of validated links with IOKR score above 95th and 90th percentile, and
significance according to Fisher’s Exact Test, compared to all links.
To increase the statistical power of the tests, we can combine the data sets. As we cannot
rely on the distribution of the scores to be identical across the data sets, due to for instance
different instrumentation in the MS2 analysis [155], simply combining the scores is not
feasible. However, by looking at the number of links that score above a given threshold
in each data set, we can pool the counts of validated and potential links, and consider the
relative overrepresentation of validated links in the top percentiles of the distribution of the
scores both for individual data sets and for the combined link count.
The number of links scoring above the 95th and 90th percentiles for all data sets can be
found in Table 5.3. Adding up the data sets, i.e. the number of validated links in the top
percentiles and the total number of links across all data sets, validated links are significantly
overrepresented above both percentiles.
5.10.4 Investigating the function of IOKR
As with many machine learning approaches, the function of IOKR is somewhat of a black
box. In order to further validate IOKR, we therefore tried, for a few BGC-spectrum pairs,
to identify specific peaks in the MS2 spectrum as belonging to specific substructures of the
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metabolites. We then removed these peaks from the spectra, in order to see if we could
identify substructures (represented by peaks) that had a particular influence on the IOKR
score of the match relative to other matches, where removing the peak lead to a change in
the ranking of the BGC-spectrum pair, and furthermore if that particular substructure could
be considered characteristic of the metabolite in some way.
The starting point for the verification was a BGC-spectrum pair, where the BGC has an
associated metabolite. To identify the peaks in the MS2 spectrum that corresponded to a
particular substructure, the metabolite was fragmented using MetFrag [156]. Using the ac-
curate mass reported by name-based search for the metabolite in NPAtlas [157], a candidate
set for MetFrag was generated by searching the NPAtlas_Aug2019 database in MetFrag
for molecules with the same neutral mass. Ideally, this should only return one candidate, but
in cases where multiple candidates were returned, only candidates where the name of the
candidate matched the name of the metabolite were analysed further. Finally, the candidate
molecules were fragmented using the MetFrag in-silico fragmentation algorithm with default
settings.
The relevant spectra from the MF were extracted using the Metabolomics Spectrum Resolver
[158] and their peaks matched to the hypothetical fragmentation spectra for the candidate
molecules. Peaks that matched were then filtered one by one from the spectra, and the change
in IOKR score against the metabolite, relative to the change in IOKR score against other
metabolites, observed. A decrease in the score relative to other potential links manifests as a
worse ranking for the BGC-spectrum pair using the filtered spectrum relative to the unfiltered
one.
Results The links subjected to this analysis were all the validated links in the Crüsemann
data set, along with two unverified links with high σIOKR and σ̄corr scores. For three examples,
a single peak identified as corresponding to a particular substructure had a large impact on
the ranking of the spectrum against the BGC, among the candidate set of other spectra.
The metabolite rosamicin, which as a product of the MIBiG BGC BGC0001830 has a val-
idated link with spectrum 93193, has an accurate mass of 581.3564, as reported by NPAt-
las. This yielded an unique match for neutral mass in the NPAtlas_Aug2019 database
in MetFrag. Comparing the predicted spectrum for that match to spectrum 93193 from the
Metabolomics Spectrum Resolver, MetFrag matched 12 out of 31 peaks with a raw score of
67.1248. Out of the matched peaks, removing the peak at m/z 158.117004 (which matched a
peak at 158.11762 Da in the predicted spectrum) changed the (0-based) rank of the metabo-
lite against the spectrum from 16 to 163. The predicted peak represents a biological subunit,
aminosugar, of the metabolite. The spectrum from the Metabolomics Spectrum Resolver,
and the metabolite from MetFrag, can be seen in Figure 5.5, with the identified subunit of
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the molecule highlighted in green.
The metabolite grisochelin, which the NPAtlas database reports as having accurate mass of
568.4339, is hypothetically linked to spectrum 51165. Searching the NPAtlas_Aug2019
database in MetFrag for molecules with neutral mass equal to the reported accurate mass
yielded two candidates. Curiously, only one result line showed up in the interface. This
metabolite was annotated as zincophorine, which is another name for grisochelin [159], and
so was used for the analysis. Comparing the predicted spectrum for the metabolite to the
spectrum from the Metabolomics Spectrum Resolver yielded two matched peaks out of 18,
with a raw score of 2.9841. Removing one of those peaks, the peak at m/z 95.086995 (which
matched a peak at 95.08558 Da in the predicted spectrum) changed the (0-based) rank of the
metabolite against the spectrum from 0 to 3. The spectrum and the metabolite from MetFrag
can be seen in Figure 5.6, with the identified subunit of the molecule highlighted in green.
The metabolite staurosporine, which as a product of the MIBiG BGC BGC0000827 has a
validated link with spectrum 44982, has an accurate mass of 466.2005, as reported by NPAt-
las. Using this as a selection criteria for neutral mass in the NPAtlas_Aug2019 database
in MetFrag yielded seven candidates, only one of which was annotated as staurosporine, and
which was used for subsequent analysis. Comparing the predicted spectrum to spectrum
44982 from the Metabolomics Spectrum Resolver, MetFrag matched seven out of 22 peaks
with a raw score of 159.7769. Out of the matched peaks, removing the peak at m/z 56.049999
(which matched a peak at 56.0495 Da in the predicted spectrum) changed the (0-based) rank
of the metabolite against the spectrum from 1 to 67. The spectrum and the metabolite from
MetFrag can be seen in Figure 5.7, with the identified subunit of the molecule highlighted in
green.
Discussion For the three examples discussed, we have identified an ion corresponding
to a particular substructure which IOKR considers important in matching the spectrum to
the metabolite. Being able to identify the substructure as characteristic of the metabolite
further validates the method, as this reinforces the validity of the link, as well as validating
the emphasis IOKR puts on that particular feature.
5.11 BGC-MIBiG IOKR
Although presented as a way to map spectra to molecules in [113], IOKR can just as easily
be trained to map BGCs to molecules, given a suitable kernel function on the BGCs. Doing
so would give the second piece needed to map MS2 spectra to BGCs, in addition to the
MS2-MIBiG IOKR discussed in the previous section.
5.11. BGC-MIBiG IOKR 87
In this formulation, instead of being the space of MS2 spectra, X is the space of BGCs. Y
remains the space of metabolites, and F the feature space of molecular fingerprints.
The calculations follow the exact same blueprint: in the first phase (training phase), we ap-
proximate a function h : X → F mapping the input BGCs to their corresponding fingerprint
vectors with a function
ĥ : X → F , x 7→
∑
xj∈X
KX (x, xj)cj (5.15)
while in the second phase (prediction phase) we search a candidate set Y ∗ ⊂ Y for the
molecule y ∈ Y ∗ that maximises the expression
〈ĥ(x), φ(y)〉F (5.16)
for a given x.
5.11.1 Kernel choices
As discussed in Section 2.2.2, defining a similarity measure on the space of BGCs is still
an open question. The most advanced such method, used by BiG-SCAPE [82], is based on
a great deal of expert knowledge, and incorporates many of the components of the distance
measures defined previously, such as Pfam domain composition (used in e.g. [83]) and
sequence similarity (used in e.g. [84], although they use a different way of evaluating the
similarity).
However, IOKR requires the similarity function on the input space to be a kernel function,
and there is no reason to believe that the similarity function used by BiG-SCAPE satisfies the
conditions. In fact, the Gram-matrix for the Crüsemann data set has non-negative eigenval-
ues, demonstrating that the BiG-SCAPE similarity function is not in fact a kernel function.
While the use of such indefinite (or non-positive) kernels in optimisation problems has been
studied to some extent, the results have been mixed, and indicated that in many cases, the
global optimality of the solution cannot be guaranteed [148, 160, 161, 162].
This leaves two options: either use a different similarity function on the BGCs, that is guar-
anteed to be a kernel, or convert the BiG-SCAPE similarity function into a kernel function.
A straightforward way of defining a similarity function on the BGCs is to consider each BGC
as a word vector, i.e. establish a “dictionary” of all the possible Pfam domains and regard
each BGC as a vector in the space where each Pfam domain has a corresponding axis, and the
magnitude of the vector along any given axis is equal to the number of times that the Pfam
domain corresponding to the axis appears in the BGC. Taking this a step further, we can
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apply tf-idf correction to the word vector, which can in many cases improve the performance
of machine learning tasks [163, 164].
Both the word count vector and the tf-idf vector are vectors in Rn, where n is the size of the
dictionary, i.e. the number of distinct Pfam domains in the set of BGCs. A wide variety of
kernels exist defined on Rn. The most common one is the Gaussian kernel in the l2-norm,
k(v, v′) = exp(−γ||v−v′||2), which we use for both the word count and tf-idf vectors going
forward [147].
Another option to define a kernel on the space of BGCs is to convert the BiG-SCAPE sim-
ilarity function into a kernel function. This can be done in several ways. An important
consideration for the purpose of using this kernelisation in our context is out-of-sample ex-
tension, i.e. given that the kernel function is defined in terms of the training set, we require
that it be extensible to new BGCs while still keeping the kernel property.
Chen and co-workers suggest four approaches to turning a similarity function into a kernel
function, given the Gram matrix of the training data set [148]. Two of these can be repre-
sented as linear transformations defined in terms of the training set, and are shown to extend
to new data points in a consistent fashion, meaning that the transformation can be computed
once, at training time, and new data points be transformed accordingly without need to re-
compute the eigendecomposition of the Gram matrix to incorporate the new points.
Both of these involve directly manipulating the eigenvalues of the matrix. The first ap-
proach (clip) sets all negative eigenvalues to zero, while the second (flip) replaces negative
eigenvalues with their magnitude, i.e. if λ is a negative eigenvalue, it is replaced with −λ.
Furthermore, as opposed to the other approaches considered in [148] and [165], Chen and
co-workers show that the two methods translate easily to new samples via linear transfor-
mations [148], and both of them have some theoretical justification – in particular, it can be
shown that for a given matrix X , that is not positive semidefinite, the matrix Xclip where
all the negative eigenvalues have been set to 0, is actually the closest positive semidefinite







where Y is a m× n matrix [148].
Recall from section 2.2.2 that the BiG-SCAPE similarity function is defined for BGCs b1
and b2 as
σBS(b1, b2) = αJI(b1, b2) + βAI(b1, b2) + γDSS(b1, b2) (5.18)
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Shared BGC No shared BGC p-value
0.9731 0.7451 8.9567× 10−65
Table 5.4: The mean similarity for the molecular fingerprints for pairs of SMILES depending
on if they are annotated as products of the same BGC. The p-value is for the t-test for the
mean of the two distributions being the same.
where JI is the Jaccard index, i.e. the percentage overlap in Pfam domains,DSS is the direct
sequence similarity for matched Pfam domains, and AI is the similarity of pairs of domains,
and α, β and γ are coefficients, potentially with different values according to product class.
As the linear combination of kernel functions is a kernel function, and the BiG-SCAPE
similarity function is a linear combination of functions, the kernelisation can be applied in
two places: Individually to each component function, or as a last step, to the final similarity
function. Furthermore, if the component functions are kernelised individually, the weights
may no longer be optimal. We therefore turn to multiple kernel alignment (MKA) [166] to
recompute the weights of the component functions and compare the performance of these
recalibrated weights with the original BiG-SCAPE weights.
In short, given a matrix Y and a set of matrices Xi, MKA solves a quadratic programming
problem to determine the vector α = {αi} such that the linear combination of matrices∑
αiXi is as close to Y as possible in the Frobenius norm.
5.11.2 Training set
As MIBiG contains structural annotations for the majority of the entries, the BGC-MIBiG
IOKR model can be trained on a large part of the MIBiG database. Recall from section
5.5 that the training data for the IOKR model consists of paired data points (x, y) where
x ∈ X ⊂ X and y ∈ Y ⊂ Y , where X and Y are the sets of BGCs and metabolites
respectively, and the training phase approximates a function h : X → F into the set F of
molecular fingerprints.
This model is not completely accurate, as the same BGC can have more than one associated
metabolite. Such instances can be found in the MIBiG training data, where for example
multiple structural annotations exist for BGC0000241, which codes for four different vari-
ants of lomaiviticin. However, as can be seen in Table 5.4, different metabolites produced
by a single BGC generally have very similar fingerprints. We therefore choose to ignore this
discrepancy and treat each BGC as producing a single molecule in the IOKR model.
The instances of multiple metabolites corresponding to a single BGC in the training data are
handled by treating each pair of BGC and metabolite as a different data point in the training
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set, i.e. the BGC x producing the metabolites y1 and y2 results in two points (x, y1) and
(x, y2) in the training data set.
As BiG-SCAPE requires a specially annotated version of MIBiG to correctly sort the entries
into natural product classes, and these annotations are not at the time of writing available for
MiBiG version 2.0, the analysis in this section is done using MIBiG version 1.4.
For version 1.4, the MIBiG training data set includes 1205 BGCs producing 1452 distinct
metabolites. The relationship between BGC and metabolite can be many-to-many, i.e. mul-
tiple BGCs can produce the same metabolite, and each BGC can produce multiple metabo-
lites. The final data set, after expanding all BGCs into a separate data point for each of their
metabolites, consists of 1692 BGC-metabolite pairs.
Performance is estimated using 10-fold cross validation on the set of BGCs, where the ran-
domisation is done in such a way that all BGCs that share a SMILES string belong to the
same fold.
5.11.3 Results
As a simple measure of the total accuracy of the model, we can look at the AUC measure-
ments of the top-n accuracy with varying n, as discussed in Section 5.10.3. Recall that AUC
of 0.5 corresponds to random, and AUC of 1.0 corresponds to the highest-ranking result
being correct in all cases.
Table 5.5 shows the AUC for the different kernels, broken down by natural product class,
with the ‘mix’ class including all of the product classes. Similar data for the top-n perfor-
mance for n = 1, n = 5 and n = 20 can be found in Table 5.7. Looking at the AUC results,
the best-performing kernel on the BGC space is the Gaussian kernel on the Pfam word vec-
tors, which outperforms the other kernels, including the tf-idf adjusted word vectors, for six
out of eight product classes, as well as on the ‘mix’ class. Furthermore, when kernelising
the component pars of the BiG-SCAPE similarity function, recalibrating the weights for the
individual metrics does not seem to significantly impact the performance (see the “recal”
columns in Tables 5.5 and 5.7). Since the weights resulting from the MKA optimisation are
not particularly close to the weights BiG-SCAPE itself uses, the similarity function appears
to be relatively robust to changes in coefficients, at least for this use.
Considering the kernelisation of the composite BiG-SCAPE similarity function, clip outper-
forms flip for all product categories, while both approaches outperform the model trained on
the raw BiG-SCAPE similarity values (which the model accepts, even though they do not ful-
fill the criteria for being kernel functions). Kernelising the component functions individually




Figure 5.4: Distribution of validated links in IOKR scores of all potential links Crüse-
mann, Leão and Gross data sets.
Figure 5.5: Substructure of rosamicin identified as influencing the IOKR score. The
metabolite rosamicin, and the verified spectrum linked with the metabolite. The substructure
identified as particularly influencing the ranking is indicated in green and can be identified as
an aminosugar. The difference in reported precursor m/z in the image and the mass discussed
in the main text is due to each MF potentially containing several different precursor ion
m/z, and σIOKR being calculated for a MF using the highest-scoring spectrum from the MF,
regardless of the precursor m/z.
Figure 5.6: Substructure of grisochelin identified as influencing the IOKR score. The
metabolite grisochelin, and the spectrum potentially linked with the metabolite. The sub-
structure of the metabolite identified as particularly influencing the ranking is indicated in
green.
Figure 5.7: Substructure of staurosporine identified as influencing the IOKR score. The
metabolite staurosporine, and the verified spectrum linked with the metabolite. The sub-
structure identified as particularly influencing the ranking is indicated in green.
bs bs clip bs flip wv tfidf bs raw clip bs recal clip bs raw flip bs recal flip
NRPS 0.568 0.735 0.646 0.819 0.780 0.754 0.757 0.754 0.628
Others 0.606 0.688 0.650 0.778 0.739 0.638 0.644 0.638 0.573
PKSI 0.547 0.741 0.646 0.794 0.758 0.773 0.768 0.726 0.604
PKS-NRP Hybrids 0.596 0.725 0.618 0.798 0.770 0.772 0.772 0.772 0.691
PKSother 0.575 0.693 0.627 0.841 0.817 0.708 0.713 0.708 0.638
RiPPs 0.666 0.762 0.718 0.757 0.764 0.857 0.850 0.860 0.768
Saccharides 0.697 0.720 0.704 0.768 0.772 0.766 0.810 0.766 0.673
Terpene 0.538 0.627 0.595 0.697 0.678 0.564 0.558 0.531 0.487
mix 0.544 0.752 0.691 0.855 0.821 0.733 0.732 0.698 0.613
Table 5.5: AUC values for BGC-MIBiG IOKR for different kernel functions, broken down by natural product class. Highest AUC per class is in
bold. Using a Gaussian kernel on a simple Pfam word vector yields the highest AUC in six out of eight natural product classes, as well as for the
combined set of all BGCs (‘mix’).
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BGCs with correct match among top-n scoring metabolites
Figure 5.8: Top-n performance for varying n for the word vector kernel, and the kernel
derived from BiG-SCAPE using the clip method, compared to a randomised baseline. While
both kernels perform better than the baseline, the word vector kernel outperforms the BiG-
SCAPE kernelised similarities.
ral product classes, with negligible difference in performance between the two kernelisation
methods applied to the component functions individually.
Considering the Top-n results presented in Table 5.7, the best-scoring method is less clear.
The Pfam word vector and the tf-idf corrected vector show similar performance for the values
of n considered, with the kernelised BiG-SCAPE metric showing comparable performance
using the clip method at n = 1.
A graph of the Top-n accuracy for varying n can be seen in Figure 5.8, for the word vec-
tor kernel and BiG-SCAPE similarity, kernelised using the clip method, on the ‘mix’ and
‘NRPS’ natural product classes, along with randomised baseline. While both kernels outper-
form the randomised baseline, the word vector kernel outperforms the BiG-SCAPE-derived
kernel by a considerable margin, as demostrated in Tables 5.7 and 5.5.
Another way of extending the BiG-SCAPE metric to the ‘mix’ class is to use the ‘mix’ sim-
ilarity measurement only for intra-class similarities, i.e. where the elements being compared
belong to different classes, and use the class-specific similarity measurements for within-
class comparisons. Based on the performance of the BiG-SCAPE kernelised versions of the
individual classes, we use the ‘clip’ method to kernelise the similarity matrix, and refer to
the measurement as BiG-SCAPE composite.
Table 5.6 shows the top-1, top-5 and top-20 accuracies for word vector, tf-idf and BiG-
SCAPE composite kernels, as well as the AUC for the kernels. Similarly as for the case of
individual classes, the BiG-SCAPE-derived kernel seems to shows similar performance to
Top-1 Top-5 Top-20 AUC
bs composite 0.0054 0.1580 0.2902 0.7461
tf-idf 0.0054 0.1502 0.3303 0.8189
wv 0.0072 0.1544 0.3339 0.8544
random 0.0006 0.0014 0.0116 0.5024
Table 5.6: Top-n performance, and AUC, of three of the best-performing kernels The BiG-
SCAPE composite kernel consists of all BGCs, where inter-class distances are computed
using the ‘mix’ distance metric, while intra-class distances are computed using the class-
appropriate metric. The simple word vector metric achieves the best performance for n = 1
and n = 20, as well as the highest AUC.
bs bs clip bs flip wv tfidf bs raw clip bs recal clip bs raw flip bs recal flip
NRPS 0.002 0.013 0.004 0.005 0.004 0.009 0.002 0.009 0.002
Others 0.002 0.004 0.008 0.004 0.006 0.012 0.004 0.008 0.004
PKSI 0.000 0.011 0.004 0.015 0.013 0.011 0.013 0.009 0.000
PKS-NRP Hybrids 0.000 0.004 0.004 0.004 0.000 0.004 0.004 0.004 0.004
PKSother 0.000 0.003 0.000 0.003 0.003 0.000 0.003 0.000 0.000
RiPPs 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Saccharides 0.000 0.000 0.015 0.015 0.000 0.000 0.000 0.000 0.000
Terpene 0.000 0.013 0.000 0.013 0.000 0.006 0.006 0.006 0.013
mix 0.002 0.013 0.004 0.008 0.005 0.009 0.010 0.006 0.001
bs bs clip bs flip wv tfidf bs raw clip bs recal clip bs raw flip bs recal flip
NRPS 0.031 0.186 0.084 0.184 0.173 0.157 0.159 0.157 0.033
Others 0.064 0.153 0.085 0.137 0.147 0.145 0.145 0.145 0.048
PKSI 0.002 0.176 0.067 0.191 0.194 0.165 0.169 0.135 0.022
PKS-NRP Hybrids 0.046 0.212 0.108 0.229 0.233 0.192 0.204 0.192 0.058
PKSother 0.048 0.168 0.082 0.175 0.148 0.134 0.148 0.134 0.045
RiPPs 0.268 0.408 0.268 0.352 0.423 0.437 0.380 0.394 0.155
Saccharides 0.388 0.403 0.358 0.388 0.358 0.358 0.418 0.358 0.164
Terpene 0.051 0.083 0.038 0.083 0.109 0.071 0.077 0.058 0.019
mix 0.016 0.169 0.077 0.160 0.156 0.155 0.151 0.124 0.039
bs bs clip bs flip wv tfidf bs raw clip bs recal clip bs raw flip bs recal flip
NRPS 0.088 0.338 0.234 0.414 0.365 0.308 0.308 0.308 0.115
Others 0.128 0.263 0.209 0.333 0.337 0.242 0.255 0.251 0.147
PKSI 0.041 0.296 0.169 0.357 0.365 0.302 0.306 0.252 0.085
PKS-NRP Hybrids 0.146 0.400 0.296 0.479 0.446 0.367 0.362 0.367 0.204
PKSother 0.127 0.326 0.210 0.447 0.467 0.278 0.278 0.278 0.220
RiPPs 0.549 0.676 0.648 0.634 0.690 0.761 0.789 0.817 0.690
Saccharides 0.597 0.582 0.567 0.597 0.612 0.657 0.731 0.657 0.478
Terpene 0.154 0.224 0.167 0.263 0.340 0.231 0.224 0.173 0.128
mix 0.045 0.291 0.184 0.344 0.336 0.275 0.272 0.246 0.121
Table 5.7: Top-n performance for the BGC kernel by natural product class, for n = 1, n = 5 and n = 20, with the best performance for each
class in bold.
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the word vector kernels for low values of n, but with a significantly lower AUC. Which one
is preferable depends on how far down the list of links we are prepared to search for correct
links.
Results on microbial data sets In the microbial data sets defined in Section 3.7, the
links are defined using MIBiG IDs. A reasonable choice of candidate set of metabolites
would be all metabolites linked to MIBiG entries, or all metabolites linked to a MIBiG entry
with significant homology to a BGC in the data set.
Either way, as the data set would include no metabolites not included in the preceding
analysis on MIBiG data, we consider analysis on the microbial data sets to be largely re-
dundant. However, implicit verification on microbial data sets will be carried out in Section
5.12, as part of the combined IOKR model.
5.11.4 Discussion
The results presented in the preceding section show the feasibility of training an IOKR model
to map BGCs to metabolites, i.e. to rank a candidate set of metabolites for a given BGC.
As previously mentioned, the performance of IOKR is greatly influenced by the choice of
kernels, both on the space of BGCs and metabolites.
Although the method is evaluated here both on the individual natural product classes, and
the collected set of all BGCs (the ‘mix’ row in Table 5.5) this is to accommodate the BiG-
SCAPE similarity function, which has a different weight vector depending on the natural
product class. Interestingly, not only does the word vector kernel on the combined set of
all BGCs outperform the other kernels in seven out of nine instances, including on the set
of all BGCs, the word vector kernel on the set of all BGCs outperforms the majority of the
other kernels, including the product-type-specific BiG-SCAPE similarities. While the BiG-
SCAPE similarities may be adversely affected by the kernelisation, it is also interesting to
note that for this method, the individual metrics do not seem to provide much additional
information over the metric for the combined classes, as evident by the very similar perfor-
mance of the composite BiG-SCAPE metric and the unaltered BiG-SCAPE metric on the
‘mix’ class.
Different kernels than ones considered here have shown considerable promise in other appli-
cations, for instance the pfam2vec embedding defined in [86], which has been successfully
used for BGC detection. While this method is not directly applicable to sequences of Pfam
domains, the word2vec model on which it is based [167] has been extended from words to
sentences (e.g. [168, 169]), and similar approaches might be applicable to pfam2vec. How-
ever, as the present work is mostly intended as a proof of concept, we leave the exact choice
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of kernels and the optimisation of parameters for future work.
5.12 MS2-BGC IOKR
The two previous sections introduced IOKR as a method to rank a candidate set of metabo-
lites against an MS2 spectrum (Section 5.10) and a BGC (Section 5.11). While these ap-
proaches can be useful in their own right [92, 170] the requirement of a candidate set of
metabolites limits their utility. When matching MS2 spectra to a candidate set of BGCs, this
restricts the use to BGCs with considerable homology to known BGCs, and for matching
BGCs to a candidate set of MS2 spectra, this restricts the use to MS2 spectra which have
been identified as belonging to a particular metabolite.
Ideally, we would like to rank a set of BGCs against a set of spectra (or vice versa) without the
intermediary of a candidate set of metabolites. To do this, we propose to join the individual
models developed in the two previous sections. We refer to this as a combined IOKR model.
5.12.1 Combining IOKR models
Recall that in Section 5.5, the IOKR model was defined in terms of an input spaceX , metabo-
lite space Y and feature space F of molecular fingerprints with inner product 〈·, ·〉F . The
function φ : Y → F was the function sending metabolites to their molecular fingerprints,
and h : X → F the function sending input objects to their molecular fingerprints. Based on
training data, we learned an approximation ĥ : X → F of h, which was then used to rank
links by computing σIOKR(x, y) = 〈ĥ(x), φ(y)〉F . Section 5.10 described this model where
X was the space of MS2 spectra, while Section 5.11 did the same where X was the space of
BGCs.
We consider the combined model to consist of two sub-models, a MS2-metabolite model,
and a BGC-metabolite model. For the combined model, let Y be the space of metabolites,
as before, and F the space of molecular fingerprints. We take X to be the space of MS2
spectra, and Z to be the space of BGCs. We denote by hX : X → Y the function mapping
MS2 spectra to their corresponding molecular fingerprints, and by hZ : Z → Y the function
mapping BGCs to their corresponding molecular fingerprint. A diagram of the model can be
seen in Figure 5.9.
The combined IOKR model calculates the scores for the BGC-MS2 pairs in the same way
as for the individual models, by computing the similarity between the predicted molecular
fingerprints, but instead of computing the similarity between a single predicted molecular
fingerprint and a candidate set of fingerprints that can be exactly calculated from known




Figure 5.9: Arrow diagram of the combined IOKR framework. φ is the mapping that
sends a molecule y in the space Y of all molecules to its molecular fingerprint φ(y) ∈ F ,
the shared latent space. ĥX and ĥZ are the learned approximation to the functions hX and
hY which take a spectrum x and a BGC z to the molecular fingerprint of the corresponding
metabolite. Given a spectrum x ∈ X and a BGC z ∈ Z , the potential link between them is
assigned a score by computing the similarity between ĥX (x) and ĥZ(z), the images of x and
y in F under the learned functions.
metabolites, the scores in the combined model are similarities between two predicted molec-
ular fingerprints, one for the MS2 spectrum and one for the BGC, with pairs that have similar
predicted fingerprints assigned a higher score than pairs that have dissimilar predicted fin-
gerprints.
We define the training data sets for the two models, MS2-metabolite and BGC-metabolite,
separately. The training data for the MS2-metabolite half of the model consists of a set SX
of tuples (x, y) where x ∈ X and y ∈ Y . Similarly, the training data for the BGC-metabolite
half of the model consists of a set SZ of tuples (z, y) where z ∈ Z and y ∈ Y . Importantly,
the training data metabolites do not need to be the same for the SX and SY sets. This matters
a great deal because otherwise the training set would in effect be restricted to the combined
MIBiG-GNPS data set described in Section 3.6. Being able to train the model on separate
data sets affords us a much bigger training data set.
Let KX be the kernel on the space X , and KZ be the kernel on the space Z , with ψX as the
function such that KX (xi, xj) = 〈ψX (xi), ψX (xj)〉F for all xi, xj ∈ X , and ψZ the func-
tion such that KZ(zi, zj) = 〈ψZ(zi), ψZ(zj)〉F for all zi, zj ∈ Z . Let furthermore MX and
MYX be the matrices of [ψX (x1), . . . , ψX (xn)] and [φ(y1), . . . , φ(yn)] respectively, where
(xi, yi) ∈ SX , i.e. the column vectors of the matrices are the images in the molecular finger-
print space of the training set points for the MS2 half of the model. Let MZ and MYZ be the
corresponding matrices for the BGC half. Finally, let KX and KZ be the Gram matrices on
the training sets for the spectrum part and the BGC part, respectively.
Similarly to Section 5.5, we aim to learn an approximation to the functions hX and hZ by
minimising the regularised least-squares loss function with regularisation parameters λX and
λZ , respectively. As demonstrated in [150], the approximation to hX has the form ĥX (x) =
WXψX (x), which has the closed-form solution
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WX = MY (KX + λX I)
−1MTX (5.19)
so
ĥX (x) = MYX (KX + λX I)
−1MTXψ(x) (5.20)
= MYX (KX + λX I)
−1kX(x) (5.21)
with kX(x) as the vector with elements KX (xi, x) = 〈ψ(xi), ψ(x)〉F for xi from the training
set SX . Correspondingly, the approximation to hZ becomes
ĥZ(z) = MYZ (KZ + λZI)
−1MTZψ(z) (5.22)
= MYZ (KZ + λZI)
−1kZ(z). (5.23)
We can then compute the score between a spectrum x and a BGC z as
σIOKR(x, y) = 〈ĥX (x), ĥZ(z)〉F (5.24)
= 〈MYX (KX + λX I)−1kX(x),MYZ (KZ + λZI)−1kZ(z)〉F (5.25)
= MYX (KX + λX I)
−1kX(x)MYZ (KZ + λZI)
−1kZ(z) (5.26)




MYZ (KZ + λZI)
−1kZ(z) (5.27)
= (KX + λX I)
−1kX(x)KYX,Z (KZ + λZI)
−1kZ(z) (5.28)
where KYX,Z is the matrix of kernel values kxy = 〈φ(yx), φ(yz)〉 where yx belongs to a tuple
in the training set SX for MS2 spectra, and yz belongs to a tuple in the training set SZ for
BGCs.
5.12.2 Results
Matching an MS2 spectrum to a candidate set of BGCs Using the MIBiG-GNPS
data set of matched MS2 spectra and BGCs introduced in Section 3.6, we can match each
individual MS2 spectrum to the candidate set of unique BGCs, ranking the BGCs by score.
When establishing the rank of the correct links in the MIBiG-GNPS data set, we again en-
counter the problem of the true relationship between objects being many-to-many, i.e. each
BGC can have multiple associated spectra, and each spectrum can have several associated
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Figure 5.10: Top-n accuracy of IOKR using individual links, matching BGCs to candidate
sets of MS2 spectra, and matching MS2 spectra to candidate sets of BGCs.




























Figure 5.11: Top-n accuracy of IOKR using equivalence classes, matching BGCs to candi-
date sets of MS2 spectra, and matching MS2 spectra to candidate sets of BGCs.
BGCs. In this case, given an MS2 spectrum, we can have multiple BGCs linked to the spec-
trum in the ground truth data set. In such cases, we can either take the ranks for the individual
links, counting each BGC that is linked to the spectrum as one link, or treat all the BGCs that
are matched to the spectrum as an equivalence class, and taking the highest rank of a BGC
belonging to the equivalence class corresponding to the spectrum, yielding a single correct
link for the spectrum. To distinguish between the two, we refer to these approaches as using
individual links or using equivalence classes.
The latter approach is better indicative of how far the researcher would need to go down
the ranked list of links before encountering a correct link for the query object. However,
when the subset of correct matches in the candidate set is relatively large, as is the case for
matching BGCs to a candidate set of MS2 spectra, this can easily drown out weak signal
when randomising the scores.
Table 5.8 shows the Top-n performance and AUC for the combined IOKR model matching
MS2 spectra to a candidate set of BGCs individually, i.e. the former of the two matching
approaches, while Table 5.9 shows the same data using only the top-ranking BGC for each
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Top-1 Top-5 Top-10 Top-20 Top-200 AUC
Data 0.0299 0.1030 0.1657 0.2746 0.9485 0.6818
Random 0.0052 0.0220 0.0504 0.0922 0.8795 0.4934
Table 5.8: Top-n performance and AUC matching MS2 spectra to a candidate set of unique
BGCs, ranking individual links.
Top-1 Top-5 Top-10 Top-20 Top-200 AUC
Data 0.0407 0.1243 0.1933 0.3094 0.9712 0.7081
Random 0.0109 0.0385 0.0657 0.1200 0.9142 0.5592
Table 5.9: Top-n performance and AUC matching MS2 spectra to a candidate set of unique
BGCs, using the highest scoring member of each BGC equivalence class.
spectrum. The randomised data set is created by shuffling the vector of scores for each
spectrum before extracting the scores for the correct matches.
Both approaches outperform the randomised baseline. The left-side graphs in Figures 5.10
and 5.11 show the comparison between the performance of the combined IOKR model on
the actual and randomised data for individual and equivalence class links, respectively.
Matching a BGC to a candidate set of MS2 spectra Using the MIBiG-GNPS data
set to match BGCs to a candidate set of MS2 spectra is complicated by the fact that there
are an order of magnitude more MS2 spectra than BGCs. Many of the BGCs have a large
number of associated spectra, and therefore treating the spectra as equivalence classes and
only choosing the best-ranked spectrum for each BGC risks drowning the signal.
Tables 5.10 and 5.11 show the top-n performance and AUC of the combined IOKR model
matcing BGCs to a candidate set of MS2 spectra. Ranking each BGC-spectrum link individ-
ually, the model shows a modest performance improvement over the randomised baseline,
which is created by randomising the score vector for each BGC before extracting the scores
for the correct spectra. However, this performance improvement disappears when treating
the spectra as equivalence classes, possibly because of the reasons discussed above.
The performance of the IOKR model on the real data compared with the randomised baseline
can be seen on the right-hand side of Figures 5.10 and 5.11 for the individual and equivalence
class links, respectively. Note that the unexpectedly high AUC value for the randomised data
in Table 5.11 is likely due to the large size of the equivalence classes for the different BGCs.
Microbial datasets To evaluate the performance of the combined IOKR model on the
microbial data sets, we again have to choose at which level we want to evaluate the links.
Since the validated links are variously at the BGC-MF or BGC-MS2 level, we choose to
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Top-1 Top-5 Top-10 Top-20 Top-200 AUC
Data 0.0011 0.0060 0.0097 0.0194 0.1683 0.5366
Random 0.0004 0.0041 0.0052 0.0112 0.1168 0.4973
Table 5.10: Top-n performance and AUC matching BGCs to a candidate set of unique MS2
spectra, ranking individual links.
Top-1 Top-5 Top-10 Top-20 Top-200 AUC
Data 0.0133 0.0177 0.0265 0.0398 0.4469 0.7485
Random 0.0044 0.0265 0.0575 0.0973 0.4823 0.7513
Table 5.11: Top-n performance and AUC matching BGCs to a candidate set of unique MS2
spectra, using the highest scoring member of each MS2 equivalence class.
do the matching using MFs rather than individual spectra, for consistency between data
sets. This makes it possible for us to pool the results to enhance the statistical power of the
analysis.
Furthermore, we choose to evaluate GCF-MF links, rather than BGC-MF links. This is
both to stay consistent with the analysis in previous sections, but also to reduce the number
of true-but-unverified links in the data set. Because many of the microbes in the data sets
are closely related, they are likely to harbour similar BGCs with similar products, yielding
potentially high-scoring, true but unverified links that might obscure the signal.
To propagate the BGC-spectrum scores to GCFs and MFs, we take the maximum score over
all pairs of BGCs and spectra in the GCF and MF respectively, as in Section 5.9.
Table 5.12 shows the proportion of validated links scoring above the 95th and 90th percentile
for each data set, compared to the proportion of validated links in the whole data set. Using
the 95th percentile as cutoff, two out of three data sets are significantly enriched for validated
links towards the top end of the distribution, while the enrichment is only significant for one
out of the three using the 90th percentile. The enrichment is significant for both cutoffs,
however, when pooling the results.
Notably, comparing Tables 5.12 and 5.3, in the Leão data set, both the 95th and 90th per-
centiles are relatively more enriched for validated links than in the MS2-MIBiG IOKR
model. This may be because analysis for the MS2-MIBiG model was restricted to BGCs
that show considerable homology to MIBiG BGCs. This means that the data set under con-
sideration here might contain more novel predictions, which at the same time might be of
lower quality. This could potentially result in a higher number of low-scoring links for the
BGCs that are included in the current analysis, but not in the analysis for the MS2-MIBiG
model, while all GCFs involved in the set of validated links have considerable homology to
MIBiG BGCs by their nature.
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Crüsemann Leão Gross total
All
Verified 15 8 5 28
Total 1404676 9900 782160 2196736
Ratio 1.0678× 10−5 0.0008 6.3926× 10−6 1.2746× 10−5
> 95% σIOKR
Verified 4 3 1 8
Total 70234 495 39108 109837
Ratio 5.6952× 10−5 0.0061 2.5570× 10−5 7.2835× 10−5
p-value 0.0112 0.0135 0.2538 0.0002
> 90% σIOKR
Verified 7 3 1 11
Total 140468 990 78126 219584
Ratio 4.9833× 10−5 0.0030 1.27998× 10−5 5.0095× 10−5
p-value 0.0026 0.0714 0.4355 0.0005
Table 5.12: Number of validated links with IOKR score above 95th and 90th percentile, and
significance according to Fisher’s Exact Test, compared to all links.
One way to verify this would be to compare the distributions of scores for all links involving
GCFs with homology to MIBiG BGCs and for all links involving GCFs that do not have
considerable homology to MIBiG GCFs. A lower average score for the latter would support
this hypothesis.
Figure 5.12 shows the distribution of validated links in the histogram of scores for all poten-
tial links for the three data sets, demonstrating the concentration of the validated links in the
upper part of the distribution.
5.13 Summary
In this section, we have proposed two IOKR models, one linking MS2 spectra to known
BGCs and the other linking BGCs to metabolites. We then described a way to combine the
models to extend them to novel BGCs and spectra, with minimal loss of performance com-
pared to the individual models. Results were demonstrated both on the combined MIBiG-
GNPS data set, and on microbial data sets, as applicable. Used as an end-to-end model, the
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Figure 5.12: Histograms of the distribution of scores for all potential links, and validated
links using the combined IOKR model.
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Chapter 6
Using multiple scoring functions
6.1 Introduction
The scoring functions described in Chapters 4 and 5 can be considered as representatives of
two fundamentally different approaches to the problem of linking genomic and metabolomic
information. While the two approaches have been used in tandem, the relation between them
has not been previously investigated.
Section 6.2 discusses the strengths and weaknesses of the two approaches to linking, while
Sections 6.3 and 6.4 demonstrate their how they each capture different aspects of the problem
and are therefore complementary. Finally, Sections 6.5 and 6.6 present a way of combining
the scoring functions into a single function which outperforms each of the individual scoring
functions on the data sets under consideration.
6.2 Comparing correlation-based and feature-based
linking
While the goal of both strain correlation-based and feature-based scoring methods is to rank
links between BGCs and MS2 spectra, the approaches discussed in the two preceding chap-
ters obviously rely on a very different set of assumptions, and are based on very different
data.
As we have already discussed, both approaches have been used to good effect, and each has
their own advantages and disadvantages.
The metabologenomics approach does not rely upon any predictions about the structure of
the BGC, and can therefore be said to be more straightforward than the the feature-based
approaches. The underlying idea is also simple to understand. However, it relies on having
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a considerable number of strains in the population, with larger population size translating
into greater statistical power. Furthermore, it relies on the BGC not being cryptic in too
many cases. Therefore, it is very sensitive to culture conditions and is not very well suited
to conclusively identify rare BGCs or BGCs that are only rarely expressed. Furthermore,
the granularity of the metabologenomics approach is by its nature limited, in that it ca not be
used to prioritise potential links that show the same correlation pattern. For instance, it offers
no way of prioritising potential links involving collections of singleton GCFs and MFs, i.e.
GCFs and MFs which only contain BGCs and spectra from one strain.
On the other hand, feature-based approaches are usually limited to a single natural product
class. The prediction of adenylation specificity used in Pep2Path [97], for instance, is only
applicable to NRPs and RiPPs, and GNP [69] focuses only on NRPs and PKs. In addition,
while feature-based methods ideally would be able to predict unique, characteristic features
for each BGC, the same features are often predicted for multiple BGCs, leading to identical
scores for more than one BGC-spectrum link. Furthermore, not all molecular properties can
be detected in MS2 at all, notably stereochemistry.
As the two approaches rely on different underlying data to draw their conclusions, it stands
to reason that they may very well be complementary. While this complementarity has in
fact been widely implicitly assumed, for instance when using strain correlation analysis as a
filtering tool for further analysis, as in [63] and [92], it has neither been quantified nor used
in a systematic manner to compensate for potential shortcomings in the different scoring
functions.
In the following sections we demonstrate how the standardised strain correlation score and
IOKR scores complement one another, and discuss how they can be used in conjunction to
better prioritise potential links.
Because the IOKR model presented in the previous Section was initially developed for MS2-
MIBiG analysis, as that application was closest to the application presented in [113], the
analysis in this chapter is mostly done using the MS2-MIBiG IOKR model. However, Sec-
tion 6.6 briefly demonstrates similar results for the combined IOKR model introduced in
Section 5.12, indicating that the results presented here for MS2-MIBiG IOKR model apply
at least partially to the combined IOKR model.
6.3 Complimentarity of correlation- and feature based
scores
To demonstrate the complementarity of the standardised strain correlation- and IOKR scores,
we can take an approach similar to the one used to demonstrate the efficacy of the individual
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Gross Leão Crüsemann all
all
verified 5 8 15 28
total 501886 9342 999362 1510590
ratio 9.96× 10−6 0.00086 1.50× 10−5 1.85× 10−5
> 95% σIOKR
verified 1 1 6 8
total 25095 437 49970 75502
ratio 3.98× 10−5 0.00211 0.00012 0.00011
> 95% σ̄corr
verified 2 6 10 18
total 35333 1560 50224 87117
ratio 5.66× 10−5 0.00385 0.00020 0.00021
> 95% both
verified 0 1 4 5
total 1537 77 2517 4131
ratio 0 0.01299 0.00159 0.00121
Table 6.1: The number of links (potential and verified) scoring above the 95th percentile for
the microbial data sets.
scores. We consider a microbial data set and look at the relative enrichment of validated
links in the top quantiles of the individual scores, and of the joint top quantiles of the scores,
i.e. links that simultaneously score higher than a given quantile on both scores.
Tables 6.1 and 6.2 show the number of links from the microbial data sets described in Section
3.7 scoring above the 95th and 90th percentiles for IOKR, standardised strain correlation, and
both scores, while Figures 6.1-6.3 show the distribution of IOKR- and standardised strain
correlation scores for all potential links in the three microbial data sets. The histograms for
the individual scoring functions are along the axes. Validated links are indicated with red
dots on the plots, and black lines on the histograms.
While the number of strains in the data sets means that the strain correlation score is only
particularly informative for the Crüsemann data set, as borne out by Tables 6.1 and 6.2, the
upper quantiles of both scores are significantly enriched for validated links, i.e. a higher pro-
portion of the links with the highest scores are validated links than the proportion of validated
links in the set of all potential links. Figures 6.1–6.3 demonstrate how the validated links for
all data sets are concentrated in quadrant I of the coordinate system, i.e. the quadrant where
both x- and y-axis are positive. Furthermore, some of the validated links score relatively
higher on the IOKR score than on the standardised correlation score, while the opposite is
true for others, again demonstrating the complementarity of the two scoring functions.
As demonstrated by Tables 6.1 and 6.2, the top percentiles for both of the scoring methods
contain a relatively higher ratio of validated links than the whole set. In addition, this ratio is
higher still when considering the links that score above the top percentiles on both functions.
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Gross Leão Crüsemann all
all
verified 5 8 15 28
total 501886 9342 999362 1510590
ratio 9.96× 10−6 0.00086 1.50× 10−5 1.85× 10−5
> 90% σIOKR
verified 1 1 6 8
total 50189 935 99937 151061
ratio 1.99× 10−5 0.00107 6.00× 10−5 5.30× 10−5
> 90% σ̄corr
verified 4 6 13 23
total 52014 1560 100494 154068
ratio 7.69× 10−5 0.00385 0.00013 0.00015
> 90% both
verified 1 1 5 7
total 5313 147 10836 16296
ratio 0.00019 0.00680 0.00046 0.00043
Table 6.2: The number of links (potential and verified) scoring above the 90th percentile for
the microbial data sets.
While the proportions of validated links in the top scoring links, even for both scoring func-
tions, is small, this is due to the low number of validated links in the data sets. The number
of true links in the data set — and in particular in the top percentiles — is likely to be much
higher.
To overcome the small number of validated links, and to get a clearer sense of the statistical
significance of the overrepresentation of links in the upper percentiles of the scoring func-
tions, we can pool the microbial data sets by ranking the potential links in each data set indi-
vidually and adding up the numbers of total links and validated links in the top percentiles,
as discussed in Section 5.10.3. This is done in the last row of Tables 6.1 and 6.2. Considering
links scoring above the 90th percentile, the enrichment is significant for both IOKR and the
standardised strain correlation scores (with p-values of 0.0139 and 2.483 × 10−11, respec-
tively), and the enrichment in the combined top percentile for both scores is significantly
higher again than for either score alone (with p-value of 2.633× 10−4 compared with IOKR
alone, and 0.0208 compared with the standardised strain correlation score alone).
These results demonstrate the complementarity of the IOKR- and standardised strain corre-
lation scores, at least in the data sets investigated here.
6.4 Links starting from individual BGCs
A common starting point for establishing correspondence between GCFs and metabolites
in microbial data sets is to start with a GCF which has significant homology to a known
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Figure 6.1: Distribution of IOKR- and standardised strain correlation scores for the
Crüsemann data set. IOKR score is on y-axis and standardised strain correlation score on
x-axis. The histograms of the individual scores are above (standardised strain correlation
score) and to the right (IOKR score) of the correlation graph. Validated links are marked in
red on the joint graph, and with black lines on the histograms.
BGC, and instead of considering the whole set of potential GCF-MF links, only ranking
links involving that particular GCF. As mentioned before, this is the approach Duncan and
co-workers used in [63] to identify retimycin A. We now turn our attention to how the scoring
functions perform in this setting, both individually and combined.
Table 6.3 shows the rankings of the validated links in the Crüsemann data set, using the
relevant GCFs as a starting point. Starting with a particular GCF, a validated link involving
that GCF, and the set of potential links that consist of that GCF and each MF in the data set,
the table shows the ranking of the validated link within that set.
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MIBiG ID BGC GCF MF
Rank of validated link
σIOKR σ̄corr ` 1
2
`1 `2 σIOKR and σ̄corr
BGC0001228 990 161 492 384 1152 253 271 317 141
BGC0000241 2688 377 381 119 16 5 12 14 1
BGC0000333 739 132 489 1810 25 32 12 12 12
BGC0000827 1642 232 206 6 1 2 1 1 1
BGC0001830 2104 295 309 673 7 7 9 24 4
BGC0000137 394 71 353 80 16 2 14 49 1
BGC0000137 394 333 353 78 189 12 29 66 3
BGC0000137 394 71 358 798 1968 1232 997 920 534
BGC0000137 394 333 358 636 612 409 642 735 120
BGC0000137 711 48 353 6 287 36 214 261 1
BGC0000137 711 123 353 6 126 14 105 122 1
BGC0000137 711 367 353 6 216 4 85 203 1
BGC0000137 711 48 358 184 282 146 271 285 17
BGC0000137 711 123 358 184 101 28 92 99 7
BGC0000137 711 367 358 184 90 19 89 88 7
Best ranks 3 2 10 2 2
Table 6.3: Scoring function performance. Columns one through four show MIBiG ID
and BGC, GCF and MF IDs of the validated links. Columns five and six show the rank
of the validated link using σIOKR and σ̄corr. Columns seven through nine show the rank of
the validated link using the `p scoring functions, and column eight using the product order.
Lower ranking is better, and the best rank for each link (excluding the product order) is
indicated in bold.
For the Crüsemann data set, this translates into 3094 potential links for each GCF, with one
potential link for each MF in the data set. For each validated link, Table 6.3 shows the IDs of
the GCF and MF in the validated link, as well as the ranking of that particular link using the
various scoring methods. In particular, columns five and six show the ranking according to
the IOKR- and standardised strain correlation scores, while the last column shows the rank
of the validated link using both scores, which gives an indication of how many links score
higher on both scores than the particular link.
In particular, while only one of the validated links is ranked highest for the relevant GCF
using a single scoring function (BGC0000827 using σ̄corr), for six out of 15 links, no link
scores higher than the validated link on both scores.
Columns seven to nine give the ranking of the validated link using a combination of the
scoring functions. The results in columns seven to ten are discussed in detail in Section 6.5.
Figures 6.4 – 6.7 show the score of the validated links, indicated with red, within the dis-
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tribution of scores for all links involving the relevant GCF for the microbial data sets. The
last column of images shows the placement of the validated link in the joint distribution of
the scores. As for the scores for all links in the data sets, shown in Figures 6.1 – 6.3, the
validated links fall in quadrant I of the coordinate system, but in some instances, validated
links with relatively high IOKR score have a relatively low strain correlation score, and vice
versa.
6.5 Combining scores
6.5.1 Ranking in multiple dimensions
Assigning a score to a set of items can be considered as positioning the items on the line of
real numbers, R. When considering more than one scoring function, the score of an item
can be considered as a point in Rn, where n is the number of scoring functions. As we are
interested in using multiple scoring functions to rank objects, we need to consider ordered
sets in general.
A totally ordered set A is a set such that for all elements x, y ∈ A, where x 6= y, either x < y
or y < x, while for a partially ordered set there may exist elements x, y ∈ A such that x 6= y
but neither x < y nor y < x. An example of a totally ordered set is the set of real numbers
R, while ordering the set of points in R by their distance from 0 would not make for a total
order, since more than one point on the line can have the same distance from 0.
The Cartesian product of two sets A and B is the set A × B with elements (a, b), where
a ∈ A and b ∈ B. The set of real numbers in two dimensions R2 = R × R is the Cartesian
product of two instances of R.
In the preceding sections, scoring functions have been used implicitly to define an order on
a set. Given a set A and a scoring function σ : A→ R, we have used this function to define
an order on the set A in an intuitive way by setting x < y if and only if σ(x) < σ(y) for
x, y ∈ A. Note, however, that since σ is not injective (not one-to-one, i.e. there may be
elements a, b ∈ A, with a 6= b, such that σ(a) = σ(b)), the order thus defined is a partial
order on the set, i.e. there may exist elements x and y inA such that neither x < y nor y < x,
but x 6= y. These are exactly the elements x and y in A where σ(x) = σ(y).
While using a scoring function to rank objects in this way is straightforward, there is no
canonical way to generalise such rankings to take more scoring functions into account. For
two scoring functions, such generalisation is equivalent to defining an order on R2, i.e. an
order on real numbers in two dimensions, or more generally, for n scoring functions, defining
an order on Rn.
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Given two ordered sets A and B, various orders can be defined on the Cartesian product A×
B. Two common ways of extending the orders on A and B to A×B are the lexicographical
order, defined by
(a1, b1) < (a2, b2) ⇐⇒
a1 < a2 ora1 = a2 and b1 < b2, (6.1)
and the product order defined by
(a1, b1) < (a2, b2) ⇐⇒ a1 < a2 and b1 < b2. (6.2)
If the orders on A and B are total orders, the lexicographical order on A×B is a total order
as well, while this is not the case for the product order, as (a1, b1) and (a2, b2) cannot be
compared if a1 < a2 but b2 < b1, or vice versa.
In the preceding section, the complementarity of σ̄corr and σIOKR is demonstrated using the
product order. However, although useful in demonstrating the complementarity of the scores,
the product order is not particularly useful in prioritising novel links for further investiga-
tion. This is because as a partial order, it leaves many elements incomparable with one
another, the product order even more so than many other partial orders. Given two elements
(a1, b1), (a2, b2) ∈ A×B, they can only be compared in the product order if both a1 < a2 and
b1 < b2, or a2 < a1 and b2 < b1. As we hope to use the complementarity of the two scoring
functions to compensate for the cases where one or the other fails, we want to minimise the
number of incomparable elements.
One potential way to prioritise links using the product order would be to consider links whose
internal order cannot be determined in the product order as equivalence classes, rank the
equivalence classes, and then try to find a different way to internally rank each equivalence
class.
The lexicographical order does not suffer from this problem to the same degree. In fact,
given two totally ordered sets A and B, the lexicographical order inherited by the Cartesian
product A × B is a total order as well, so if the sets are not totally ordered, the only ties
inherited by that order are elements that are tied in the individual orders on the sets A and
B. However, informally speaking, the lexicographical order involves giving precedence to
one of the scoring functions and only using the other scoring function in case of ties in the
former. This means that, for instance, a high IOKR score only has meaning within the context
of two links having the same strain correlation score. Since we hope to use the two scoring
functions to complement one another, looking at Figures 6.1 – 6.3, this is likely not optimal
behaviour, and we hope to be able to do better.
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6.5.2 Combined scoring functions
As stated in the previous section, for a set X , any function f : X → R can be used to define
a (possbily partial) order on the set. In particular, if X and Y are sets with scoring functions
σx and σy, this applies to the Cartesian product X × Y , so we can define a new real-valued
function, with domain X × Y , by combining the individual scoring functions as we see fit,
and use that function to define an order on the set.
If X = Y , we can use this to define a new order on the set X , based on the two functions:
if σx : X → R and σy : X → R are two scoring functions on the set X , we can use any
function g : R2 → R to define a new scoring function ψ : X → R by setting ψ(x) =
g(σx(x), σy(x)), and use that to define a new order on the set X .
To make sure that the standardised strain correlation score σ̄corr and the IOKR score σIOKR




with the variance and expected value estimated using the scores for all potential links.
We now turn to the problem of defining a combined scoring function based on both σ̄corr and
σ̄IOKR.
An intuitive way to define a combination of scoring functions in R2 is considering concentric
rings centered at the origin, and assigning the points a score equal to the distance from the
origin. This applies particularly in quadrant I, where both scores are positive.
Looking at the joint plots for the score distributions, in particular Figure 6.1, however, a
couple of things become clear:
• As we would hope, the validated links are all in quadrant I, i.e. both scores are positive
for all of the validated links.
• The distributions of the scores of the potential links are in fact not independent. Links
with a high σ̄IOKR are over-represented among the links with σ̄corr close to 0, and links
with high σ̄corr are over-represented among the links with σ̄IOKR close to 0.
Distances in R2 are usually measured in the Euclidean norm, also called the `2-norm. The




2, and generalises to the
`p-norm as
`p(x) = (|x1|p + |x2|p)
1
p (6.3)
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for a real number p ≥ 1. While this only fulfills the conditions for being a norm for p ≥ 1,
we can still define the function `p for 0 < p < 1, sacrificing the triangle inequality. Figure
6.8 shows the set of points where x = 1 for p = 1
2
, p = 1 and p = 2.
As we are mainly interested in using the score to order links, rather than evaluate the differ-
ence in scores, and the power function f(x) = xp is monotonic for all p, we can simplify Eq.
6.3 to
`p(x) = |x1|p + |x2|p (6.4)
without affecting the resulting order.
In the positive quadrant of the coordinate system (quadrant I) we can use Eq. 6.4 directly,
with x1 as σ̄corr and x2 as σ̄IOKR. As `p is calculated using the absolute value of the scores,
and we still want to penalise points coming from quadrants other than I, in particular from
quadrant III, where both scores are negative, we can multiply the scores with their signs after
the power function. Using sgn(x) as the function sending x to 1 if x ≥ 0 and to -1 otherwise,
we can combine the standardised strain correlation score σ̄corr and the standardised IOKR
score σ̄IOKR into a new score `p, by setting
`p = sgn(σ̄corr)|σ̄corr|p + sgn(σ̄IOKR)|σ̄IOKR|p (6.5)
Table 6.3 shows the ranking of the validated links in the Crüsemann data set, starting from
the validated BGC, using the ranking inherited from the various scoring functions, as well
as the product order. Columns five through nine show the rank of the links using the order
inherited from σIOKR, σ̄corr, and the `p scores using p = 12 , p = 1 and p = 2. The last column
shows the rank of the link using the product order. The best rank for each link is indicated in
bold, with lower numbers being better. This excludes the product order, since as discussed
before it is not particularly useful to prioritise links due to the large number of incomparable
elements.
While none of the rankings consistently places the validated link at the top of the list of
links, the ` 1
2
score gives the best ranking in 10 out of 15 cases, including in three out of the
five cases where the link is unambiguous. For instance, the ` 1
2
-ranking for BGC0001228
(retimycin A) is 253, and for BGC0000241 (lomaiviticin A) is 5, both of which are consider-
ably better than for the individual scoring functions, as well as for other values of p explored.
While other values of p, or other approaches to combining the scoring functions, may very
well yield better results, we have clearly demonstrated the utility of combining the scoring
functions.
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Gross Leão Crüsemann All
All
Verified 5 8 15 28
Total 782160 9900 1404676 2196736
Ratio 6.39× 10−6 0.00081 1.07× 10−5 1.27× 10−5
≥ 95% σIOKR
Verified 1 3 4 8
Total 39108 495 70234 109837
Ratio 2.56× 10−5 0.00606 5.70× 10−5 7.28× 10−5
≥ 95% σ̄corr
Verified 2 5 10 17
Total 56634 1493 68560 126687
Ratio 3.53× 10−5 0.00335 0.00015 0.00013
≥ 95% both
Verified 1 1 3 5
Total 3101 72 4895 8068
Ratio 0.00032 0.01389 0.00061 0.00062
Table 6.4: The number of links (potential and verified) scoring above the 95th percentile for
the microbial data sets using the combined IOKR model.
6.6 Combining scores using the combined IOKR model
While the experiments previously detailed in this Section were performed for the MS2-
MIBiG IOKR model described in Section 5.10, similar results hold for the combined IOKR
model described in Section 5.12. In particular, Tables 6.4 and 6.5 show the enrichment of
validated links above the 95th and 90th percentiles respectively, for the combined IOKR
score, the standardised strain correlation score and both scores. Similar to Tables 6.1 and
6.2, the higher percentiles are significantly enriched for validated links.
Similar to Figures 6.1 – 6.3, Figures 6.9 – 6.11 show the joint distribution of the combined
IOKR score and correlation score, demonstrating the concentration of the validated links in
quadrant I of the coordinate system, i.e. where both scores are positive.
Finally, Table 6.6 shows that similarly to Table 6.3, the ` 1
2
achieves the best rank of validated
links starting from BGCs for the combined IOKR model as well as the MS2-MIBiG IOKR
model described in Section 5.10, although not by as large a margin as for the MS2-MIBiG
IOKR model.
6.7 Summary
In this section, we have conclusively demonstrated the complementarity of the feature-based
and correlation-based approaches to scoring BGC-MS2 links. While this complementarity
has been implicitly assumed, it has previously neither been demonstrated nor quantified.
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Gross Leão Crüsemann All
all
Verified 5 8 15 28
Total 782160 9900 1404676 2196736
Ratio 6.39× 10−6 0.00081 1.07× 10−5 1.27× 10−5
> 95% σIOKR
Verified 1 3 7 11
Total 78216 990 140468 219674
Ratio 1.28× 10−5 0.00303 4.98× 10−5 5.01× 10−5
> 95% σ̄corr
Verified 4 5 13 22
Total 82622 1493 123829 207944
Ratio 4.84× 10−5 0.00335 0.00010 0.00011
> 95% both
Verified 1 1 7 9
Total 9566 172 18538 28276
Ratio 0.00010 0.00581 0.00038 0.00032
Table 6.5: The number of links (potential and verified) scoring above the 90th percentile for
the microbial data sets using the combined IOKR model.
Furthermore, we have proposed a way to combine the two scoring methods proposed in
Chapters 4 and 5 to yield a single scoring function that can be used to prioritise links for
further verification, based on observations of the correlation of the scores.
While further optimisation of the combination of functions is surely possible, we believe
that a principled approach such as the one described here present a sensible way to prioritise
potential links.
MIBiG ID BGC GCF MF
Rank of validated link
σIOKR σ̄corr ` 1
2
`1 `2 σIOKR and σ̄corr
BGC0001228 990 161 492 1774 1152 1680 1699 1726 629
BGC0000241 2688 377 381 642 16 19 17 17 9
BGC0000333 739 132 489 1069 25 23 11 11 10
BGC0000827 1642 232 206 74 1 1 1 1 1
BGC0001830 2104 295 309 149 7 3 3 7 3
BGC0000137 394 71 353 130 16 7 6 9 4
BGC0000137 394 333 353 130 189 41 51 169 17
BGC0000137 394 71 358 475 1968 889 853 904 293
BGC0000137 394 333 358 473 612 301 524 774 117
BGC0000137 711 48 353 79 287 129 154 166 15
BGC0000137 711 123 353 79 126 47 88 115 8
BGC0000137 711 367 353 80 216 25 37 99 9
BGC0000137 711 48 358 628 282 198 451 701 94
BGC0000137 711 123 358 614 101 73 97 108 28
BGC0000137 711 367 358 526 90 71 92 138 20
Best ranks 1 3 9 5 2
Table 6.6: Scoring function performance. Columns one through four show MIBiG ID and
BGC, GCF and MF IDs of the validated links. Columns five and six show the rank of the
validated link using σIOKR with the combined IOKR model, and σ̄corr. Columns seven through
nine show the rank of the validated link using the `p scoring functions, and column eight
using the product order. Lower ranking is better, and the best rank for each link (excluding
the product order) is indicated in bold.
Figure 6.2: Distribution of IOKR- and standardised strain correlation scores for the
Leão data set. IOKR score is on y-axis and standardised strain correlation score on x-axis.
The histograms of the individual scores are above (standardised strain correlation score) and
to the right (IOKR score) of the correlation graph. Validated links are marked in red on the
joint graph, and with black lines on the histograms.
Figure 6.3: Distribution of IOKR- and standardised strain correlation scores for the
Gross data set. IOKR score is on y-axis and standardised strain correlation score on x-axis.
The histograms of the individual scores are above (standardised strain correlation score) and
to the right (IOKR score) of the correlation graph. Validated links are marked in red on the
joint graph, and with black lines on the histograms.
Figure 6.4: Distribution of scores Distribution of scores starting from verified BGCs in the
Crüsemann data set.
Figure 6.5: Distribution of scores Distribution of scores starting from verified BGCs in the
Crüsemann data set (continued).
Figure 6.6: Distribution of scores Distribution of scores starting from verified BGCs in the
Leão data set.


















Figure 6.8: `p iso-lines in R2. The set of points (x, y) such that `p(x, y) = (xp + yp)
1
p = 1
for p = 1
2
, p = 1 and p = 2. `2 is the usual Euclidean norm. This demonstrates the form
of the iso-lines of scores using the `p-function for different values of p to combine σ̄corr and
σ̄IOKR, i.e. `p(σ̄corr, σ̄IOKR).
Figure 6.9: Distribution of IOKR- and standardised strain correlation scores for the
Crüsemann data set. IOKR score is on y-axis and standardised strain correlation score on
x-axis. The histograms of the individual scores are above (standardised strain correlation
score) and to the right (IOKR score) of the correlation graph. Validated links are marked in
red on the joint graph, and with black lines on the histograms.
Figure 6.10: Distribution of IOKR- and standardised strain correlation scores for the
Leão data set. IOKR score is on y-axis and standardised strain correlation score on x-axis.
The histograms of the individual scores are above (standardised strain correlation score) and
to the right (IOKR score) of the correlation graph. Validated links are marked in red on the
joint graph, and with black lines on the histograms.
Figure 6.11: Distribution of IOKR- and standardised strain correlation scores for the
Gross data set. IOKR score is on y-axis and standardised strain correlation score on x-axis.
The histograms of the individual scores are above (standardised strain correlation score) and
to the right (IOKR score) of the correlation graph. Validated links are marked in red on the





The resurgent interest in microbial natural products in drug discovery makes the development
of efficient ways of linking microbial BGCs to their corresponding MS2 spectra ever more
important. As laid out in Section 1.1, this thesis addresses four important aspects of this
development.
To begin with, in Chapter 3 we addressed the problem of quantifying the performance of
link scoring methods. In the absence of benchmark data sets we merged the industry-
standard MIBiG [66] and GNPS [64] databases of BGCs and MS2 spectra, respectively,
to obtain a benchmark database of verified BGC-MS2 links. We also described how the
Paired omics Data Platform [108] facilitates access to paired data sets of microbial genomic
and metabolomic data, and validated BGC-MS2 links in those data sets, which can be used
for performance evaluation.
Second, starting with the correlation-based approach to link BGCs and MS2 spectra, Chap-
ter 4 demonstrated a serious flaw in the commonly-used strain correlation score and then
proceeded to mitigate it by standardising the score to make comparison between different
potential links easier. We then demonstrated how the strain correlation score can penalise
BGCs shared by HGT and further showed how the phylogenetic relation between the strains
in the population can be taken into account to prioritise those BGCs.
Third, turning to the feature-based approach to link BGCs and MS2 spectra, Chapter 5 in-
troduced the a novel feature-based scoring method which unlike most such methods is not
dependent on natural product class.
Finally, Chapter 6 demonstrated the complementarity of the two approaches, which has until
now only been implicitly assumed, and suggested a principled way of combining multiple
scoring functions to rank potential links.
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Each of these presents potential avenues of inquiry.
7.2 Future directions
7.2.1 Data sets and tools
As described earlier the lack of standardised data sets makes comparison of methods difficult.
Linking the MIBiG and GNPS databases using structural annotations, as described in Section
3.6, can hopefully be a step in the direction of establishing such data sets, while the Paired
omics Data Platform [108] stands to vastly improve the access to microbial data sets of
paired MS2 and genomic data. The success of the latter, however, is very much dependent
on the adoption of the platform. In general, improvements in the sharing of data, adherence
to data standards, and the richness of metadata are important factors to encourage further
development of computational methods in the field.
The importance of data sharing can hardly be overstated. Although scientific journals and
funding bodies increasingly require data to be shared, in the absence of commonly accepted
benchmark data sets researchers in the field must do more than the bare minimum to make
their data accessible. The free sharing of data sets encourages innovation by levelling the
playing field and making comparison between competing approaches easier.
It is the responsibility of the researchers to make sure their data is accessible to other re-
searchers, whether for replication of their own results or development of novel methods.
This applies not only to newly created data, but also to data sets derived from existing data,
where the downstream analysis required to produce the data set used must at least be properly
documented if the derived data sets themselves are not made available.
Facilitating the reuse of data, as well as making analysis of multi-strain microbial data sets
easier, the recently-published NPLinker platform [170] aims to make linking BGCs and
MS2 spectra easier. The framework uses user-provided data, but is also integrated with
antiSMASH DB [171], BiG-SCAPE [82] and PoDP [108], and allows researchers to imple-
ment their own scoring functions in addition to the built-in ones. Improved tools for data
analysis will help drive further research in the area as well as facilitate development of new
methods of analysis.
To increase the discriminative power of the strain correlation based approaches, the ability
to pool results from different experiments would be highly useful. While genomic data is
standardised and comparable, the same cannot always be said for the metabolomic data. The
development of methods to evaluate similarity between MS2 spectra resulting from experi-
ments with different instrumentation or instrument configuration would allow researchers to
more efficiently use the data that already exists.
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While the genomic data is comparable between experiments, the assignment of BGCs into
GCFs can give different results depending on the tools used for the assignment.
As discussed in Section 3.8.1, given a known BGC in MiBIG, BiG-SCAPE and the KCB
function of antiSMASH can be considered as two facets of the same thing, i.e. the actual
metabolomic potential of the microorganisms. Ideally, for BGCs homologous to a MIBiG
entry, the GCF containing the MIBiG entry and the set of BGCs identified as close matches
to the MIBiG entry should be identical.
Cursory experiments demostrate that this is not always the case, as demonstrated by the
case of BGC0000872 in the Crüsemann data set discussed in Section 3.8.1. While this may
to some extent be explained by runtime parameters affecting clustering, the behaviour is
consistent across all values of BiG-SCAPE cutoff parameters tested, and in any case the
stability of the BiG-SCAPE clustering with regards to parameter selection would benefit
from careful investigation.
A potential reason for this discrepancy is that the similarity metric on the space of BGCs is
in some way incomplete or incompatible with the antiSMASH KCB results: the results can
be interpreted as BiG-SCAPE and antiSMASH disagreeing on how similar the BGCs are in
fact to the MIBiG BGC.
7.2.2 Similarity metrics and kernels
The underlying assumption is that similar BGCs will produce similar metabolites. While this
may seem a reasonable assumption, in fact it is dependent on the similarity metric on both
the space of BGCs, and of the metabolites.
The similarity metric on the space of BGCs impacts both the IOKR model and the strain cor-
relation model. While the impact of the similarity metric is obvious in the case of the IOKR
model, as it directly impacts the calculations, in the case of the strain correlation score, the
BGC similarity metric impacts the clustering of the BGCs into GCFs. The word vector met-
ric proposed on the space of BGCs in Section 5.11.1 has known limitations, because small
changes in Pfam domain composition can represent significant structural changes [82]. The
fact that a single Pfam domain represents all adenylation domains, irrespective of specificity,
serves to emphasise the point that theoretically, two BGCs can encode products with fun-
damental differences — namely composed of different amino acids — but still be identical
when considered in terms of Pfam domains.
To circumvent this, BiG-SCAPE relies heavily on sequence similarity when comparing mod-
ular product classes, but on the whole, this similarity measure shows worse performance in
the IOKR model than the word vector metric, even with the shortcomings mentioned above.
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While the weights used for the component metrics in BiG-SCAPE are optimised using avail-
able, validated data sets, they are nevertheless only based on a limited selection of component
metrics. Further development of metrics on the space of BGCs represents a promising av-
enue of inquiry with repercussions for the whole field. While the pfam2vec model proposed
in [77] still does not provide granularity beyond the Pfam domain level, vector embedding
models represent a promising avenue of inquiry as BGC similarity metrics, particularly given
their success in text mining tasks [172].
In a similar vein, the choice of kernels on the space of MS2 spectra is still an open question.
In particular, after filtering — which is usually done either based on intensity or predicted
fragmention tree — current similarity functions treat all peaks in the MS2 spectra as equally
informative in deciding similarity, while in fact, some m/z values are ubiquitous and should
therefore arguably be downweighted.
While Brouard and co-workers achieved their best IOKR performance using a weighted com-
bination of kernels using MKA [113, 152, 166], the recently-proposed spec2vec algorithm
[173] has demonstrated promising results in initial tests with IOKR. MS2DeepScore [174]
has also demonstrated good performance predicting similarity of spectra, but remains to be
tested in combination with IOKR.
Both of the latter algorithms take into account how informative each m/z peak is likely to be
when computing the similarity between two spectra.
As the results on microbial data sets presented in this thesis are based on classical molecular
networking, the choice of similarity function on the space of MS2 spectra might influence
the clustering of spectra into MFs, and thus influence both the IOKR score and the strain
correlation score.
Finally, the choice of molecular fingerprints influences the IOKR model. By their design,
molecular fingerprints abstract a complete description of a molecule into structural features
of the molecule. Designing molecular fingerprints to target chemical substructures or proper-
ties particular to microbial specialised metabolites, such as discussed in [175], can potentially
increase the power of the IOKR models.
7.2.3 Clustering
A major step in the preprocessing of information for metabologenomics is clustering, both
BGCs into GCFs and spectra into MFs. Both are active and rapidly developing research
areas. This is particularly true for BGC clustering, where the recent creation of BiG-SCAPE
and BiG-SLICE lays the groundwork for further rigorous experimentation with BGC clus-
tering.
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As mentioned in Section 3.2, data to verify these approaches is hard to come by and has until
now been poorly standardised. To quantify their performance, BiG-SCAPE [82] and BiG-
SLICE [90] are tested on a set of known BGCs where a number of clusters are pre-defined.
Furthermore, BiG-SCAPE is tested on a microbial data set using the (non-standardised)
strain correlation scoring, to demonstrate the presence of validated links in the upper end
of the distribution of scores.
The performance of the clustering in both domains, BGCs and spectra, depends on two
factors: the similarity function and the clustering algorithm. With multiple viable options to
define similarities on both BGCs and spectra (including the metrics defined by BiG-SCAPE
[82] and BiG-SLICE [90] as well as pfam2vec [86] for BGCs, and including PPKr [151],
cosine similarity, modified cosine similarity [58], spec2vec [173] and MS2DeepScore [174]
for MS2 spectra) the choice of metric on either space may need to take into account not
only the correspondence with the similarity between metabolites, but also the metric being
used on the other space. For instance, the metric defined on the space of BGCs may exhibit
some properties which make it more compatible with a particular metric on the space of MS2
spectra, even if other metrics on that space show closer correspondence with the similarity
metric defined on the space of metabolites.
After defining the similarity metric, a wide variety of clustering algorithms exists to choose
between, depending on the properties of the data [176]. The choice of clustering algorithm
depends to a large extent on the properties of the data set, but arguably the choice of pa-
rameters for the algorithms is just as important [176]. All of the clustering tools mentioned
above use different clustering algorithms, with different levels of parameter tuning, both in-
ternally and user-provided. It is highly likely that further research in this area will benefit all
downstream data analysis.
Other approaches to the task than traditional clustering may also be viable. For instance,
using antiSMASH to create GCFs from MIBiG entries using KCB allows the same BGC to
belong to more than one GCF. Approaches such as mixture models may work to assign BGCs
to GCFs in a more flexible way than by clustering, where the association is probabilistic
rather than absolute.
7.2.4 Structure predictions for BGCs
In Section 5.10, antiSMASH-assigned MIBiG IDs were used to assign molecular structures
to the BGCs for use with IOKR. However, antiSMASH [73] and the recently-released version
4 of PRISM [102] make structural predictions for some of the metabolites encoded by the
predicted BGCs. As the methods presented here are considered in relation to BGC clustering,
and PRISM 4 has not yet been integrated with BiG-SCAPE or other BGC clustering tools,
the structural predictions provided by PRISM are not evaluated in this thesis.
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While attempts were made to use generate fingerprint vectors from the molecular structures
predicted by antiSMASH, the initial results were not promising. As predicting molecular
structure is a difficult problem, many of the predictions were for molecular substructures and
not entire molecules. Since many molecular fingerprints represent the presence or absence
of particular substructures, building such fingerprints from partial structures is difficult, as
the absence of a feature from the predicted substructure does not necessarily translate into
the absence of the feature from the entire molecule. Reflecting this, CDK, which was used
to create the molecular fingerprints, does not handle such partial predictions.
While PRISM 4 has been demonstrated to offer a greater number of structure predictions
than antiSMASH, it still only predicts structures in about a quarter of the cases [102], and
their applicability to linking approaches remains to be evaluated.
7.2.5 Joint IOKR model
As demonstrated in section 5.12, two individually-trained IOKR models can be combined
to score BGC-spectrum links. Each model learns a mapping from the set of BGCs or MS2
spectra into the space of molecular fingerprints. However, these learned mappings may not
necessarily be optimal with respect to the shared latent space, i.e. the approximations that
one model makes may be incompatible with the approximations that the other model makes.
Ideally, if θ is the mapping from the space of BGCs to molecular fingerprints, and ψ from
the space of MS2 spectra to molecular fingerprints, and x and y are linked BGC and spec-
trum, respectively, and both in the training data set, then the images θ(x) and ψ(y) should
be particularly close in the space of molecular fingerprints. Since the models are trained
individually, and in particular make their errors independent of one another, this need not be
the case.
To mitigate this problem, the IOKR models can be trained jointly, by incorporating the dis-
tance between the fingerprint vectors for the training samples into the error function and
learning the mappings into the feature space with the constraint that similar metabolites map
to similar points in the fingerprint space.
This complicates the training phase of the model, however, as there is no longer a known
closed-form solution to the optimisation problem. Instead, the objective can be minimised
using gradient descent.
Even so, using IOKR to model BGC-MS2 relations has a fundamental theoretical flaw. Re-
call that the BGC-MIBiG IOKR model learns a function from the space of BGCs to the space
of molecular fingerprints. However, as a single BGC can encode multiple metabolites, this
behaviour cannot in fact be precisely modelled by a function. As the IOKR model assumes
a single output value for any input value, this will inevitably lead to inaccuracies in the out-
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put space for a BGC that encodes multiple metabolites, assuming that the chosen molecular
fingerprints capture the difference between the metabolites.
7.2.6 Combining multiple scores
Combining different scores, or a higher number of scores, represents a clear way forward as
well. While Chapter 6.5 demonstrates the complementarity of strain correlation scoring and
IOKR scoring in particular, other scoring approaches may well complement or outperform
each of those.
Many of the feature-based algorithms discussed in Sections 5.2 and 2.3.1 can be converted
into scoring functions and combined with others, such as Pep2path [97].
Apart from feature-based scoring, algorithms to predict natural product class from MS2 spec-
trum, i.e. if a spectrum belongs to a NRP, RiPP, PK or other class, can be used as a basis
for a scoring function, taking the natural product class prediction from antiSMASH or other
such tools as input for a GCF.
Different ways of combining individual scores represent an open question. As the `p func-
tions are a generalisation of the concept of a sphere, they can easily be extended to any
number of dimensions to accommodate any number of distinct scoring functions. However,
the scoring functions could also be combined in fundamentally different ways. Such com-
binations could for instance include constructing polynomials from the scoring functions.
While this would allow for more nuanced weighing of the individual functions, the choice of
coefficients would create another optimisation problem in turn.
7.3 Summary
Microbial specialised metabolites remain one of the most promising sources of novel antibi-
otics, much needed to counter the spread of AMR. This is supported not only by the historic
record but also by the vast chemical space represented by microbial secondary metabolites,
the scale of which has only recently become apparent.
Furthermore, even though novel antibiotics are discovered, the ease with which microbes
seem to develop resistance to antibiotics guarantees that there will always be a need for new
antibiotics. As microbes develop resistance to current last-line antibiotics, new ones are
needed to take their place. Judicious use of current antibiotics, both in humans and livestock,
and careful management of pharmaceutical waste can delay the development of resistance,
but not prevent it.
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A key step in harnessing the metabolomic potential of microbes is establishing the correspon-
dence between BGCs and the metabolites for which they encode. Increased throughput in
genomic and metabolomic experiments enables statistical- and machine learning approaches
to be brought to bear on problems related to this linking in a more effective and principled
manner than before. As methodological advances in machine learning make it ever easier to
process large amounts of data and detect subtle patterns therein, the application of machine
learning to combined genomic and metabolomic data offers the promise of a paradigm shift




The Salinispora phylogeny tree used in Section 4.5 was created using a local installation of
the autoMLST pipeline [134], commit 231601f, run with default parameters and bootstrap
replicates enabled. The local version is identical to the public web version in that the 50-
genome limit in the public version is not in place.
The key processes for the tree generation are a concatenated alignment using MAAFT for
every gene detected in the provided sequences from a given set of genes, as described in
[134]. Following alignment, the pipeline does automated trimming using trimAL and phy-
logenetic inference with IQtree using gene partitions (for per-gene parameter estimation) to
generate the final tree.
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